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Abstract 
 
N-type calcium channels (CaV2.2) are pseudotetrameric voltage-gated calcium 
channels (VGCCs) predominantly expressed at the presynaptic terminals in the 
peripheral and central nervous system. CaV2.2 channels are highly calcium 
selective and play a crucial role in neurotransmitter release, coupling extracellular 
calcium entry to neurotransmitter exocytosis. The activity of CaV2.2 has multiple 
forms of regulation including: post-translational modifications (PMTs), proteolytic 
degradation and subcellular localisation. In addition, the behaviour of VGCCs is 
modulated by their auxiliary α2δ and β subunits. In this study, I first examine the 
role of proteolytic α2δ processing on CaV2.2. I find that unprocessed α2δ subunits, 
while unable to enhance whole-cell CaV2.2 currents, retain the ability to promote 
cell-surface expression of CaV2.2 in cell lines. Subsequent restoration of α2δ 
processing did not influence the protein expression of α2δ or of coexpressed 
CaV2.2. Thereafter, I examined the properties of CaV2.2 mutants featuring 
substitutions of crucial P-loop glutamate residues within the selectivity filter. I find 
that mutation of these glutamate residues renders these channels deficient in 
trafficking both in non-neuronal cell lines and primary neuronal cultures. These 
data are pertinent given the use of P-loop CaV mutants as dominant negative 
channels in previous studies. Finally, I compare the influence of α2δ-1, α2δ-2 and 
α2δ-3 subtypes on the cell-surface and total expression of CaV2.2. Both cell-surface 
and total expression of CaV2.2 was found to be enhanced by all three subtypes 
albeit to differing degrees. Further investigation reveals that α2δ-1 and α2δ-2 
promote the net forward trafficking of CaV2.2 through Rab11a-dependent recycling. 
CaV2.2 does not appear to participate in Rab11a-dependent recycling when 
expressed in the absence of α2δ or with α2δ-3. This study reveals differential 
regulation of CaV2.2 channels among α2δ subtypes through targeted endosomal 
trafficking.  
6 
 
Impact Statement 
Voltage-gated calcium channels are essential components in a range of biological 
processes such neurotransmission, gene transcription muscle contraction to name 
a few. Given the importance of these channels, it is unsurprising that dysregulation 
of their function is associated with numerous pathologies such as neuropathic pain 
associated with nerve injury. Currently, there are relatively few viable therapeutics 
that treat neuropathic pain, with Gabapentinoid drugs being the most commonly 
used. However, existing therapeutics are noted to have variable efficacy or - in the 
case of Ziconotide - require intrathecal administration and have a narrow 
therapeutic window, necessitating hospital-bound treatment. Of note, Ziconotide is 
a direct inhibitor of N-type calcium channels, while gabapentinoids appear to 
influence N-type channels indirectly by targeting their auxiliary α2δ subunits. In 
order to develop therapeutic options for neuropathic pain with more desirable traits, 
it important to improve our understanding of N-type channels and the mechanisms 
that regulate them. I believe the work presented in this thesis will contribute to the 
field of voltage-gated calcium channel research by examining the interplay 
between N-type voltage-gated calcium channels and their auxiliary subunits. 
Furthermore, it is likely that many of the processes that govern N-type channel 
function are conserved among other voltage-gated calcium channel members, 
giving this work potentially broader application to the field of calcium channel 
research. 
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Chapter 1 Introduction 
1.1 Background 
1.1.1 Resting membrane potential 
The resting membrane potential is determined by the ionic balance between the 
intra and extracellular composition of a cell. The principal ions involved are K+, Na+, 
Ca2+, HCO3- and Cl- with the general intra to extracellular concentrations shown in 
Table 1 below. Each ion has an equilibrium potential at which there is no net 
movement across the plasma membrane. Taken together, these equilibrium 
potentials determine the resting membrane potential which can be calculated using 
the Nernst equation shown below (equation 1). Ions are able to cross the plasma 
membrane through channels, pumps and transporters with the resting potential 
most heavily influenced by K+ which moves passively through leak K+ channels 
which have a reversal potential of around -70mV. The resting potential of a cell 
tends to be negative with regards to the extracellular solution so active transport 
of positively charged ions is required for the gradient to be maintained. Na+/K+ 
pumps are particularly important as they transport two K+ into the cell and three 
Na+ ions out of the cell; this is an active process and requires adenosine 
triphosphate (ATP). 
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Ion Intracellular (mM) Extracellular (mM) 
K+ 140 5 
Na+ 12 145 
Cl- 4 116 
Ca2+ 0.0001 1.8 
Mg2+ 0.8 1.5 
 
 
1.1.2 Ion channels 
Ion channels are intrinsic membrane proteins that allow the movement of ions 
across phospholipid bilayers. Ions can pass through ion channels via a permeation 
pathway through a water-filled pore within the channel. The conductance of ions 
through the channel pore is generally close to the limit of diffusion allowing 
Table 1. Typical ion concentrations for mammalian cells under 
physiological conditions. 
Equation 1. Nernst equation for calculating the electrical potential of a cell 
E = Cell potential under specific conditions (V), E˚= Cell potential under 
standard state conditions, R = ideal gas constant, T = temperature (Kelvin), n = 
number of moles of electrons transferred in balanced equation, F = Faraday 
constant, Qc = reaction quotient, the product of the concentrations of reaction 
products divided by the product of the concentrations of reactants, Ln = natural 
log. 
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extremely fast movement of ions through the permeation pathway. Ion channels 
are often highly selective with rigid constraints on the charge and size of permeant 
ions. Ion channels can exist in both open and closed states and are broadly divided 
into two major classes based on their mechanism of gating between these states. 
These classes are voltage-gated and ligand-gated ion channels. Voltage-gated 
channels respond to changes in local membrane potentials through the movement 
of a voltage-sensing motif, whereas ligand-gated channels possess binding sites 
for specific ligands that induce a conformational rearrangement of the channel.  
 
1.1.3 Action potential 
First measured by Hodgkin and Huxley in the squid giant axon, an action potential 
(AP) is a large plasma membrane depolarisation and repolarisation in excitable 
cells. Work by Hodgkin & Huxley determined the time and voltage-dependence of 
inward Na+ and outward K+ currents in AP generation, while later studies have 
detailed in-depth the coordinated activity of ion channels during each step 
(Hodgkin & Huxley, 1952; Narahashi, 1964). When the membrane potential of an 
excitable cell is sufficiently depolarised, voltage-gated Na+ channels (NaVs) in the 
plasma membrane open allowing an influx of Na+ into the cell along an 
electrochemical gradient. The influx of Na+ further depolarises the membrane 
potential which is capped by the inactivation of NaVs at around +40mV. At this 
depolarised potential voltage-gated K+ channels (KVs) open, allowing efflux of K+ 
down its electrochemical gradient which repolarises the cells. This process initially 
reduces the membrane potential below resting potential, known as 
hyperpolarisation. As the membrane is repolarised, voltage-gated Na+ and K+ 
channels inactivate and remain desensitised. This phase is known as the refractory 
period, during which no new action potentials can be generated. In neurons, the 
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initial depolarisation that elicits an action potential is often caused by the activation 
of post-synaptic ligand-gated ion channels, such as α-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors. 
Plasma membrane depolarisation must reach a threshold potential (approx. -
55mV) to activate NaVs and generate an action potential. The action potential is 
propagated along the axon as the depolarisation activates adjacent NaVs along its 
length to the presynaptic terminal. A general schematic of AP generation is shown 
below (Figure 1.1)  
 
Figure 1.1 The action potential 
At rest, a typical neuron has a membrane potential of ~-70 mV. Electrical 
stimulation of the neurons depolarises the membrane potential. If the 
membrane potential reaches a threshold of ~-55 mV, NaV channels open 
allowing an influx of Na+ which further depolarises the cell to a maximal potential 
of ~+40mV. After reaching the maximal potential, the neuron is rapidly 
depolarised by the inactivation of NaVs and opening of KVs. Repolarisation of 
the neuron overshoots the resting potential (hyperpolarisation). Following this 
is a brief refractory period during which further action potentials cannot be 
generated. 
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1.1.4 Neurons  
In humans, a network of approx. 86 billion neurons comprise the central and 
peripheral nervous systems (Herculano-Houzel, 2009). Neurons are excitable cells 
with a typical resting potential of around -70 mV maintained by a plethora of plasma 
membrane ion channels and transporters (Bean, 2007). Functionally, neurons 
transmit information between one another through coordinated changes in 
membrane potential and chemical signals at the synaptic junctions between 
connected neurons. Neurons are highly specialised cells with a variety of 
adaptations to suit their role as conduits and integrators of information. Neurons 
differentiate to form structurally and functionally distinct compartments: axons, 
dendrites and cell body (soma). Axons are generally long, thin projections and their 
synaptic terminals contain neurotransmitter-laden synaptic vesicles which are 
released in response to changing membrane potential. Dendrites are relatively 
short projections from the soma, becoming thinner with increasing distance from 
the cell body. Dendrites possess neurotransmitter receptors allowing them to 
respond to incoming signals from connected neurons (reviewed in Arimura & 
Kaibuchi, 2007). 
 
1.1.5 Neurotransmission 
By altering the ionic balance of their intra and extracellular environments, cells can 
transmit information between one another. A neuron utilises many 
neurotransmitters and ion channels to transmit information between connected 
neurons, endocrine cells and other targets. In addition, neurons convert this 
information from an electric signal (changing membrane potential) into a chemical 
one. This process occurs at the junctions between connected neurons and 
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synapses. Here, arriving action potentials depolarise the presynaptic terminal 
which allows the entry of extracellular Ca2+ through presynaptic VGCCs. Entrant 
Ca2+ triggers vesicular fusion and exocytosis of neurotransmitters across the 
synaptic cleft to connected post-synaptic membranes (Katz & Miledi.,1965). 
Typically, neurotransmitters are ligands that bind to and activate ion channels or G 
protein-coupled receptors (GPCRs) at the post-synaptic membrane. This can 
either be excitatory or inhibitory depending on the channels involved. Activation of 
post-synaptic cation channels - for example nicotinic acetylcholine (nACh) 
receptors or AMPA receptors - facilitates an influx of positive ions that reduces the 
membrane potential of the post-synaptic neuron. If this depolarisation is sufficient 
to reach a threshold potential, then a new action potential will be generated and 
propagated along the neuron. Conversely, inhibitory ion channels, such as γ-
aminobutyric acid (GABA)A receptors, allow the entry of negatively charged ions 
that hyperpolarise the post-synaptic neuron, moving it further from the activating 
threshold thereby suppressing action potential generation. 
 
1.1.6 Neurotransmitter release 
Fundamental to neurotransmission is the process of neurotransmitter release from 
a presynaptic terminal to a postsynaptic interface. This process occurs at the 
junctions between integrated neurons and converts an electrical signal (changing 
membrane potential) to a chemical one (neurotransmitter release). The events that 
underlie neurotransmitter release are orchestrated to allow extremely fast coupling 
between arriving depolarisation, presynaptic Ca2+ entry and exocytosis of synaptic 
vesicles, which can be achieved within a 1 ms period (see Südhof, 2012 for more 
details). Presynaptic terminals contain an abundance of neurotransmitter-filled 
synaptic vesicles which can be triggered by intracellular Ca2+ to fuse with the 
presynaptic plasma membrane, thereby releasing their contents into the synaptic 
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cleft. The cycle of vesicle fusion events is illustrated below (Figure 1.2) and will be 
described here. Initially a synaptic vesicle is docked to an active zone at the 
presynaptic membrane by the assembly of a “trans-SNARE” complex. The trans-
SNARE complex is formed between the vesicular Soluble NSF Attachment 
REceptor (SNARE) proteins: synaptobrevin (VAMP) and synaptotagmin, with the 
presynaptic membrane SNAREs: syntaxin-1 and Synaptosomal Associated 
Protein 25 (SNAP-25) (Söllner et al,.1993). The Sec1/Munc-like (SM) protein, 
Munc-18-1, binds to the trans-SNARE assembly via an interaction with the N-
peptide of Syntaxin-1 (Dulubova et al., 2007; Hata et al,. 1993). Next, the pre-
fusion complex is joined by complexin, which appears to be essential for Ca2+ 
mediated vesicle fusion. With this assembly, the pre-fusion complex is “super-
primed” and awaits Ca2+ binding to synaptotagmin to trigger fusion-pore opening 
(McMahon et al., 1995). Initial fusion-pore opening involves a progressive zipping 
of the four-helical SNARE complex in an N-C direction (Hanson et al,. 1997). The 
progressive zipping of the trans-SNARE complex forces the vesicular and 
presynaptic membranes in close proximity thereby destabilising these hydrophobic 
surfaces. After fusion-pore opening additional N-ethylmaleimide sensitive fusion 
(NSF) and SNAP proteins join the complex mediating fusion-pore expansion. The 
resulting “cis-SNARE” complex is subsequently disassembled by NSF/SNAP 
ATPases to be recycled for future fusion events (Söllner et al., 1993). 
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Figure 1.2 Schematic of the SNARE/SM protein cycle mediating vesicle 
fusion (modified from Südhof, 2013) 
Assembly of the pre-fusion “trans” SNARE complex sees vesicular SNARE 
proteins, synaptobrevin and synaptotagmin bind the presynaptic SNARES, 
syntaxin-1 and SNAP-25. Following this, the SM protein munc-18-1 and 
complexin join the trans-SNARE complex which is now “super-primed”. The 
super-primed SNARE complex awaits Ca2+ entry through associated VGCCs 
which binds to sites on synaptotagmin to trigger fusion-pore opening. Fusion-
pore expansion is then mediated by arriving NSF and SNAP proteins which join 
the complex. Following complete membrane-fusion, the “cis” SNARE complex 
is disassembled by NSF/SNAP ATPases with the component proteins recycled 
for future fusion events.  
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1.1.8 Organisation of neurotransmitter release machinery 
Fast and coordinated neurotransmitter release in response to presynaptic 
depolarisation requires close association between primed synaptic vesicles and 
CaV channels at the active zone. Tethering of CaVs to docked synaptic vesicles is 
mediated by a multi-protein complex comprised of Rab3-interacting molecule 
(RIM), RIM-binding protein (RIM-BP) and munc13 (Kaeser et al., 2011). RIM is 
able to bind to the Ras-related proteins (Rabs) Rab3 and Rab27 which are 
localised to synaptic vesicles as well as binding to and activating Munc13 (Kaeser 
et al., 2011). In turn, munc13 acts as a priming factor that catalyses the 
conformational switch of syntaxin-1 from a close to open state which promotes 
SNARE complex assembly (Dulubova et al., 2005; Lu et al., 2006). Both RIM and 
RIM-BP bind to CaVs as well as to one another positioning these channels 
generally within 100 nm of docked synaptic vesicles. The importance of RIM and 
RIM-BP to CaV tethering can be seen by deletion of RIM in mice and deletion of 
RIM-BP in Drosophila which both lead to a loss of CaV abundance at the active 
zone and a loss of Ca2+ influx (Kaeser et al., 2011; Liu et al., 2011).  
 
1.2 Voltage-gated calcium channels 
VGCCs are comprised of an α1 subunit – encoded by the CACNA1x genes – which 
contains all the functional machinery of the channel, including the channel pore, 
voltage-sensor and selectivity filter. To date, 10 mammalian isoforms have been 
identified (Fig 1.3) which were initially divided into two major classes: high-voltage 
activated (HVA) CaV1 and CaV2 channels, and low-voltage activated (LVA) CaV3 
channels. Later, these CaV subtypes were categorised based on their susceptibility 
to a range of pharmacological blockers (detailed in table 1.2).  
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Figure 1.3 VGCC subtypes 
The VGCC family contains 10 distinct members which can be broadly divided 
into two major classes, HVA (CaV1s and CaV2s) and LVA (CaV3s). Members of 
the HVA class associate with auxiliary α2δ and β subunits whereas LVA are not 
dependent on auxiliary subunits. Previously used nomenclature is shown in 
brackets. 
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Table 1.2 General characteristics of VGCCs in terms of tissue distribution, 
known pharmacological blockers and principal functions (adapted from 
Catterall 2000) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type Subtype Tissue 
distribution
Pharmacological
blockers
Known functions
L CaV1.1 Skeletal muscle DHPs Excitation-contraction coupling
Ca2+ homeostasis
Gene regulation
CaV1.2 Cardiac muscle
Endocrine cells
Neurons
Excitation-contraction coupling
Ca2+ homeostasis
Gene regulation
CaV1.3 Neurons Hormone secretion
Gene regulation
CaV1.4 Retina Tonic transmitter release
P/Q CaV2.1 Nerve terminals
Dendrites
ω-Agatoxin IVA Neurotransmitter release
Dendritic Ca2+ transients
N CaV2.2 Nerve terminals
Dendrites
ω-Conotoxin GIVA Neurotransmitter release
Dendritic Ca2+ transients
R CaV2.3 Nerve cell bodies
Nerve terminals
Dendrites
SNX-482 Neurotransmitter release
T CaV3.1 Cardiac muscle
Skeletal muscle
Neurons
TTA-A2
TTA-P2
Pacemaking and repetitive AP 
firing
CaV3.2 Cardiac muscle
Neurons
None
CaV3.3 Neurons None
29 
 
1.2.1 Domain structure of VGCCs 
The structure of the α1 subunit is a pseudotetramer having four homologous 
repeating domains, each containing six transmembrane segments (S1-S6) 
arranged in a clockwise orientation from an extracellular view (Catterall, 2011). 
VGCCs are closely related to NaVs and are believed to share a common ancestor 
with bacterial NaVs like NaVAb and NaChBac, sharing many key structural features. 
Much of our understanding of VGCC mechanics has been gleaned from structure-
function studies of bacterial NaVs, with more recent structural information coming 
from direct cryo-electron mycroscopy (cryoEM) studies of CaV1.1 (Ren, 2001; 
Koishi et al., 2004; Wu et al., 2016). A general schematic of a VGCC in complex 
with auxiliary subunits is shown on page 31 (Figure 1.4). 
 
1.2.2 Entering the permeation pathway 
Extended extracellular L5 loops of Domain I, II and III of α1 appear to be stabilised 
by multiple intraloop disulphide bonds, forming a “windowed dome” above the 
selectivity filter (Wu et al., 2016). The L5 loops are enriched with negatively charge 
residues and may constitute the main entrance for Ca2+ ions to the selectivity filter 
(Wu et al., 2016). 
1.2.3 Selectivity filter 
VGCCs possess exquisite ion selectivity, allowing the movement of Ca2+ through 
the channel pore while excluding monovalent cations, despite their far higher 
extracellular concentration (Ellinor et al., 1995; Yang & Tsien, 1993). Ca2+ ion 
selectivity is largely determined by conserved glutamate residues in the pore-
forming S5-S6 loop. Excellent work by Tang et al (2014) and supported by recent 
cryoEM data, suggest there are three consecutive Ca2+ binding sites (site 1-3 from 
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an extracellular view). The conserved glutamates residues form a high affinity Ca2+ 
binding site (site 2) (Tang et al., 2014; Wu et al., 2016). Site 1 and 2 are predicted 
to have high Ca2+ affinity with site 2 thought to mediate divalent cation block. Site 
3 is predicted to be a lower affinity binding site, consistent with a role facilitating 
entry of Ca2+ into the central vestibule. The proximity of these Ca2+ binding sites to 
one another and the electrostatic repulsion of bound Ca2+ ions make it energetically 
unfavourable for Ca2+ to bind adjacent sites simultaneously. Instead, Tang et al 
(2014) propose a mechanism whereby either Sites 1 and 3 (State 1), or Site 2 
alone (State 2) are occupied. In this model, Ca2+ from either side would prompt a 
transition between these two states, with a transition from State 1 to State 2 
expelling a distal Ca2+ ion. This process results in a “knock-on” movement of Ca2+ 
through the selectivity filter and into the central vestibule. 
 
1.2.4 Voltage sensor 
As the name implies, VGCCs respond to changes in local membrane potentials 
through structural rearrangements within the channel that permit or deny Ca2+ 
access to the permeation pathway. In the resting (closed) state, the S6 
transmembrane domains converge at the intracellular side of the channel 
obstructing the permeation pathway, serving as an activation gate. The voltage 
sensor itself is comprised of the S4 units of each domain, which lie parallel to the 
pore domains of the channel. In the resting state, these S4 units sit in a “down 
state”, below the Charge Transfer Centre (CTC). The CTC is formed by negative 
or polar residues as well as a highly conserved hydrophobic residue on S2 (Wu et 
al., 2016). Upon membrane depolarisation, the S4 domains move upwards 
(towards the extracellular side); once each S4 unit is in the “up state” the S6 units 
are able to disengage from the permeation pathway, allowing ion flux through the 
31 
 
channel pore. The S4 units contain numerous positively charged residues, whose 
interactions with negative residues of the CTC facilitate the sequential upward 
movement of the S4 units (Domene et al., 2005; Hering et al., 2018). Upon 
membrane repolarisation, the S4 units return to the down state allowing the S6 
units to re-engage, obstruct the pore and close the channel (Domene et al., 2005; 
Hering et al., 2018).  
 
 
1.2.5 Channel pore 
The pore-forming region of α1 is comprised of segments of the S5 and S6 
transmembrane units from each domain and the re-entrant P-loop between them 
(Wu et al., 2016). Each of the P-loop regions contains highly conserved negative 
residues that cooperate to form a highly selective permeation pathway, permitting 
permeant cations such as Ca2+ and Ba2+. The inner pore is lined by S6 segments 
which form the dihydropyridine (DHP) binding site for DHP-sensitive VGCCs (Wu 
et al., 2016). Interestingly, the N-type specific peptide inhibitor ω-conotoxin GVIA, 
binds with high affinity to a site between the S5 and S6 segments of domain III and 
was initially thought to obstruct the channel pore (Ellinor et al.,1994), however 
more recent work suggests that ω-conotoxin GVIA may in fact modulate channel 
gating properties, acting to destabilise the open state of the channel (Yarotskyy & 
Elmslie, 2010; Yarotskyy et al., 2012). 
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1.3 Regulation of VGCCs  
VGCCs are key mediators for a variety of cellular functions, permitting entry of 
extracellular Ca2+, an extremely potent second messenger. As such, VGCC activity 
is tightly regulated at both translational and post-translational levels, as well as 
through protein-protein interactions with regulatory partners.  In this section, I 
discuss a number of processes though which VGCC function is modulated.  
 
 
Figure 1.4 Schematic of a VGCC in complex with auxiliary α2δ and β 
subunits 
The principal α1 subunit is a pseudotetramer with each domain repeat 
comprised of six transmembrane units (S1-S6) connected by intracellular 
loop regions between these domains. The pore of the channels is formed by 
re-entrant P-loops between S5 and S6 of each domain (shown in red). The 
voltage-sensor is comprised of the S4 segments of each domain (shown in 
green). The β subunit binds to the AID sequence of the domain I-II linker 
(shown in blue) to promote refolding of the loop and channel trafficking. α2δ 
is extracellular and remains anchored to the plasma membrane through a 
GPI-anchor, interacting with extracellular loops of α1 via its VWA domain.   
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1.3.1 GPCR modulation of VGCCs 
The activity of VGCCs is modulated by a range of GPCRs including those activated 
by dopamine, glutamate and opioids. Upon GPCR activation, Guanosine-5'-
triphosphate (GTP)-loading of the Gα subunit induces a conformational shift in the 
heterotrimeric complex resulting in dissociation of Gαβγ into two active signalling 
molecules, Gα-GTP and Gβγ. Gαs-GTP activates adenylate cyclase which 
generates cyclic-adenosine monophosphate (cAMP), a potent second messenger. 
cAMP activates Protein kinase A (PKA) which can in turn phosphorylate VGCCs 
(Arnot et al., 2000; Herlitze et al., 1996). Gβγ has been shown to interact directly 
with both CaV2.1 and CaV2.2 channels, with in-depth structural analysis of CaV2.2 
revealing the presence of a Gβγ-binding pocket comprised of the I-II linker and N-
terminal regions of the α1 subunit (Cantí et al., 1999). The binding of Gβγ to CaV2.2 
appears to stabilise the closed conformation of the channel reflected by a 
depolarising shift in voltage-activation. This form of inhibition can be overcome by 
repeated application of short depolarising pulses and is thereby referred to as 
voltage-dependent inactivation (VDI) (Boland & Bean, 1993). In this instance, 
depolarisation causes a temporary dissociation of Gβγ from the channel, which is 
now unmodulated, prior to re-association of Gβγ and subsequent re-inhibition of 
the channel.  
In addition to regulation by heterotrimeric G proteins, there are numerous 
examples of physical coupling of CaV channels and GPCRs. The first description 
of such a complex was between CaV1.2 and β-adrenergic receptors, followed by 
reports of an interaction between CaV2.1 and metabotropic glutamate receptor 1   
(mGluR1) (Davare et al., 2001; Kitano et al., 2003). Interactions have also been 
reported between CaV2.2 and all four members of the opioid receptor family 
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(Beedle et al., 2004; Altier et al., 2006). Further to this CaV2.2 interacts directly with 
both dopamine (D)1 and D2 receptors, GABAB receptors and melatonin 1 receptors 
(MT1) (Kisilevsky et al., 2008; Laviv et al., 2011; Benleulmi-Chaachoua et al., 
2016). The interaction of CaV2.2 and D1 receptors appears to occur through 
intracellular regions of the D1 receptor and the C-terminus of CaV2.2 (Kisilevsky et 
al., 2008). However, it remains unclear if other reported GPCR-CaV2.2 interactions 
are direct or occur through an intermediate scaffolding protein.  
 
1.3.2 Ca2+-dependent regulation of VGCCs 
Ca2+-dependent regulation offers a means to fine tune VGCC activity, often in the 
form of negative-feedback inhibition that prevents excessive Ca2+ influx following 
channel activation. Ca2+-dependent regulation of VGCCs is mediated by the Ca2+-
sensor, Calmodulin (CaM) (Tadross et al., 2008). CaM interacts with the C-terminal 
IQ-like domain and EF-hand region of α1 subunits, acting as a resident Ca2+-sensor 
for the channel (Kim et al., 2008; Ben-Johny & Yue, 2014). CaM possesses Ca2+ 
binding sites on both its N- and C-lobes, which induce conformational change in 
the C-terminus/CaM complex upon Ca2+ binding. The N- and C-lobe Ca2+-binding 
sites have distinct Ca2+ affinities and impart different forms of channel regulation 
depending on which site is occupied (Ben-Johny & Yue, 2014). The most well 
documented form of CaV-CaM regulation is Ca2+-dependent inactivation (CDI). CDI 
can be observed when comparing current-decay kinetics in the presence of Ca2+ 
or Ba2+, with the speed of current decay drastically increased with Ca2+ present. 
Mechanistically, local increases of Ca2+ at the inner mouth of the channel pore lead 
to Ca2+-CaM binding and conformational changes in the C-terminal/CaM complex 
that inactivate the channel (Ben-Johny and Yue, 2014). Early experiments, 
demonstrated CDI for all CaV1 subtypes, however it was not initially apparent in 
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CaV2 channels (Zamponi, 2003). It has since emerged that CDI of CaV2 channels 
requires a global rise in intracellular Ca2+ as opposed to a local increase for CaV1s. 
Site-directed mutagenesis of the N- and C-lobe Ca2+-binding sites of CaM have 
revealed that differing sensitivity of CaV1s and CaV2s to CDI, is due to the 
differential involvement of the high and low affinity CaM binding sites (Kim et al., 
2008; Mori et al., 2008).  
 
1.3.3 Post-translational modifications of VGCCs 
PTMs are covalent modifications of proteins that occur following biosynthesis. 
PTMs may involve the addition of functional groups such as phosphates, glycans 
or lipid moieties or the removal of existing features i.e. through proteolytic 
processing or phosphatase activity. PTMs play an essential role in regulating 
signalling pathways and may influence the activity of their protein targets or 
subcellular localisation, as well as facilitating or inhibiting protein-protein 
interactions. 
 
1.3.3.1 Phosphorylation of VGCCs 
The addition of phosphate groups to the side chains of residues – most commonly 
serine and threonine – by protein kinases, modulates the function of an abundance 
of proteins including VGCCs. Indeed, all VGCC subtypes are phosphorylation 
targets for prominent kinases such as PKA, Protein Kinase C (PKC) and CaM 
Kinase (CamK) among others. The earliest reported example of VGCC-kinase 
interplay was the PKA-dependent phosphorylation of cardiac CaV1.2 channels 
which produced a sizeable increase in whole-cell current amplitude (Yue et al., 
1990). This form of regulation is believed to be part of the fight-or-flight response, 
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whereby the activity of cardiac and skeletal CaV1.2 and CaV1.1 is enhanced in 
response to noradrenaline release (Catterall, 2013). However, it was a number of 
years before examples of VGCC-kinase regulation could be reproduced in 
heterologous expression systems. The first demonstrated case of VGCC 
phosphorylation in a heterologous expression system required coexpression of the 
15 kDa cAMP-dependent protein kinase anchoring protein (AKAP15) to observe 
CaV1.2 current enhancement (Gao et al., 1997). The involvement of AKAP15 as 
necessary for CaV1.2 phosphorylation revealed greater complexity to VGCC-
kinase regulation than had previously been thought. Ultimately, it has emerged that 
the C-terminus of CaV1.2 contains a cleavage site allowing for proteolytic 
processing of the channel (Fu et al., 2011). The C-terminal processing of CaV1 was 
not initially reproduced in heterologous expression systems leaving an intact C-
terminus which was found to act as an auto-inhibitory domain preventing the 
binding of AKAP15 to a site present in the C-terminal region (Fu et al., 2011). Proof 
of this principle was demonstrated through heterologous expression of truncated 
CaV1.2 lacking the auto-inhibitory C-terminal domain, which was found to have 
increased whole-cell currents and a loss of β-adrenergic sensitivity (Fu et al., 
2011). More recently, a study was carried out using mass spectrometry to identify 
phosphorylated CaV3 residues immunoprecipitated from rat brain tissue as well as 
transfected tsA-201 cells (Blesneac et al., 2015). Such analysis revealed over 30 
basally phosphorylated sites for CaV3.2, many of which were clustered in 
functionally important intracellular residues (Blesneac et al., 2015). It therefore 
seems likely that VGCC phosphorylation constitutes a major component of channel 
regulation. 
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1.3.3.2 Glycosylation of VGCCs 
Glycosylation is a post- or co-translational addition of glycans to a protein and is a 
common feature among extracellular and intrinsic membrane proteins. 
Glycosylation typically occurs in the endoplasmic reticulum (ER) and Golgi network 
with the most common form being N-linked glycosylation. N-linked glycosylation 
targets asparagine residues within an NxS or NST consensus sequence often 
playing a role in protein folding and cell sorting. Based on amino acid sequence 
analysis, canonical N-linked glycosylation sites are present in all ten VGCC 
subtypes (Lazniewska & Weiss, 2017). In CaV3.2, four potential N-glycosylation 
sites have been identified. Mutating two of the four N-linked sites was found to 
reduce cell-surface expression of the channel as well as alter gating properties 
(Orestes et al., 2013). In line with this observation, CaV3 activity is upregulated in 
vivo in hyperglycaemic rodents, but downregulated by the introduction of the 
deglycosylating enzyme neuraminidase (Orestes et al., 2013). Four potential sites 
of N-linked glycosylation are also present in rabbit CaV1.2, two in domain I (N124, 
N299) and two in domain IV (N1359 and N1410). Site-directed mutagenesis of 
these positions individually was not found to influence biophysical properties of the 
channel (Park et al., 2015). However, concurrent N to Q mutations at sites N124 
and N299 did produce a depolarising shift in voltage-dependent activation when 
expressed in Xenopus oocytes (Park et al., 2015). In addition, simultaneous 
mutation of all four N-linked sites in CaV1.2 expressed in Xenopus oocytes leads 
to a substantial decrease in current density correlating with a reduction in cell-
surface expression of the channel (Park et al., 2015).   
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1.3.3.3 Proteolytic processing of VGCCs 
Recent, and somewhat controversial, analysis of CaV1.2 in mice have reported that 
the channel undergoes extensive mid-channel proteolysis in the domain II-III linker 
regions, mediated by the Ca2+-dependent Calpain proteases. The authors suggest 
the presence of activity-dependent feedback inhibition whereby Ca2+ entry through 
CaV1.2 leads to calpain-mediated downregulation of channel activity (Michailidis et 
al., 2014). However, more recent work by Buonarati et al (2017) provides 
compelling evidence that previously reported “mid-channel” proteolysis of CaV1.2 
was due to misidentification of cross-reactive proteins for cleaved α11.2 fragments 
(Buonarati et al., 2017). Systematic analysis of CaV1.2 size forms was carried out 
using region specific antibodies and increasing acrylamide concentrations for 
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) in 
conjunction with analysis of α11.2 KO samples. This analysis supports previous 
observations of distal C-terminal proteolysis, while suggesting that 150 and 90 kDa 
fragments, identified by Michailidis et al (2014) as proteolytically processed α11.2 
fragments, are due to antibody cross-reactivity (Buonarati et al., 2017).  
 
1.3.3.4 Ubiquitination of VGCCs 
Ubiquitination is a process whereby ubiquitin ligases attach single or multiple 
ubiquitin groups to lysine residues of target proteins. The outcome for an 
ubiquitinated protein is variable depending on the type of ubiquitination involved 
(poly versus mono-ubiquitination). CaV1.2 is a known target of the ubiquitin ligase, 
RING finger protein 2 (RFP2), which takes place in the ER and leads to association 
of CaV1.2 with the chaperone proteins P97 and Derlin-1, which results in 
retrotranslocation and proteasomal degradation (Altier et al., 2011). Notably, this 
process is strongly antagonised by coexpression of auxiliary CaVβ subunits. 
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Another example of VGCC-ubiquitin regulation is reported for CaV3.2, which is 
targeted by the cell-surface ubiquitin ligases WWP1 and WWP2 (García-Caballero 
et al., 2014). The CaV3.2 residues targeted for ubiquitination sit upstream of an 
interaction site for the deubiquitinating enzyme Ubiquitin carboxyl-terminal 
hydrolase 5 (USP5). USP5 is known to be upregulated in various chronic pain 
conditions (Garcia-Caballero et al., 2016). 
 
1.4 CaV2.2/N-types 
CaV2.2 channels are encoded by the CACNA2B gene which is widely expressed 
in both the central and peripheral nervous systems. Initial identification of CaV2.2 
currents was based on observed differences in voltage dependence from isolated 
chick Dorsal Root Ganglion neurons (DRGs) (Nowycky et al., 1985). CaV2.2s can 
be further distinguished pharmacologically through their insensitivity to 
dihydropyridines (DHPs) and selective block by ω-conotoxin GVIA. 
 
1.4.1 Role of CaV2.2 
As a VGCC, CaV2.2 mediates extracellular Ca2+ entry in response to membrane 
depolarisation. While entrant Ca2+ can influence a multitude of cellular functions, 
CaV2.2 activity is most commonly associated with fast Ca2+-neurotransmitter 
release coupling at presynaptic terminals. CaV2.2 is localised to presynaptic active 
zones through interactions between the C-terminus of CaV2.2 and PSD95, 
Drosophila disc large tumour suppressor, zonula occludens-1 (PDZ) domain of the 
active zone scaffold, RIM (Kaeser et al., 2011). Upon membrane depolarisation by 
an arriving action potential, presynaptic CaV2.2 channels open prompting an influx 
of extracellular Ca2+ which binds to and activates Synaptotagmin, initiating fusion 
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of primed vesicles and exocytosis of neurotransmitter into the synaptic cleft 
(Südhof, 2012). In the somatodendritic compartments of neurons, CaV2.2 also 
plays a role in excitation-transcription coupling, although this function is 
predominantly mediated by CaV1 channels. In addition, a study by Wheeler et al 
(2012) reported that Ca2+ entry through CaV2 channels is preferentially buffered by 
the ER and Mitochondria relative to CaV1 (Wheeler et al., 2012). Preferential Ca2+ 
buffering in this fashion was suggested to indicate a form of excitation-metabolism 
coupling (Wheeler et al., 2012). Both CaV2.1 and CaV2.2 participate in excitation-
release coupling at presynaptic nerve terminals (Iwasaki et al., 2000). However, 
the relative contribution of these channels is variable between synapses. For 
example, CaV2.2 is the predominant mediator of neurotransmitter release at 
presynaptic DRG terminals (Kerr et al., 1988).  
 
1.4.2 Alternative splicing of CaV2.2 
CaV2.2 is encoded by 46 exons and several alternatively spliced variants have 
been identified which exhibit differential biophysical properties, such as voltage-
dependence of activation, as well as augmented trafficking and tissue distribution. 
For example, the peripheral isoform of CaV2.2 contains an alternative exon 31a 
which inserts a two residue ET sequence into the S3-S4 loop of domain IV, 
resulting in a hyperpolarising shift of voltage activation, thereby reducing channel 
activity (Lin et al.,1997; Lin et al., 1999). Alternative splicing of exon 37 – located 
at the C-terminus of CaV2.2 – has been shown to produce two mutually exclusive 
variants, e37a and e37b. Notably, CaV2.2a has an extremely restricted distribution 
being mainly expressed at nociceptive DRG neurons (Bell et al., 2004; Castiglioni 
et al., 2006). Functionally, CaV2.2 e37a expression is associated with larger whole-
cell currents than e37b. Recently, a study by Macabuag & Dolphin (2015) revealed 
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that canonical binding motifs for the clathrin-associated adaptor protein complex-1 
(AP-1) (Yxxϕ and [DE]xxx[LI]) are present in e37a but absent in e37b (Macabuag 
and Dolphin, 2015). AP-1 is primarily functional at the trans-Golgi network (TGN) 
generating vesicles destined for endosomes although it is also found on sorting 
endosomes suggesting a role in recycling to the plasma membrane. Abolition of 
these AP-1 binding motifs in CaV2.2 e37a severely disrupts channel trafficking to 
the plasma membrane and neurites of DRG neurons (Macabuag and Dolphin, 
2015). 
 
1.5 Auxiliary VGCC subunits  
1.5.1 The α2δ subunit 
There are four mammalian α2δ subtypes, α2δ-1-4, encoded by the genes 
CACNA2D1-4 respectively. Each α2δ subtype is expressed from a single gene with 
the protein product post-translationally cleaved between the α2 and δ domains. 
Heterologous expression of α2δ in Xenopus laevis oocytes or tsA-201 cells 
produces an increase in whole-cell CaV currents between 3-9 fold depending on 
the specific subunit pairing (Felix et al., 1997; Gurnett et al., 1996). There is limited 
evidence that α2δs influence single-channel CaV properties and they are not 
reported to affect these properties for natively or heterologously expressed CaV2.1 
or CaV2.2 (Wakamori et al., 1999). However, α2δ-1 coexpressed with CaV2.2 and 
β1b was reported to reduce single-channel opening times, while also reducing the 
% of null sweeps recorded (Wakamori et al., 1999). It should be noted that low 
levels of endogenous α2δ and β are present in a number of expression systems 
complicating the task of assessing the roles of individual channel subunits. There 
are however several, sometimes contradictory, reports that α2δ subunits can 
influence the voltage-dependence of CaV activation/inactivation. A study by Felix 
42 
 
et al (1997) found α2δ-1 produced a 10 mV hyperpolarising shift in voltage-
dependent activation of CaV1.2/β1b, while another report found α2δ-1 to cause a 
depolarising shift in voltage-dependent activation of CaV2.3 (Felix et al., 1997; Qin 
et al., 1998). Since α2δs appear to have a modest effect on single-channel CaV 
properties, whole-cell CaV current enhancement has generally been attributed to 
increased plasma membrane CaV expression under these conditions. Indeed, α2δs 
have established roles in enhancing plasma membrane CaV expression in 
heterologous systems, as well as increasing the presynaptic and active zone CaV 
population in neurons (Cassidy et al., 2014; Hoppa et al., 2012).    
  
1.5.1.1 α2δ topology and domain structure 
Despite considerable variance in sequence homology, the general topology of all 
α2δ subtypes is believed to be quite similar. All α2δs possess an N-terminal signal 
sequence, notably longer for α2δ-2, which is absent in the cell-surface expressed 
protein (Brodbeck et al., 2002; Douglas et al., 2006). The N-terminal signal 
sequence is co-translationally cleaved with the α2 domain inserted into the lumen 
of the ER, ultimately becoming extracellular. Detailed bioinformatics analysis has 
revealed that all α2δs possess a Von Willebrand Factor A (VWA) domain (Whittaker 
& Hynes, 2004). VWA domains are approximately 200 residues in length and 
present in a number of extracellular proteins such as laminins, collagens and some 
integrins (Humphries, 2000). VWA domains possess a metal ion adhesion site 
(MIDAS) motif that serves to coordinate a divalent cation, usually Ca2+ or Mg2+ 
(Whittaker & Hynes, 2004). VWA domains are generally thought to be involved in 
protein-protein interactions via shared coordination of a divalent cation. A 
functional MIDAS motif contains a 5-residue sequence near the N-terminus of the 
VWA domain which must include DxSxS residues in order to coordinate the 
divalent cation. α2δ-1 and α2δ-2 possess a perfect MIDAS sequence, in which all 
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coordinating residues are present. α2δ-3 and α2δ-4 are not predicted to have a 
perfect MIDAS sequence although the DxSxS sequence is present in both. α2δs 
have four bacterial chemosensory-like (Cache) domains positioned downstream of 
the VWA domain. In bacteria, Cache domains are associated with nutrient sensing 
as well as avoiding harmful substances; however, the role of Cache domains in 
α2δ function remains unclear (Anantharaman & Aravind, 2000; Cheung & 
Hendrickson, 2010).  
 
1.5.1.2 Post-translational modifications of α2δs 
All α2δ subtypes are expressed as a single pre-protein that is post-translationally 
cleaved between its α2 and δ domains. This initially led to the misidentification of α2 
and δ as distinct proteins, however, western blotting of purified α2δ under non-
reducing conditions revealed that these domains remain associated throughout via 
pre-existing disulphide bonds (Jay et al., 1991).  While post-translational cleavage 
has long been established for all α2δ subtypes, the functional role of this processing 
step has remained elusive until recently. One of the first insights into the role of α2δ 
processing was a study by Andrade et al (2007) in which point mutations were 
introduced around the endogenous cleavage site of heterologously expressed α2δ-
1, resulting in a reduction of associated CaV currents (Andrade et al., 2007). More 
recently two studies by the Dolphin lab have shed light on α2δ processing. In these 
studies, the group generated α2δ-1 and α2δ-3 mutants in which the endogenous 
cleavage sequence was substituted for an artificial inducible cleavage sequence 
(Ferron et al., 2018; Kadurin et al., 2016). Heterologous expression of these α2δ 
cleavage mutants in non-neuronal cell lines showed they were unable to enhance 
whole-cell CaV2 currents but retain the ability to enhance CaV plasma membrane 
expression. However, when expressed in primary hippocampal cultures, it was 
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found that unprocessed α2δ lacked the ability to traffic CaV channels to the neurites 
despite being able to do so itself, when expressed independently of other CaV 
subunits (Kadurin et al., 2016). These somewhat surprising results reveal that α2δs 
play a role in both enhancing CaV trafficking and in activation of CaV channels, 
although these roles appear to be only partially related. Furthermore, the inability 
of unprocessed α2δ to facilitate neurite trafficking of CaV2s strongly suggests the 
presence of a neuron specific regulatory step, in which the immature CaVα1:β:α2δ 
complex is unable to exit the soma prior to proteolytic α2δ processing (Kadurin et 
al., 2016). As proof of principle, induced cleavage of these α2δ mutants rescued 
their ability to enhance CaV currents in cell lines and facilitate CaV trafficking in 
neurons. Following their initial study, the Dolphin lab went on to demonstrate that 
stimulus-dependent vesicular release probability and asynchronous release in rat 
hippocampal neurons is inhibited by expression of unprocessed α2δ and rescued 
by induction of α2δ cleavage (Ferron et al., 2018). In addition, CaV2.2 was found to 
co-immunoprecipitate preferentially with cleaved wild-type (WT) α2δ suggesting a 
stronger association between these subunits following α2δ cleavage (Ferron et al., 
2018).  
1.5.1.3 Recent tools to study proteolytic α2δ processing 
As mentioned in section 1.5.1.2, the Dolphin lab developed several non-
cleavable or cleavage-inducible α2δ mutants in order to study this processing 
step. Three such α2δ mutants, termed (V6), (Th) and (3C) were developed with 
their properties relative to WT α2δ described below.  
When expressed in tsA-201 cell lines, the (V6), (Th) and (3C) α2δ mutants are not 
cleaved into α2 and δ polypeptides. Western blotting of (V6), (Th) and (3C) α2δs 
shows the presence of a single 150 kDa band corresponding to the combined 
molecular weight of these polypeptides; this is shown below in data from (Kadurin 
et al., 2016) (Fig 1.5A, B). For α2(Th)δ and α2(3C)δ, cleavage between α2 and δ 
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can be induced by coexpression of Thrombin or 3C-protease respectively, 
producing the expected lower weight band around 125 kDa correlating to the 
cleaved α2 domain (Fig 1.5B). Cell surface biotinylation – shown below for α2(3C)δ-
3 – also confirms that the α2δ mutants can reach the plasma membrane in tsA-201 
cells (Fig 1.5B). Crucially, unprocessed α2δ mutants were shown to be unable to 
enhance whole-cell currents through CaV2.2, unlike their WT counterparts, 
although this effect could be rescued by expression of the relevant protease (Fig 
1.5C).   
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1.5.1.4 Glycosylation of α2δ 
For all α2δ subtypes, there are numerous potential glycosylation sites in both the 
α2 and δ domains. α2δs are likely to be heavily glycosylated based on the observed 
Figure 1.5 Data from Kadurin et al., 2016, western blotting and whole-
cell CaV currents with α2δ cleavage mutants 
(A) Western blot from WCL of WT α2δ-1-HA (lane 1) and α2(V6)δ-1-HA (lane 
2). (B) Western blot of cell-surface biotinylated WT α2δ-3 (lane 1, lane 2) and 
α2(3C)δ-3-HA (lane 3, lane 4) coexpressed with either inactive 3C-protease 
C147V or WT 3C-protease. (C, D) Example traces and mean whole-cell Ba2+ 
currents through CaV2.2 coexpressed with β1b, α2(3C)δ-1 and either  WT 3C-
protease (blue), inactive C137V 3C-protease (cyan) or no protease (black). 
All experiments carried out in tsA-201 cells. This work was carried out by Ivan 
Kadurin and Simon Rothwell. 
C D 
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reduction in molecular weight when treated with deglycosylating enzymes (Kadurin 
et al., 2012). Experimental evidence for the importance of α2δ glycosylation was 
provided in a study by Sandoval et al (2007) in which two sites of N-linked 
glycosylation, N-136 and N-184, in the α2 domain of α2δ-1 were substituted for 
glutamine and heterologously expressed with CaV2.2 and β4 (Sandoval et al., 
2007). The study found that whole-cell Ba2+ currents through CaV2.2 were reduced 
by approx. 45% with mutation of either residue and by approx. 70% with mutation 
of both residues concurrently (Sandoval et al., 2007). The authors note that there 
was little difference in currents between conditions lacking α2δ entirely and those 
expressing N136Q/N184Q α2δ (Sandoval et al., 2007). In addition, Sandoval et al 
(2007) observed significant changes in CaV2.2 current amplitude but minimal 
changes in other channel properties when expressed with N136Q/N184Q α2δ. 
These results are indicative of a reduction in the plasma membrane population of 
CaV2.2, and likely reflect a loss of the trafficking functionality of α2δ-1 (Sandoval et 
al., 2007). One possible interpretation for these results would be that glycosylation 
of α2δ promotes correct folding of the protein and exit from ER, as the study notes 
that WT α2δ-1 appeared to have a faster rate of ER exit than mutant α2δ-1 
(Sandoval et al., 2007). 
 
 
1.5.1.5 α2δ membrane anchoring 
All α2δ subtypes are predicted to have a short intracellular sequence following a C-
terminal hydrophobic stretch that forms a potential transmembrane region (Davies 
et al., 2007). However, the putative intracellular domain for each subtype is likely 
too short to form a transmembrane α-helix and it has since been shown through 
numerous biochemical, immunological and electrophysiological assays that α2δs 
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are highly likely to be membrane-associated through Glycosylphosphatidylinositol 
(GPI) anchoring (Davies et al., 2010). The predicted GPI anchoring motifs, GCC 
and GAS are present in all α2δ subtypes (Fankhauser & Maser, 2005; Davies et 
al., 2010). A previous study into the behaviour of a truncated α2δ-1 construct 
lacking the putative GPI-site found the construct to be predominantly secreted in 
the extracellular medium, strongly suggesting GPI-anchoring to be a principal 
means of membrane association (Kadurin et al., 2012). The study by Kadurin et al 
(2012) also found that some GPI-truncated α2δ-1 remained associated to 
detergent-resistant membrane fractions (DRMs/lipid rafts) presumably bound to as 
yet unidentified binding partners (Kadurin et al., 2012) 
 
1.5.1.6 Tissue and subcellular distribution of α2δs 
α2δ-1 is strongly expressed in skeletal muscle and is a principal associate of 
CaV1.2 in cardiac muscle (Gong et al., 2001; Marais et al., 2001). However 
expression of α2δ-1 is fairly ubiquitous with both messenger ribonucleic acid 
(mRNA) and protein detectable in central and peripheral neurons (Bauer et al., 
2009; Newton et al., 2001). In addition, α2δ-1 mRNA expression is partially 
correlated with excitatory neurons (Cole et al., 2005). α2δ-2 is less widely 
expressed than α2δ-1 but is present in both the human and rodent brain and is 
particularly high in Purkinje cells of the cerebellum as well as in the striatum and 
hippocampus (Hobom et al., 2000). In addition, α2δ-2 mRNA expression in the 
central nervous system was found to partially correlate with GABAergic neurons 
(Cole et al., 2005). α2δ-3 expression in mice is restricted to the brain with 
particularly high expression in the caudate putamen, cerebral cortex and 
hippocampus (Gong et al., 2001; Cole et al., 2005). However, there is wider 
distribution in humans with α2δ-3 detectable throughout the brain as well as in 
skeletal and cardiac muscle. α2δ-4 differs significantly from other α2δ subtypes, 
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having very low expression in the brain. α2δ-4 expression is largely restricted to 
endocrine tissues and the retina (Wycisk et al., 2006). 
Concentration of α2δ in cholesterol-rich DRMs has been reported for both 
heterologous and natively expressed α2δ (Kadurin et al., 2012). The existence of 
DRMs remains controversial but was first proposed by Simons & Ikonen (1997) 
after observing that glycosphingolipid clusters were formed within the exoplasmic 
leaflet of the Golgi membrane, these microdomains appeared to act as sorting 
centres for proteins destined for delivery to the apical plasma membrane in 
epithelial cells (Simons & Ikonen, 1997) 
An interesting possibility is that DRMs serve as a platform to coordinate and 
colocalise functionally related membrane proteins. In line with this concept, α2δ-4 
in the retina has been shown to localise to DRMs (Mercer et al., 2011). Disruption 
of DRMs using cholesterol-depleting agents such as MβCD and COase results in  
increased α2δ-4 plasma membrane movement (Mercer et al., 2011). 
 
1.5.1.7 α2δs in health and disease 
α2δ-1 has a well-established role in the development of neuropathic pain. 
Experimental peripheral nerve injury models have shown increased α2δ-1 mRNA 
in trigeminal and DRG neurons using in situ hybridisation, quantitative-polymerase 
chain reaction (Q-PCR) and microarrays (Newton et al., 2001; Wang et al., 2002). 
Increased α2δ-1 mRNA levels have corresponded to elevated α2δ-1 expression 
using western blotting and immunohistochemical approaches in DRGs and the 
spinal cord (Luo et al., 2001; Bauer et al., 2010). Interestingly, these models do not 
show a change in CaV2.2 expression. However, increased α2δ expression 
correlates well with enhanced neurotransmitter release in hippocampal cultures, 
despite an apparently paradoxical reduction in Ca2+ entry upon presynaptic 
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depolarisation. It has been proposed that α2δ-1 tightens the coupling of Ca2+-
dependent neurotransmitter release, thereby reducing the amount of intracellular 
Ca2+ required to elicit vesicle-fusion events (Hoppa et al., 2012).  
α2δ-1 is the likely therapeutic target of the antiepileptic drugs Gabapentin and 
Pregabalin which are used in the treatment of chronic pain associated with nerve 
injury. While Gabapentinoids bind to both α2δ-1 (Kd = 59nM/L) and α2δ-2 (Kd = 
153nM/L), mutational studies in mice strongly suggest that α2δ-1 is the principal 
therapeutic target (Gee et al., 1996; Field et al., 2006). In these studies, 
Gabapentinoid binding was abolished by mutation of the putative Gabapentin 
binding sites of α2δ-1/2 (R217A in α2δ-1 and R279A in α2δ-2). Pregabalin’s 
therapeutic effect was abolished by mutation of α2δ-1 but unaffected by mutation 
of α2δ-2 (Davies et al., 2006; Hendrich et al., 2008). Mechanistically, 
gabapentinoids reduce the cell-surface expression of α2δ-1 by inhibiting α2δ-1 
recycling from Rab11-positive recycling endosomes (Tran-Van-Minh & Dolphin, 
2010). As α2δ-1 has the well-defined function of enhancing presynaptic expression 
of – and whole-cell currents through – CaVs, the Gabapentin-mediated reduction 
in plasma membrane α2δ-1 expression reduces CaV2.2 activity. 
Studies of α2δ-1 knockout mice, reveal deficits in the behavioural response to 
mechanical and cold stimulus, which corresponds to the action of wide-dynamic 
range neurons. This is believed to be a result of reduced CaV2.2 activity at primary 
sensory afferents in the dorsal horn (Li et al., 2006; Patel et al., 2013). A corollary 
of this data, is the observation that α2δ-1 overexpressing mice show mechanical 
withdrawal thresholds comparable to that of WT nerve-ligated control mice. In 
addition, α2δ-1 null mice have delayed onset of mechanical hypersensitivity 
following nerve injury, suggesting that α2δ-1 activity is highly involved in, but non-
essential to, the onset of chronic hypersensitivity.  
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Mutation of the CACNA2D2 gene, which encodes α2δ-2, is found to occur in mice 
producing a phenotype of spike-wave epilepsy and cerebellar ataxia (Barclay et 
al., 2001). The CACNA2D2 mutation of these “Ducky” (du) mice results in a loss of 
full-length α2δ-2 expression with du/du mice exhibiting reduced Ca2+ currents from 
Purkinje cells (Donato et al., 2006). 
Deletion of the α2δ-3 gene in mice or the fly homolog “Straightjacket” in Drosophila 
has been shown to produce impairments of noxious heat-avoidance which is 
attributed to altered central processing (Neely et al., 2010). In addition, Neely et al 
(2010) reported two intronic α2δ-3 SNPs associated with altered pain perception in 
humans (Neely et al., 2010). 
There are relatively few examples of diseases associated with α2δ mutations in 
humans. However, several missense CACNA2D1 mutations have been identified 
that correlate with congenital arrhythmias (Burashnikov et al., 2010). Two α2δ-1 
mutants identified by Burashnikov et al (2010), D550Y and S709N, were found to 
have decreased cell-surface expression in HEK293T cells, with reduced peak 
currents through associated CaV1.2 channels (Bourdin et al., 2010). A missense 
α2δ-2 mutant, L1040P, was also identified in three siblings, offspring to 
cosanguinous parents, presenting early-onset encephalopathy and global 
developmental delay (Edvardson et al., 2013). α2δ-2 L1040P expression in 
Xenopus laevis oocytes was found to reduce Ba2+ currents through CaV2.2 and 
CaV1.2 currents by 65% and 85% respectively (Edvardson et al 2013).  Truncating 
mutations of the α2δ-4 gene have been found to underlie a disease phenotype 
featuring dysfunctional photoreceptors, night blindness and slowly progressing 
cone cell dystrophy (Dolphin, 2012). In addition, spontaneous mutations have been 
identified in mouse α2δ-4, which produce a similar phenotype to that observed in 
humans. Reported α2δ-4 disease mutations all produce a truncated protein product 
and reduced CaV1.4 activity (Wycisk et al., 2006).   
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1.5.2 The β subunit  
The first β subunit to be cloned was a skeletal muscle isoform termed β1a (Curtis 
& Catterall, 1984). Following this, three further subtypes were identified: β2, β3, β4 
and a neuronal splice variant β1b. Unlike α2δ, the functional role of β is reasonably 
well understood and is predominantly a mediator of correct α1 folding and trafficking 
through intracellular interactions with the main subunit.  
 
1.5.2.1 Domain structure 
β subunits are 50-75 kDa cytosolic proteins with a conserved motif of three core 
domains:  Src Homology domain 3 (SH3). Guanylate kinase domain (GK) and a 
HOOK domain flanked by highly variable N- and C-terminal regions (Elias & Nicoll, 
2007; Funke et al., 2005). SH3 is highly conserved between β subtypes and 
mediates hydrophobic protein-protein interactions via a PxxP site in SH3 and target 
proteins. The GK domain is also highly conserved but does not retain the 
enzymatic function of a nucleotide monophosphate kinase, which can convert ATP 
to guanosine monophosphate (GMP) in order to generate adenosine diphosphate 
(ADP) and GDP; this domain identifies β as a member of the Membrane-
Associated GK protein (MAGUK) family. The GK domain of β subunits are involved 
in a number of protein-protein interactions with RGKs, GTPases and BK channels 
among those shown to interact (For details see Buraei & Yang, 2010). 
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1.5.2.2 Role as an auxiliary subunit of CaVs 
β subunits have a well-defined role as chaperones of CaV1 and CaV2 channels with 
very little cell-surface expression of these channels in the absence of β. β subunits 
interact directly with the proximal part of the domain I-II linker of CaV1 and CaV2 
channels. Specifically, β subunits bind to an 18-residue sequence within the I-II 
linker termed the α-interacting-domain (AID) (Chen et al., 2004). The AID 
sequence has the conserved residues “QQxExxLxGYxxWIxxxE” in CaV1 and CaV2 
channels and these channels interact with all known β subtypes with an affinity 
between 2-52 nM depending on the specific CaV-β pairing (De Waard et al., 1995). 
Mutation of the conserved AID residues dramatically reduces binding which has 
been demonstrated with in vitro binding assays as well as through reductions in β-
mediated CaV current enhancement in heterologous expression systems 
(Campiglio et al., 2013). Mechanistically, the AID sequence of α1 binds to a groove 
in the GK domain of β formed by three hydrophobic regions termed the α-binding 
pocket (ABP), this interaction induces a dramatic change in the secondary 
structure of the I-II linker from a random coil in solution to an α-helix, seen in crystal 
structures (Chen et al., 2004; Opatowsky et al., 2004; Van Petegem et al., 2004). 
Restructuring of the I-II linker is extremely important in allowing CaVs to exit the ER 
although the nature of this regulation appears to differ among CaV subtypes. In the 
case of CaV1.2 for example, the absence of β leads to ubiquitination and 
degradation of the channel (Altier et al., 2011). Similarly, β binding, originally 
thought to hide an ER retention sequence (Bichet et al., 2000), protects CaV2.2 
from polyubiquitination and allows CaV2s to exit the ER (Waithe et al., 2011). 
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1.5.2.3 Role of β subunits in disease 
As β subunits are associated with a number of physiological roles, it is unsurprising 
that mutations and deletions of these genes have deleterious effects in both 
humans and mouse models. Homozygous deletion of β1 and β2 genes in mice are 
lethal (Arikkath & Campbell, 2003; Karunasekara et al., 2009). Homozygous β1-
null mice die shortly after birth due to asphyxiation and exhibit reduced L-type 
currents as well as diminished muscle mass and other structural abnormalities 
(Arikkath & Campbell, 2003; Karunasekara et al., 2009). Interestingly, 
heterozygous β1 deletion appears to be asymptomatic, suggesting that 50% β1 
expression is sufficient for normal function. The lethality of homozygous β1 deletion 
is likely due to the lack of alternative neuronal β subtypes.  
Analysis of genome-wide single nucleotide polymorphisms (SNP) associated with 
psychiatric disorders revealed four loci in the β2 gene CACNB2. In addition, a 
separate genome-wide association study (GWAS) for schizophrenic patients 
revealed 3 loci in CACNB2 (Breitenkamp et al., 2014). These findings are 
consistent with a study by Breitenkamp et al (2014) which found three mutations 
of CACNB2 in patients with Autism spectrum disorder. Further to this, human 
juvenile myoclonic epilepsy is associated with mutations in both coding and non-
coding regions of CACNB4. One such mutation, R482X leads to truncation of the 
final 38 residues of β4. Expression of this truncated β4 with CaV2.1 was found to 
produce alterations in channel gating kinetics which are believed to underlie the 
pathology. Together these data show that β mutations are associated with a 
number of neurological disorders which likely result from a loss of associated 
VGCC activity.     
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1.5.3 γ subunits 
The γ1 subunit was originally identified as a subunit of skeletal CaV1 (Jay et al., 
1990). In skeletal muscle γ1 appears to have a suppressive effect on CaV1 currents 
with γ1 knockout studies showing increased skeletal CaV currents. A further 6 
neuronal γ subtypes have since been identified (γ2- γ7), although there is little 
evidence that these proteins can act as CaV subunits (Klugbauer et al., 2000). γ2- 
γ8 have however been shown to interact, through a PDZ domain, with AMPA 
receptors, hence the term Transmembrane AMPA Receptor Proteins (TARPs) 
(Kato et al., 2007). Previous studies by Moss et al (2002) in which γ7 was cloned, 
and Ferron et al (2008) examined whether γ7 might act as an auxiliary subunit of 
CaVs. γ7 expression was found to abolish expression of CaV2.2 with the study 
suggesting that γ7 does not act as a CaV subunit but instead binds and sequesters 
the RNA binding protein, hnRPR A2, doing so prevents interactions between 
hnRPR A2 and specific mRNA targets (Ferron et al., 2008).  
 
1.6 Rab GTPases guardians of endocytic trafficking  
The Rabs constitute the largest family of small GTPases with 66 distinct members 
of the Rab family expressed in humans (Hutagalung & Novick, 2011). Rabs are 
known as key regulators of intracellular traffic with different Rabs localising to, and 
regulating traffic of, distinct membrane compartments. Typically, Rabs control the 
specificity and directionality of membrane trafficking pathways and are commonly 
associated with vesicle transport. As individual Rabs tend to localise to distinct 
membrane compartments, they confer a membrane “identity” that ensures cargoes 
are transported to the correct destinations (Chavrier et al., 1990; Pfeffer, 2013). 
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1.6.1 How Rabs work 
Similar to other small GTPases, Rabs principally function as molecular switches 
which cycle between a GTP-bound “on state” and GDP-bound “off state”. 
Conformational differences between these GDP and GTP bound states generally 
involves restructuring of 2 regions, Switch I and Switch II, which appear unfolded 
in a GDP-bound state, but adopt well defined helices when GTP-bound that 
interact with effector proteins (Sato et al., 2007; Dong et al., 2007) . 
 
1.6.2 Membrane targeting by Rabs 
Membrane targeting requires C-terminal prenylation (geranylgeranylation) of two 
cysteine residues of each Rab as well as the cognate Rab Guanine Nucleotide 
exchange factor (RabGEF) on the target membrane (Blümer et al., 2013; Pfeffer, 
2013). Upon membrane association RabGEFs catalyse a GDP-GTP exchange, 
activating Rab and allowing it to interact with effectors. Active Rab is subsequently 
packaged into transport vesicles to mediate formation, movement and fusion of a 
vesicle with the target membrane. Having reached the target membrane, Rab 
GTPase activating proteins (RabGAPs) catalyse GTP hydrolysis, inactivating the 
Rab which is subsequently transported back to the donor compartment with the 
assistance of GDP-dissociation inhibitor (GDI) (Soldati et al., 1993; Ullrich et 
al.,1994). 
 
1.6.3 RabGEFs 
The general mechanism of RabGEF activity involves displacing the Switch I region 
of Rabs, disrupting Mg2+ coordination and stabilising of the nucleotide-free form of 
Rab (Li & Marlin, 2015). This process facilitates GDP-GTP exchange in cells in 
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which GTP concentrations are 2 orders higher than GDP (Li & Marlin, 2015). There 
are 5 identified RabGEF families in humans. The principles of RabGEF activity are 
similar between different RabGEF families, however, they share no sequence or 
structural homology to one another in the catalytic domain (Barr & Lambright, 2010; 
Blümer et al., 2013). 
 
1.6.4 RabGAPs 
By contrast to RabGEFs, RabGAPs possess a common Trc-2/Bud2/Cdc16 (TBC) 
domain for catalysis. The TCB domains contain conserved “IxxDxxR” and “YxQ” 
motifs from which Arg and Gln side chains insert into the GTP-binding site of Rab 
and stabilise the transition state for GTP hydrolysis, known as the “dual finger” 
mechanism (Barr & Lambright, 2010). While Rabs do possess innate GTPase 
activity, this process is typically very slow with RabGAPs being required for efficient 
GTP hydrolysis. 
 
1.6.5 Rab mediation of vesicular transport 
GTP-bound “active” Rabs can interact with multiple effectors to facilitate cargo 
selection, vesicle movement along actin/microtubulin filaments and vesicle 
tethering for subsequent fusion events (Hutagalung & Novick, 2011). Rabs may 
interact directly with cargo, for example Rab5 – in the early endocytic pathway – 
binds directly to the α subunit of β1 integrins to promote endocytosis (Pellinen et 
al., 2006). Cargo selection may also be achieved indirectly through Rab effectors 
such as Rab9 which recruits Mannose-6-phosphate receptors into late endocytic 
transport vesicles via the effector tail-interacting protein 47 (TIP47) (Carroll et al., 
2001). Exocytotic and recycling Rabs such as: Rab3, Rab 8, Rab11 and Rab25, 
58 
 
interact with microtubule motor proteins: Myosins, Kinesins and Dyneins to 
promote vesicle transport (Lindsay et al., 2013). Class V myosins for example; 
possess an N-terminal actin-binding motor domain and C-terminal cargo-binding 
globular tail domain (GTD) which can bind to a number of Rabs on post-Golgi 
secretory vesicles and recycling endosomes. Recruitment of motor proteins by 
Rabs can also be indirect, for example Rab11 which can recruit Kinesin I, Kinesin 
II, Dynein light intermediate chain (LIC)1 and Dynein LIC2 via the Rab11 effectors 
FH protein interacting protein (FIP)3 and FIP5 (Horgan et al.,2010). 
 
1.6.6 Additional Rab functions 
While Rab function is typically associated with cargo selection and vesicle 
transport, a number of Rab effectors have defined signalling properties suggesting 
a role for Rabs in these signalling pathways. This can be seen through with the 
Rab5 effectors Adaptor protein, phosphotyrosine interacting with PH domain and 
leucine zipper  (APPL)1 and APPL2 which are localised to early endosomes by 
Rab5 and in turn recruit protein kinase B (AKT) and modulate its target specificity 
for Glycogen synthase kinase (GSK)-β, rather than Tuberosclerosis complex 
(TSC)2 (Miaczynska et al., 2004). 
 
1.6.7 Rabs in disease 
Despite the primacy of Rabs in numerous trafficking pathways, there are relatively 
few pathologies associated with mutations to, or altered expression of, Rab genes. 
This is likely due to a significant degree of redundancy between Rab isoforms. 
Nonetheless, 5 of the 66 human Rab genes (Rab7, Rab23, Rab27, Rab38 and 
Rab39b) are linked with genetic disorders (Li & Marlin, 2015). Among the Rab 
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family, only Rab7 has ubiquitous expression with other Rab members exhibiting 
cell and tissue type specificity. For Rab7, 4 gain-of-function mutations are 
associated with Charcot-Marie-Tooth type 2 (CMT2B) disease, a hereditary motor 
and sensory neuropathy (Verhoeven et al., 2003). All 4 Rab7 mutations increase 
the rate of nucleotide exchange with Rab7 GEFs, thereby promoting the GTP-
bound active form of Rab7 (Spinosa et al., 2008). Interestingly, increased Rab7 
activity is most strongly felt in peripheral neurons, with CMT2B also being a 
neurological disorder, despite the ubiquitous expression of Rab7 (Li & Marlin, 
2015). This could reflect a lack of redundancy in peripheral neurons for Rab7 
functionality.     
 
 
Figure 1.6 Schematic overview of the endocytic pathway 
Endoplasmic Reticulum (ER), Golgi Network (GN), Synaptic Vesicle (SV), 
Recycling Endosome (RE), Early/Sorting Endosome (EE), Late Endosome 
(LE), Lysosome (LY), Autophagosome (AP). 
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1.7 Aim of thesis 
The principal aim of this thesis is to determine the mechanisms through which 
CaV2.2 trafficking is regulated in terms of the relationship between the principal α1B 
(CaV2.2) subunit and associated α2δ and β subunits. In particular, this study will 
examine the trafficking influence of post-translational α2δ processing and the role 
of P-loop glutamate residues in α1B. In addition, this study seeks to evaluate 
whether the previously described ability of α2δ to influence CaV2.2 expression is 
consistent between α2δ subtypes, and the basis for the differences observed.  
The functional importance of proteolytic α2δ processing has been alluded to in 
previous mutational studies (Andrade et al., 2007; Kadurin et al., 2016). Whole-cell 
CaV currents have been shown to be diminished in the presence of unprocessed 
α2δ mutants. However, the mechanistic explanation for this current decrease has 
yet to be established. The present study attempts to address this question by 
examining the behaviour of inducible-cleavage α2δ mutants in cell lines and 
primary neuronal cultures.  
Previous work by Kadurin et al (2016) has strongly suggested the presence of a 
neuron specific mechanism that regulates the trafficking of immature CaV2.2. 
Kadurin et al (2016) considered the possibility that such a mechanism may be 
dependent on the functionality of CaV2.2. The present study will attempt to address 
this question by comparing the trafficking and localisation of wild-type and pore-
mutated CaV2.2 channels in primary neurons and non-neuronal cultures. 
Lastly, the work presented here utilises the exofacially-tagged CaV2.2 developed 
by Cassidy et al (2014) to study the differential effect of α2δ subtypes on CaV2.2 
trafficking and localisation. While α2δ-1 has been demonstrated to reliably increase 
cell-surface CaV2.2 expression, this has yet to be demonstrated for other α2δ 
subtypes. α2δ-1 is an established therapeutic target in the treatment of neuropathic 
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pain. As such, establishing the distinct properties of α2δ subtypes may be important 
in the development of novel α2δ-targeting therapeutics as well as understanding 
the off-target effects of currently used drugs such as gabapentin and pregabalin. 
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Chapter 2 Materials and Methods 
2.1 cDNA constructs 
Table 2.1 Description of all cDNA constructs used in this study   
 
Construct Vector Tag  Species Genbank 
Accession 
number 
Source 
HA - CaV2.2 PCDNA3 2xHA (A566 - 
V567) 
Rabbit D14157 (Cassidy et al., 2014) 
bbs - CaV2.2 PCDNA3 2xBBS (A566 
- V567) 
Rabbit D14157 (Cassidy et al., 2014) 
HA - CaV2.2-
GFP 
PCAGGS GFP- (N 
terminus), 
2xHA (A566 -
V567) 
Rabbit D14157 Subcloned by J. Meyer 
HA - CaV2.2-
EIVA 
PCDNA3 
PCAGGS 
2xHA (A566 - 
V567) 
Rabbit D14157 Developed by W. Pratt 
HA - CaV2.2-
EIVK 
PCDNA3 2xHA (A566 - 
V567) 
Rabbit D14157 Developed by W. Pratt 
HA - CaV2.2-
EI-IVA 
PCDNA3 
PCAGGS 
2xHA (A566 - 
V567) 
Rabbit D14157 Developed by W. Pratt 
CaV2.2 PMT2  Rabbit D14157  
α2δ1- HA PCDNA3 HA (N549 - 
D550) 
Rat M86621 (Davis et al 2006) 
α2δ1 - bbs PCDNA3 BBS (N549 - 
D550) 
Rat M86621  
α2δ1 PCDNA3 
PCAGGS 
PMT2 
 Rat M86621  
α2(3C)δ1 - 
HA 
PCDNA3 
PCAGGS 
HA (N549 - 
D550) 
Rat M86621 Developed by I. 
Kadurin 
α2δ2 - HA PCDNA3 HA (L652 - 
Q653) 
Mouse AF247139  
α2δ3 - HA PCDNA3 HA (K595 - 
R596) 
Mouse AJ010949  
α2δ3 - bbs PCDNA3 BBS (K595 - 
R596) 
Mouse AJ010949 Subcloned by J. Meyer 
α2δ3 PCDNA3 
PCAGGS 
PMT2 
 Mouse AJ010949 Developed by Dolphin 
lab 
β1b PCDNA3 
PMT2 
  X61394 From Dr T.P. Snutch 
Rab11 S25N pCMV  Human AF000231 From Prof. T. Hebert, 
McGill University 
CD8      
mCherry PCAGGS     
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2.2 Primary antibodies used in experiments 
Name Epitope Species Dilution Source 
HA (3F10), 
YPYDVPDYA 
Rat 1:500 Roche 
II-III loop II-III loop CaV Rabbit 1:500 In-house 
(Raghib et al., 
2001) 
GAPDH  Mouse 1:25000 Ambion 
 
2.2.1 Secondary antibodies used in experiments 
Name Species Dilution Conjugate 
Anti rabbit IgG Goat 1:500 AF488, AF594 
Anti rat IgG Goat 1:500 
1:1000 
AF488, AF594, 
Biotin, 
Horseradish 
peroxidase 
Anti Mouse IgG Goat 1:1000 Horseradish 
peroxidase 
α-Biotin  1:100 AF488, 
unlabelled 
Streptavidin  1:500 AF594, AF633 
 
2.3 Cell lines: culture and transfection 
2.3.1 tsA-201 Cells 
tsA-201 cells are a variant of Human Embryonic Kidney cells (HEK293), that have 
been stably transfected with the SV40 large T-antigen, a protein from the Simian 
Vacuolating Virus 40. This antigen promotes the replication of transfected plasmids 
containing a SV40 origin of replication. tsA-201 cells were grown in Dulbecco's 
Modified Eagle Medium (DMEM) (Invitrogen) supplemented with 10% Foetal 
Bovine Serum, 50 U/ml penicillin/streptomycin and 1% GlutaMAX (Invitrogen). 
Cells were maintained in tissue culture flasks at 37°C in a humidified atmosphere 
of 5% CO2 and grown up to 70-90% confluence prior to transfection or further 
passage. 
64 
 
 
2.3.2 N2a cell culture  
Neuro2a (N2a) cells are a fast-growing cell line derived from a mouse 
neuroblastoma. N2as may be differentiated by a number of environmental factors 
to expresses classical neuronal features such a neurofilaments or be used in an 
undifferentiated “non-neuronal” state. In this study, N2as were cultured in 50% 
DMEM (with high glucose and L-glutamine) and 50% OPTI-MEM (with L-
glutamine), supplemented with 50 U/ml penicillin/streptomycin, 5% FBS, and 1% 
GlutaMAX (Life Technologies).  The N2a cells were cultured to 80% confluence in 
a 5% CO2 incubator at 37 °C and passaged every 3 to 4 days. 
 
2.3.3 tsA-201 and N2a cell transfection  
To transiently express recombinant proteins, N2a or tsA-201 cells were transfected 
using either PolyJet™ (SignaGen Laboratories) or Fugene® 6 (Promega) in a 3:1 
ratio with cDNA mix. tsA-201 cells were plated to 30-60% confluence >3 h prior to 
transfection. Typically for a 35mm cell culture dish, 2μg cDNA was mixed in a 100μl 
total with serum-free DMEM, and 6μl PolyJet™ was mixed in a 100μl total volume 
with serum-free DMEM in separate tubes by pipetting; mixing was done by 
additional gentle pipetting. DNA and transfection reagent mixes were then 
combined and incubated for 15 min at room temperature before being added 
dropwise to the cells. Fugene-transfections were used for electrophysiological 
experiments with tsA-201 cells, these followed a similar protocol to Polyjet™, with 
the following changes: DNA and Fugene reagent mixes were incubated for 5 min 
at room temperature before being combined, once combined the mixture was 
incubated for a further 30 min at room temperature before being added dropwise 
to cells. 
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 A typical cDNA mix was 2μg total DNA per 35mm culture dish at a ratio of 3:2:2 = 
CaV2.2: β1b: α2δ. In experiments using Rab11aS25N the cDNA mix was 3:2:2:1 = 
CaV2.2: β1b: α2δ: Rab11aS25N. In conditions lacking a given construct, the DNA 
mix was supplemented with the appropriate empty vector to have the same total 
DNA. 
For fluorescence imaging experiments in either tsA-201 or N2a cells, all constructs 
were expressed in a PCDNA3, PRK5 or CMV vector. In electrophysiological 
experiments using tsA-201 cells, all constructs were expressed in a PMT2 vector, 
with the exception of Rab11aS25N (CMV).  
 
2.3.4 Hippocampal culture and transfection 
Hippocampal neurons were isolated from the hippocampus of P0 rats, which were 
killed under the Schedule 1 procedure. The cerebrum was cut into two, and the 
hippocampi were extracted from each hemisphere in ice cold HBSS with 10 mM 
HEPES.  The hippocampi were then cut into small segments and digested gently 
in Papain solution (7 U/ml Papain, 0.2 mg/ml L-Cysteine, 0.2 mg/ml Bovine Serum 
Albumin (BSA), 5 mg/ml glucose, 10 mM HEPES in HBSS with 200 μl DNase) in 
a shaking water both for 40 min at 37 °C. The cells were washed twice with the 
growth medium (NeuroBasal, 2% B27supplement, 1 unit/ml penicillin, 1 μg/ml 
streptomycin, 1% Glutamax, 0.1% β-mercaptoethanol), and triturated gently. The 
cells were plated onto the coverslips that are coated with poly-L-lysine and laminin 
at 750 cell/μl, 100 μl per coverslip. The entire growth medium was changed after 2 
h of plating, and half of the medium was then changed every 3-4 days.  
Hippocampal neurons were transfected after 7 days in culture. 2 hours prior to 
transfection, the growth medium was replaced with a mixture of 50% conditioned, 
and 50% fresh growth medium. The transfection process was as follows: 4 μg 
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cDNA was mixed in a 50 μl total with OPTI-MEM™ (Thermo Fischer), 2 μl 
Lipofectamine®2000 (Thermo Fischer) was mixed in a 50μl total volume of OPTI-
MEM™ in separate tubes by pipetting; mixing was done by gentle pipetting. DNA 
and transfection reagent mixes were then combined and incubated for 5 min at 
room temperature before being added dropwise to cultures. Hippocampal neurons 
were cultured for a further 7 days after transfection before fixation and 
immunostaining. 
 
2.4 Visualisation of calcium ion channels   
2.4.1 Immunocytochemistry  
Cells were plated onto either coverslips or glass-bottomed dishes (MatTek 
Corporation) which were coated with poly-L-lysine prior to transfection, and 
cultured in a 5% CO2 incubator at 37°C.  After 36-48 h expression, cells were fixed 
with ice cold 4% paraformaldehyde (PFA), 4% sucrose in phosphate-buffered 
saline (PBS), pH 7.4 at room temperature for 5 min. For labelling the HA epitope 
on the cell surface in non-permeabilised conditions, cells were incubated with 
primary antibody with 2% BSA and 10% goat serum in PBS at room temperature 
for 1 h for cell lines or overnight at 4°C for neurons. The secondary antibody was 
added with 2.5% BSA and 10% goat serum in PBS and incubated for 1 h at room 
temperature. Cell nuclei were stained with 0.5 µM 4’,6’-diamidino-2-phenylindole 
(DAPI) in PBS for 10 min. The coverslips were mounted onto glass slides using 
VECTASHIELD® mounting medium (Vector Laboratories). In experiments probing 
for both cell-surface and intracellular HA epitopes, cells were fixed and blocked as 
described above, then immunostained for 1 h incubation anti-HA rat antibody, 1 h 
incubation with anti-rat biotin to mask extracellular HA epitopes. Following this, 
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cells were permeabilised with 0.2% triton-x-100 for 5 min and re-probed with anti-
rat HA antibody 1 h. 
 
2.4.2 Antigen retrieval  
This process serves to improve immunocytochemical (ICC) staining by partially 
denaturing fixed samples as well as breaking some of the covalent bonds created 
by PFA fixation. By doing so, epitopes that may have been masked - by protein-
protein interactions for example - can be exposed for antibody binding.  
In this study, the method used for antigen retrieval was achieved by incubating 
fixed samples in pH 6 citrate buffer at 98˚C for 10 minutes prior to carrying out ICC 
steps. 
 
2.4.3 Forward trafficking assay  
Transfected cells were plated onto 22x22 mm glass coverslips coated with poly-L-
lysine, and cultured in a 5% CO2 incubator at 37°C. After 40 h expression, N2a or 
tsA-201 cells were washed twice with Krebs-Ringer-HEPES (KRH) buffer and 
incubated with 10 μg/ml unlabelled α-bungarotoxin (α-BTX) (Life technologies) for 
30 min at 17°C. The unbound BTX was washed off with KRH, and the cells were 
then incubated with 10 µg/ml BTX-488 in KRH at 37°C. To terminate the reaction, 
cells were washed twice with cold KRH and then fixed with 4% PFA, 4% sucrose 
in PBS at specified times for the kinetic assay. After fixation cells were 
permeabilised and intracellular expression markers and/or nuclei were labelled as 
described above. The 22x22 mm coverslips were mounted onto glass slides using 
VECTASHIELD® mounting medium.  
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2.4.4 Confocal microscopy  
All images were acquired using a LSM 780 Meta scanning confocal microscope 
(Zeiss), equipped with a Plan-Apochromat 63x/1.4 or a Plan-Apochromat 20x/0.8 
M27 objective lens, 16-bit mode. For each experiment, the laser power, gain and 
acquisition settings were kept constant between images that were used for 
quantification, although laser power and gain settings may have been adjusted 
between experiments depending on expression and staining quality of the 
samples. Where possible, the region of interest was determined by identifying cells 
with expression of a transfection marker or intracellular staining of the protein of 
interest (e.g. GFP, CaV2.2 II-III loop staining), without selecting for the cell surface 
immunostaining to avoid bias. In experiments where an appropriate intracellular 
expression marker was absent, nuclei staining with DAPI was used to identify 
viable cells (having an intact nucleus); cell surface measurements were made for 
all viable cells per field of view. In addition, on the LSM 780 confocal microscope, 
the region of interest was selected as described here, and a tile scan of 2x2 or 3x3 
was performed to further remove the bias in selecting cells with high expression. 
For cell surface expression analysis, images were taken with 1 μm optical section 
when using 63x magnification and a 4.5 μm optical section when using 20x 
magnification. Confocal images were imported and analysed in ImageJ (National 
Institutes of Health). The plasma membrane fluorescence was quantified using the 
freehand brush tool with a selection width of 0.66 μm and tracing the membrane 
region manually. Intracellular fluorescence was quantified using the freehand 
selection tool, omitting the signal intensity from the nuclei. The background 
fluorescence in each channel was measured and subtracted from mean cell 
surface or intracellular fluorescence measurements in image analysis.  
For analysis of neurite expression in hippocampal neurons, an average of 10-15 
cells were selected per condition for an individual experiment. Neurons were 
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selected based on expression of free mCherry as a transfection marker. The 
freehand brush tool was used to manually trace neurite lengths 25-60 µm in length 
and 2 µm in width, beginning from a 100 µm distance of the cell soma. Neurites 
were selected and traced using mCherry to avoid bias, measurements then taken 
in channels for expression of HA and/or green fluorescent protein (GFP) tags on 
expressed CaV2.2 constructs. Background fluorescence measurements were 
taken for each condition and subtracted from mean fluorescence values during 
image analysis. Mean neurite signal intensity for each channel was calculated per 
cell in a given condition and normalised to internal controls. Normalised data was 
then pooled between experiments with a minimum of three separate experiments. 
Fluorescence measurements at the neuronal soma were done using the freehand 
brush tool to manually draw and measure around the cell surface with the freehand 
selection tool used to measure intracellular fluorescence excluding the nuclei.  
In cell surface expression and forward trafficking experiments, all cells chosen for 
analysis contained CaV2.2 II-III loop immunostaining, confirming the CaV2.2 α1 
subunit expression.  
For the forward trafficking assay, the membrane fluorescent intensities were fitted 
to the single exponential association equation (Equation 2), where x is time, y is 
intensity, y0 is the initial intensity, A is amplitude, and τ is the time constant.  
      
(Equation 2) 
𝑦 = 𝑦0 + 𝐴(1 − 𝑒 ି௫
ఛ
)  
 
All experiments were repeated n=3 to n=5, and approximately 30 to 50 cells (N2a) 
were analysed for each experiment. All data were presented as pooled in the 
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resulting graphs, except for the trafficking rates and time constants, which are 
averages of separate experiments.    
  
 2.5 Electrophysiology  
tsA-201 cells were transfected with cDNA mix containing CaV2.2, α2δ-1, β1b, and 
CD8 at a ratio of 3:2:2:0.8 using a Fugene transfection protocol. After 40 h 
expression, cells were replated in cell culture medium at 1 in 3 or 5 dilution 
depending on their confluency. Transfected cells were identified by co-expression 
of CD8. CD8 expression was detected with CD8 Dynabeads (Life Technologies).  
Whole-cell currents were recorded in voltage-clamp mode in following solutions; 
intracellular (electrode) solution (mM): 140 Cs-aspartate*, 5 EGTA, 2 MgCl2, 0.1 
CaCl2, 2 K2ATP, 20 HEPES, pH 7.2, 310 mOsm (* 0.5 M stock is made with 6.65 
g L-aspartic acid in 50 ml H2O and 3 M CsOH was added to adjust the pH to 7.2, 
then H2O was added to make up to 100 ml). Extracellular solution (mM): 1 BaCl2, 
3 KCl, 1 NaHCO3, 1 MgCl2, 10 HEPES, 4 D-glucose, 160 tetraethylammonium 
bromide, pH 7.4, 320 mOsm. The borosilicate glass electrode resistance was 
between 1.5 and 4 MΩ. Cell capacitance and series resistance were compensated 
to 60-70 %. Whole-cell currents were recorded on Axopatch-200B amplifier using 
pClamp 9 or 10 (Molecular Devices). The cells were held at -90 mV, and 50 ms 
pulses were applied in +10 mV steps between -50 mV and +50 mV. To correct for 
the leak current, P/8 leak subtraction protocol was applied. Recordings were made 
at 20 kHz sampling frequency and filtered at 5 kHz (lowpass 4-pole Bessel filter) 
in the amplifier. The digital low-pass 8-pole Bessel filter with 1 kHz 3dB cut-off was 
applied in Clampfit 10.7 (Molecular Devices) before the current amplitudes were 
determined. Average peak currents were taken between 8–13 ms after the test 
potentials were applied and normalized to the cell capacitance to obtain current 
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density. Current-voltage (IV) relationships were fitted to a modified Boltzmann 
equation (Equation 3) to give V50 activation (V50, act), conductance (Gmax), and 
reversal potential (Vrev) using OriginPro 2018.     
(equation 3) 
I = ீ௠௔௫(௏ି௏௥௘ )
ଵା௘ 
ష (ೇషೇఱబ ೌ೎೟)
಼
 
 
2.6 Sample numbers  
The number of samples (n) in most of the experiments in this study is the total 
number of individual cells analysed, which are pooled from a minimum of three 
separate experiments unless stated otherwise. Data from individual experiments 
were normalised to their control conditions prior to being pooled to account for 
inter-experimental variance. Mean values and standard error of mean (SEM) were 
calculated for normalised, pooled data. The only exception is for the experiments 
determining the rates of CaV2.2 trafficking, in which the rate of CaV2.2 trafficking 
was determined from each experiment by analysing 20 to 50 cells per data point, 
with the mean and SEM values determined from the repeated experiments.    
  
2.7 Statistical analysis  
Statistical analysis was performed using Student’s t test or one-way ANOVA with 
Bonferroni post-hoc test as appropriate in GraphPad Prism. All the data were 
expressed as mean ± SEM.    
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Chapter 3  
Establishing the role of proteolytic α2δ processing  
3.1. Introduction 
α2δ was first purified from skeletal muscle tissue along with the L-type calcium 
channel (Curtis & Catteral., 1984). This work identified 5 components: α1 (170 
kDa), α2 (150 kDa), δ (17-25 kDa), β (52 kDa) and γ (30 kDa) (Takahashi et al., 
1987). Initially α2 and δ were thought to exist as distinct proteins. However, 
subsequent purification of these subunits under non-reducing conditions 
suggested that α2 and δ remain associated through disulphide bonding. It has since 
been established that all α2δ subtypes are expressed as a single protein that is 
proteolytically cleaved between the α2 and δ domains, which remain associated by 
pre-existing disulphide bonds (Jay et al., 1991; Patel et al., 2003). When purified 
from plasma membrane fractions, endogenously expressed α2δ is found to be 
almost universally cleaved (Kadurin et al., 2012). However, unprocessed “pro-α2δ” 
is observed at the plasma membrane in heterologous overexpression systems 
such as tsA-201 cells (Kadurin et al., 2012, 2016). This result indicates that pro-
α2δ is able localise to the plasma membrane, at least in cell lines. In addition, pro-
α2δ has been shown to accumulate within the cell bodies of DRG neurons from 
spinal nerve ligated rats (Bauer et al., 2009). In both native and heterologous 
systems, significant fractions of pro-α2δ seem only to be found under conditions of 
elevated α2δ expression. This could suggest that sizeable pro-α2δ populations are 
present only when α2δ expression exceeds the capacity of an as-yet-unknown 
protease(s). Consistent with this interpretation, an upregulation of α2δ-1 mRNA and 
protein levels in sensory neurons is observed in a number of peripheral nerve injury 
(Luo et al., 2001; Newton et al., 2001; Bauer, Tran-Van-Minh, et al., 2010). It is 
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also possible that proteolytic α2δ processing activity is reduced in peripheral nerve 
injury models; however, the responsible protease(s) would need to be identified 
before this could be investigated.  
While α2δ processing has long been established, the functional purpose, 
subcellular location of proteolysis and responsible proteases have been poorly 
understood. Seminal work by the Catterall and Campbell groups identified the 
cleavage site of α2δ-1 through peptide sequencing (De Jongh et al., 1990; Jay et 
al., 1991). To study the function of α2δ processing, a number of α2δ mutants were 
developed in our lab in which the residues of the predicted α2δ cleavage site had 
been mutated to prevent endogenous cleavage. The first of these α2(V6)δ-1, 
features a hexavaline substitution in place of the endogenous α2δ-1 cleavage site, 
following unsuccessful attempts to prevent cleavage with more conservative 
mutations. 
In the present study, three α2δ cleavage mutations were used: α2(3C)δ, α2(Th)δ 
and α2(V6)δ, with variants for both α2δ-1 and α2δ-3; these constructs were also 
Haemeglutinin (HA) tagged as described in (Davies et al., 2007). The endogenous 
cleavage sequence of α2δ-1 and α2δ-3 as well the mutations used and key 
structural features of α2δs are shown in (figure 3.1) below:  
 
 
 
 
 
 
 
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
The purpose of this study was to identify the role of proteolytic α2δ processing. 
Since α2δ cleavage mutants do not enhance whole-cell CaV2 currents, I examined 
whether incomplete processing might prevent efficient trafficking of α2δ to the 
plasma membrane or the ability of α2δ to enhance cell-surface CaV2.2 expression. 
To achieve this, I used confocal microscopy to compare the expression level and 
localisation HA-tagged WT and unprocessed α2δ mutants in N2a cells. After this, I 
assessed the ability of processed and unprocessed α2δ variants to enhance cell-
surface and total expression of exofacially-tagged CaV2.2 in both N2a and tsA-201 
cells. 
 
Figure 3.1. Schematic of α2δ structure  
Shows key conserved α2δ structural domains, position of inserted HA-
tag, site of proteolytic processing for α2δ-1 and α2δ-3 and sequences for 
(V6), (Th) and (3C) cleavage mutations, N and C termini are indicated. 
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3.2 Expression and localisation of non-cleavable α2δ 
mutants 
3.2.1 α2(V6)δ-1 shows limited cell-surface expression but high 
intracellular expression relative to WT α2δ-1 
Western blotting analysis has shown that α2(V6)δ-1 can be expressed in tsA-201 
cells and resists proteolytic processing (Chapter 1, Fig 1.5A). Here, I express HA-
tagged α2(V6)δ-1 or α2δ-1 WT in N2a cells with and without additional channel 
subunits. After 48 h expression, cells were fixed and immunostained for cell-
surface and intracellular HA expression prior to confocal imaging and analysis (Fig 
3.2A). When expressed without additional CaV subunits, cell-surface α2(V6)δ-1 
was 62% lower than WT (Fig 3.2B), while intracellular α2(V6)δ-1 expression was 
60% higher than WT (Fig 3.2C). When either HA-tagged WT or (V6) α2δ-1 are 
coexpressed with CaV2.2 and β1b subunits, I observe a reduction in cell-surface 
and intracellular HA signal intensity; cell-surface signal intensity was 65% lower for 
WT and 70% lower for (V6) α2δ-1 (Fig 3.2B), while intracellular signal was reduced 
by 42 and 70% for WT and (V6) respectively (Fig 3.2C).  
When directly compared, α2(V6)δ-1 appears to be far less efficient at either 
trafficking to – or occupying – the plasma membrane than WT α2δ-1 (Fig 3.2A,B). 
Reduced cell membrane α2(V6)δ-1 is unlikely to be a consequence of diminished 
protein expression as α2(V6)δ-1 displayed notably higher intracellular signal than 
WT (Fig 3.2C). These results could suggest that α2(V6)δ-1 is retained intracellularly 
although not subject to extensive proteolytic degradation, which might be expected 
if α2(V6)δ-1 were misfolded. A loss of HA signal intensity was observed for WT and 
(V6) α2δ-1 when expressed with CaV2.2/β1b subunits; this effect has previously 
been reported by Cassidy et al (2014) who provided evidence that protein-protein 
interactions between CaVα1 and α2δ-1 occlude the HA epitope which is positioned 
76 
 
in the α2 domain. It therefore seems likely that the α2 domain of α2(V6)δ-1 retains 
an interaction with the principal α1 subunit.  
It is tempting to consider that α2δ-1 requires proteolytic processing for normal cell-
surface expression. However, this is difficult to verify with α2(V6)δ-1 as it is not 
possible to induce cleavage unlike with α2(Th)δ-1 and α2(3C)δ-1. It should also be 
considered that the introduction of the 6-valine sequence to α2δ-1 could promote 
hydrophobic interactions, potentially making the protein susceptible to 
aggregation. 
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Intracellular 
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Figure 3.2 Cell-surface and intracellular expression of WT and (V6) α2δ-1 
in the presence or absence of CaV2.2 and β1b 
(A) Example confocal images of intracellular (top row) and cell-surface (middle 
row) HA-tagged α2δ-1 WT or α2(V6)δ-1 expressed in N2a cells with either 
CaV2.2/β1b or empty vector PCDNA3 (bottom row). (Scale bar 5µm). (B) 
Normalised mean cell surface fluorescence (bar chart) of α2δ-1 (black, n = 193), 
α2δ-1 + CaV2.2/β1b (black striped, n = 183), α2(V6)δ-1 (red, n = 137), α2 (V6)δ-1 
+ CaV2.2/β1b (red striped, n = 121). (C) Normalised mean intracellular 
fluorescence (bar chart) of α2δ-1 (black), α2δ-1 + CaV2.2/β1b (black striped), 
α2(V6)δ-1 (red), α2 (V6)δ-1 + CaV2.2/β1b (red striped). Data collected from 3 
separate transfections. Data are plotted ± SEM values. Data analysis was 
blinded. Statistical significance was determined using 1-way ANOVA and 
Bonferroni post hoc tests ***p<0.001.  
A 
B C 
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3.2.2 α2(Th)δ-1 shows reduction in cell-surface expression relative to 
WT α2δ-1 
Here I compare the cell-surface and intracellular expression of α2(Th)δ-1 to WT 
α2δ-1 in N2a cells using the same immunocytochemical approach as carried out 
for α2(V6)δ-1. WT α2δ-1-HA or α2(Th)δ-1-HA were transiently expressed in N2a 
cells for 48 h with either empty vector PCDNA3 or CaV2.2 and β1b subunits. After 
this, cells were immunostained for cell-surface HA, intracellular HA and II-III loop 
expression (Fig 3.3A) as described in section 2.4.1 In the absence of CaV2.2 and 
β1b subunits, cell-surface α2(Th)δ-1 expression is 33% lower than α2δ-1 WT (Fig 
3.3B), however there was no statistically significant difference in intracellular HA 
expression between WT and (Th) α2δ-1 (Fig 3.3C). I observe a large reduction in 
cell-surface α2δ-1 signal intensity for both α2δ-1 WT and α2(Th)δ-1 when expressed 
with CaV2.2 and β1b subunits; cell-surface α2δ-1 WT with CaV2.2 and β1b was 
91% lower than when α2δ-1 was expressed alone (Fig 3.3B). Cell-surface α2(Th)δ-
1 with CaV2.2 and β1b was similarly reduced by 89% relative to α2(Th)δ-1 
expressed with empty vector (Fig 3.3B). Interestingly, intracellular α2(Th)δ-1 signal 
intensity was not significantly different whether expressed with empty vector or CaV 
subunits (Fig 3.3C). I do however observe a statistically significant 44% reduction 
in intracellular signal intensity for WT α2δ-1 with CaV2.2 and β1b coexpressed, 
relative to WT α2δ-1 with empty vector (Fig 3.3C). 
As with seen with α2(V6)δ-1, cell-surface α2(Th)δ-1 signal intensity was found to 
be consistently lower than that of WT α2δ-1 (Fig 3.3A), although the 33% difference 
in cell-surface intensity between WT and (Th) α2δ-1 was considerably smaller than 
the 62% disparity between WT and (V6) α2δ-1 (Fig 3.3B). This would suggest that 
that α2(Th)δ-1 is more efficiently trafficked to, or maintained at, the cell-surface 
than α2(V6)δ-1. The reduced cell-surface intensity of α2(Th)δ-1 is unlikely to be a 
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result of diminished total expression as I do not observe a difference between WT 
and (Th) α2δ-1 in this regard.  
As with WT and (V6) α2δ-1, cell-surface α2(Th)δ-1 signal intensity is reduced by 
coexpression of CaV2.2 and β1b subunits (Fig 3.3A), possibly indicating a 
conserved CaV2.2-α2(Th)δ-1 interaction masking the antibody binding epitope. 
However, unlike for WT α2δ-1, I do not observe a decrease in intracellular α2(Th)δ-
1 signal intensity with CaV2.2/β1b coexpression. A possible explanation is that the 
interaction between α2(Th)δ-1 and CaV2.2 is diminished or that there is a change 
in the spatial orientation of the complex in which the HA-tag of α2(Th)δ-1 is not 
occluded by CaV2.2.  As previously mentioned (section 3.1), α2(Th)δ-1 does not 
undergo proteolytic cleavage in the absence of thrombin. During this study it was 
discovered that α2(Th)δ-1, possesses an additional ectopic thrombin cleavage site. 
As such, it was not possible to test the effect of specific α2 and δ-1 cleavage 
through thrombin coexpression or extracellular  application. However, subsequent 
work using an α2(Th)δ-3 construct, which does not possess ectopic thrombin sites, 
reveals that α2(Th)δ-3 cleavage can be induced by application of extracellular 
thrombin. Furthermore, thrombin-cleaved α2(Th)δ-3 is able to enhance whole-cell 
CaV2.2 currents (Kadurin et al, 2016). 
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Figure 3.3 Cell surface and intracellular expression of WT and (Th) α2δ-
1 in the presence or absence of CaV2.2 and β1b 
 (A) Example confocal images of cell-surface (top row) and intracellular 
(middle row) HA-tagged α2δ-1 wild type or α2(Th)δ-1 expressed in N2a cells 
with either CaV2.2/β1b or empty vector PCDNA3 (bottom row). (Scale bar 
5µm). (B) Normalised mean cell surface fluorescence (bar chart) of α2δ-1 
(black, n = 78), α2δ-1 + CaV2.2/β1b (black striped, n = 61), α2(Th)δ-1 (blue, n 
= 59), α2 (Th)δ-1 + CaV2.2/β1b (blue striped, n = 51). (C) Normalised mean 
intracellular fluorescence (bar chart) of α2δ-1 (black), α2δ-1 + CaV2.2/β1b 
(black striped), α2(Th)δ-1 (blue), α2 (Th)δ-1 + CaV2.2/β1b (blue striped). Data 
were collected across 2 separate transfections. Data analysis was blinded. 
Data are plotted ± SEM values. Statistical significance was determined using 
Bonferroni and post hoc tests ***p<0.001, **p<0.01. 
A 
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3.2.3 α2(3C)δ-1 shows partial reduction in cell-surface and intracellular 
expression relative to WT α2δ-1 
Human Rhinovirus (HRV) is a small single stranded virus belonging to the 
picorinviridae family (Palmenberg et al., 2011). HRV encodes three proteases (2A, 
3CD and 3C) which are responsible for processing of viral proteins and have also 
been linked to cleavage of host cell transcription machinery for the purpose of 
shutting down replication of host proteins and leading to upregulation of viral 
transcription and translation (Svitkin et al., 1999). Unlike thrombin, 3C-protease is 
exogenous to mammalian cells and is not predicted to cleave endogenous 
sequences in α2δ. α2(3C)δ-1 and α2(3C)δ-3 express as single unprocessed 
proteins with α2 and δ cleavage inducible by coexpression of 3C-protease (Kadurin 
et al., 2016).  
Using the same confocal microscopy approach described for α2(V6)δ and α2(Th)δ 
(Section 2.4.1), I compared the expression and localisation of WT and (3C) α2δ-1 
in N2a cells in the presence or absence of CaV2.2 and β1b subunits (Fig 3.4A). I 
found that mean cell-surface signal intensity for α2(3C)δ-1 is 28% lower than WT 
α2δ-1 when expressed in the absence of additional channel subunits (Fig 3.4B). 
While statistically significant, this disparity in cell-surface staining between WT and 
(3C) α2δ-1 (28% reduction) is smaller than that observed for α2(V6)δ-1 (62% 
reduction). Intracellular signal intensity for α2(3C)δ-1 was found to be 52% lower 
than for WT α2δ-1 (Fig 3.4C), making it difficult to conclude whether α2(3C)δ-1 has 
proportionally reduced membrane expression or whether the difference observed 
in cell-surface signal is due to lower total expression of α2(3C)δ-1 relative to WT 
α2δ-1. Indeed, as the difference in intracellular signal for WT and (3C) α2δ-1 
appears larger than the difference in cell-surface signal, it may be the case that 
α2(3C)δ-1 has a similar or greater plasma membrane expression compared to WT 
α2δ-1 as a proportion of its total expression in a cell.  
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When expressed with CaV2.2 and β1b subunits, I observe the characteristic loss 
of cell-surface staining for α2(3C)δ-1, which is 78% lower than that for α2(3C)δ-1 
expressed with empty vector (Fig 3.4B); once again the loss of cell-surface signal 
intensity can be attributed to occlusion of the HA-eptiope of α2(3C)δ-1 through its 
interaction with CaV2.2. However, I do not observe a change in intracellular signal 
intensity for α2(3C)δ-1 when expressed with or without CaV subunits (Fig 3.4C), 
despite a 26% reduction in the intracellular signal of WT α2δ-1 when expressed 
with CaV subunits. This result mirrors my observations for α2(Th)δ-1 (Fig 3.3C) and 
may be indicative of an altered intracellular interaction between unprocessed α2δ-
1 mutants and CaV2.2. Furthermore, the lack of change in intracellular signal 
intensity when α2(3C)δ-1 is expressed with CaV2.2 provides good evidence that 
the observed loss of cell-surface α2(3C)δ-1 signal is not due to a decrease in total 
α2(3C)δ-1 expression under these conditions. 
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Figure 3.4 Cell-surface and intracellular expression of WT and (3C) 
α2δ-1 in the presence or absence of CaV2.2 and β1b 
(A) Example confocal images of cell-surface (top row) and intracellular 
(middle row) HA-tagged WT α2δ-1 or α2(3C)δ-1 expressed in N2a cells with 
either CaV2.2/β1b or empty vector PCDNA3 (bottom row). (Scale bar 5µm). 
(B) Normalised mean cell surface fluorescence (bar chart) of α2δ-1 (black, n 
= 197), α2δ-1 + CaV2.2/β1b (black striped, n = 175), α2(3C)δ-1 (green, n = 
204), α2 (3C)δ-1 + CaV2.2/β1b (green striped, n =  193). (C) Normalised mean 
intracellular fluorescence (bar chart) of α2δ-1 (black), α2δ-1 + CaV2.2/β1b 
(black striped), α2(3C)δ-1 (green), α2 (3C)δ-1 + CaV2.2/β1b (green striped). 
Data collected from 3 separate transfections. Data analysis were blinded. 
Data are plotted ± SEM values. Statistical significance was determined using 
1-way ANOVA and Bonferroni and post hoc test ***p<0.001. 
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3.2.4 Induced cleavage of α2(3C)δ-3 does not affect cell-surface or 
intracellular expression 
As demonstrated by Kadurin et al (2016), cleavage of α2(3C)δ-1 and α2(3C)δ-3 can 
be induced by coexpression of 3C-protease, allowing a more direct comparison of 
the role of proteolytic processing on the expression and trafficking of α2δ. The effect 
of induced cleavage on α2(3C)δ-1 was previously examined by Ivan Kadurin of the 
Dolphin lab, and found not to influence total or cell-surface α2(3C)δ-1 expression 
(Kadurin et al., 2016). However, I considered the possibility that induced cleavage 
may differentially influence α2δ subtypes. Here, I investigate whether induced 
cleavage of α2(3C)δ-3 affects cell-surface or total α2(3C)δ-3  levels in cell lines. I 
expressed α2(3C)δ-3 in N2a cells along with empty vector or 3C-protease, then 
used confocal microscopy to compare cell-surface and intracellular expression of 
α2(3C)δ-3 under these conditions (Fig 3.5A). When comparing these conditions, I 
did not find any statistically significant change in either cell-surface signal (Fig 
3.5B) or intracellular signal (Fig 3.5C). The inability of induced cleavage to rescue 
or enhance α2(3C)δ-3 signal intensity suggests that proteolytic processing of α2δ-
3 is not a determinant of trafficking or membrane occupation, at least when α2δ is 
expressed without CaV channel subunits. However, it remains a possibility that 
induced cleavage of α2(3C)δ-3 does not precisely replicate endogenous 
processing of WT α2δ-3. With this caveat in mind, it should be noted that induced 
cleavage of α2(3C)δ-3 has been shown to rescue whole-cell currents through 
CaV2.2, as shown with α2(Th)δ-3 (Kadurin et al, 2016). Together, these results 
imply a trafficking-independent role for α2δ when expressed in non-neuronal cell 
lines.      
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Figure 3.5 Cell-surface and intracellular expression of α2(3C)δ-3  
with and without induced α2δ cleavage. 
(A) Confocal Images showing cell-surface (upper row) and intracellular 
(lower row) α2(3C)δ-3-HA in N2a cells, with empty vector (panel 1) or 
3C-protease (panel 2). Scale bar 5µm. (B) Lack of effect of 3C-protease 
(bar chart) on cell-surface expression of α2(3C)δ-3 (green bar, n = 164) 
or α2(3C)δ-3 with 3C-protease (green, striped bar, n = 187). (C) Lack of 
effect of 3C-protease (Bar chart) on intracellular expression of α2(3C)δ-
3 (green bar) or α2(3C)δ-3 with 3C-protease (green, striped bar). Data 
were collected across 3 separate transfections. Data analysis was 
blinded. Data are plotted ± SEM values. Statistical difference 
determined by Student’s t test, ns = P>0.05. 
A 
B C 
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3.3 The influence of α2δ cleavage on CaV2.2 expression and 
localisation 
3.3.1 Proteolytic processing of α2δ-1 is not required for trafficking of 
the CaV2.2 complex in cell lines.  
To investigate whether α2δ processing was required for enhancing the trafficking 
of the CaV2.2 complex, I transiently expressed exofacially-tagged CaV2.2-bbs and 
β1b in undifferentiated N2a cells and compared cell-surface and total CaV2.2-bbs 
expression when coexpressed with either WT or (3C) α2δ using confocal 
microscopy and image analysis. After 48 h expression, N2a cells were live-labelled 
with α-BTX AF488 to identify the plasma membrane-inserted CaV2.2 population. 
Cells were then fixed, permeabilised and immunostained for the II-III loop epitope 
of CaV2.2, used to measure total CaV2.2 expression (Fig 3.6A). This revealed that 
both WT and (3C) α2δ-1 are able to enhance cell-surface CaV2.2 expression by 
~130% when compared to their expression in the absence of α2δ (Fig 3.6B). In 
addition, expression of CaV2.2, as assessed by II-III loop antibody staining, showed 
an increase of (70%) and (48%) with coexpression of WT or (3C) α2δ-1 respectively 
(Fig 3.6C). Furthermore, no difference was observed in either cell-surface or total 
CaV2.2 expression when coexpressed with HRV3C protease (Fig 3.6D, E, F). 
These data strongly suggest that the function of α2δ-1 as an enhancer of CaV2.2 
expression in cell lines does not require proteolytic processing. 
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Figure 3.6 Cell-surface and total expression of CaV2.2-bbs coexpressed with β1b 
and either WT, (3C) or no α2δ-1 
A 
B C 
D 
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3.3.2 Proteolytic processing of α2δ-3 is not required for trafficking of 
the CaV2.2 complex in N2a cell lines.  
α2δ-3 is topologically similar to α2δ-1, undergoes proteolytic processing, and 
enhances currents through CaV channels in a similar fashion. In this study, I used 
confocal microscopy to examine whether proteolytic α2δ-3 processing influences 
the expression and localisation of CaV2.2-bbs in N2a cell lines using the same 
approach described in (section 3.5). CaV2.2-bbs and β1b subunits were transiently 
expressed in N2a cells along with either α2δ-3 WT, α2(3C)δ-3 or empty vector and 
probed for cell-surface and total CaV2.2 expression (Fig. 3.7A). I find that cell-
surface expression of CaV2.2-bbs is 31% higher when coexpressed with α2δ-3 than 
empty vector (Fig 3.7B). When CaV2.2-bbs was coexpressed with α2(3C)δ-3, I 
observed a small 8% increase in cell-surface CaV2.2 relative to empty vector which 
was not statistically significant (Fig 3.7B). Surprisingly, cell-surface CaV2.2 
expression with α2(3C)δ-3 was not found to be significantly different from CaV2.2 
Figure 3.6 Cell-surface and total expression of CaV2.2-bbs coexpressed 
with β1b and either WT, (3C) or no α2δ-1 
(A) Confocal images of cell-surface CaV2.2-bbs expression with β1b, and empty 
vector (left), WT α2δ-1 (middle) or α2(3C)δ-1 (right) in N2a cells. Top row: cell-
surface CaV2.2-bbs (grey-scale; bottom row: total CaV2.2 (red). Scale bar 5 µm. 
(B) Normalised mean cell-surface CaV2.2-bbs expression (bar chart) with β1b 
and: empty vector (black bar, n = 206), WT α2δ-1 (red bar, n = 191) or α2(3C)δ-
1 (blue bar, n = 181). (C) Normalised mean total CaV2.2-bbs expression (bar 
chart) with β1b and: empty vector (black bar), WT α2δ-1 (red bar) or α2(3C)δ-1 
(blue bar). (D) Confocal images of cell-surface CaV2.2-bbs with β1b, α2(3C)δ-1 
and: empty vector (left panel) or 3C-protease (right panel). Top row: cell-surface 
CaV2.2-bbs (grey-scale), bottom row: total CaV2.2 (red). Scale bar 5µm. (E) 
Lack of effect of 3C-protease (bar chart) on cell-surface expression of CaV2.2-
bbs with β1b, α2(3C)δ-1, and: empty vector (red bar, n = 181) or 3C-protease 
(red striped bar, n = 200). (F) Total CaV2.2-bbs expression with β1b, α2(3C)δ-1 
and: empty vector (red bar) or 3C-protease (red, striped bar). Data were 
collected across 3 separate transfections. Data analysis was blinded. Data are 
plotted ± SEM values. Statistical differences were determined using one-way 
ANOVA and Bonferroni post-hoc test; ***p<0.001. 
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expressed with WT α2δ-3. When comparing total CaV2.2 levels, I found that WT 
and (3C) α2δ-3 coexpression increases II-III loop signal intensity by 47% and 31% 
respectively (Fig 3.7C) with no statistically significant difference between these 
values suggesting that proteolytic α2δ-3 processing does not influence total CaV2.2 
expression in cell lines. Using the same approach, I compared cell-surface and 
total CaV2.2-bbs when expressed with β1b and α2(3C)δ-3 in the presence or 
absence of 3C-protease (Fig 3.7D). However, I found no difference in either cell-
surface (Fig 3.7E) or total (Fig 3.7F) CaV2.2-bbs between these conditions, 
providing further evidence that proteolytic α2δ processing does not play a 
prominent role in the expression or localisation of CaV2.2 in non-neuronal cell lines. 
Interestingly, α2(3C)δ-3 has reduced influence on cell-surface CaV2.2-bbs 
expression relative to WT, but this is not rescued by coexpression of 3C-protease. 
This could mean that the conformation of cleaved α2(3C)δ-3 does not recapitulate 
the WT form, preventing complete rescue of function. From these data alone, it is 
difficult to determine if proteolytic processing is necessary for α2δ-3-mediated 
enhancement of cell-surface CaV2.2 expression. 
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Fig 3.7 Cell surface and total expression of CaV2.2-bbs coexpressed with β1b 
and either WT, (3C) or no α2δ-3 
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3.4. α2(3C)δ-1 retains CaV2.2 trafficking enhancement in tsA-
201 cells under basal and hyperpolarised conditions 
Whole-cell patch clamp recordings in tsA-201 cells have shown that uncleaved 
α2(3C)δ-1 does not enhance currents through CaV2.2 channels, however this is 
partially rescued by coexpression of 3C-protease (Kadurin et al., 2016). In N2a cell 
lines, α2(3C)δ-1 is able to promote CaV2.2 trafficking, however α2(3C)δ-1 is unable 
to facilitate CaV2.2 traffic when expressed in primary hippocampal neurons 
(Kadurin et al., 2016). Here, I sought to determine whether the inability of α2(3C)δ-
1 to enhance CaV2.2 currents in tsA-201 cells might be due to a loss of CaV2.2 
trafficking – as seen in hippocampal neurons – or a loss of function distinct from 
the role of α2δ in CaV trafficking. To do this, I transiently expressed bbs-tagged 
CaV2.2 and β1b in tsA-201 cells with either α2δ-1, α2(3C)δ-1 or empty vector. 
Thereafter, cells were probed for cell-surface and total CaV2.2-bbs (Fig 3.8A) as 
Figure 3.7 Cell surface and total expression of CaV2.2-bbs 
coexpressed with β1b and either WT, (3C) or no α2δ-3 
(A) Confocal images of cell-surface CaV2.2-bbs expression with β1b, and: 
empty vector (left), WT α2δ-3-HA (middle) or α2(3C)δ-3-HA (right) in N2a 
cells. Top row: cell-surface CaV2.2-bbs (grey-scale); bottom row: total 
CaV2.2 (red). Scale bar 5 µm.  (B) Normalised mean cell-surface CaV2.2-
bbs (bar chart) with: empty vector (black bar, n = 188), WT α2δ-3 (green bar, 
n = 164) or α2(3C)δ-3 (magenta bar, n = 181). (C) Normalised mean total 
CaV2.2-bbs (bar chart) with: empty vector (black bar), WT α2δ-3 (green bar) 
or α2(3C)δ-3 (magenta bar). (D) Confocal images of cell-surface CaV2.2-bbs 
with β1b, α2(3C)δ-3 and: empty vector (left panel) or 3C-protease (right 
panel). Top row: cell-surface CaV2.2-bbs (grey-scale), bottom row: total 
CaV2.2 (red). Scale bar 5µm. (E) Lack of effect of 3C-protease (bar chart) 
on cell-surface expression of CaV2.2-bbs with β1b, α2(3C)δ-1, and: empty 
vector (magenta bar, n = 164) or 3C-protease (magenta striped bar, n = 
187). (F) Total CaV2.2-bbs expression with β1b, α2(3C)δ-3 and: empty 
vector (magenta bar bar) or 3C-protease (magenta striped bar). Data were 
collected across 3 separate transfections. Data analysis was blinded. Data  
are plotted ± SEM values. Statistical differences were determined using 
one-way ANOVA and Bonferroni post-hoc test; *p<0.05 
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described (section 3.5). I found that cell-surface CaV2.2-bbs signal intensity is 
higher when coexpressed with either WT α2δ-1 (123%) or α2(3C)δ-1 (62%) relative 
to no α2δ (Fig 3.8B). In addition total CaV2.2 expression was increased by 46% 
with α2δ-1 and 36% with α2(3C)δ-1 compared with no α2δ (Fig 3.8C). These results 
are largely consistent with my observations in N2a cells showing that uncleaved 
α2(3C)δ-1 increases both the total and plasma membrane-inserted population of 
CaV2.2. It should be noted that α2(3C)δ-1 produced a smaller increase in plasma 
membrane CaV2.2 than WT under these conditions, However, as cell-surface 
CaV2.2 expression was 62% higher with α2(3C)δ-1 than no α2δ (Fig 3.8B), the 
complete inability of α2(3C)δ-1 to enhance CaV2.2 currents in tsA-201 cells is 
unlikely to be the result of diminished cell-surface channel expression.  
The resting membrane potential of excitable cells such as pyramidal neurons is 
approximately -70mV, while tsA-201 cells have a typical membrane potential of 
around -20mV (Kadurin et al., 2016). This study considered the possibility that 
membrane hyperpolarisation in neurons might account for the difference in α2δ-
enhanced CaV2.2 plasma membrane expression observed between these cell 
types. To test this, I expressed the two-pore K+ channel, TASK-3, in tsA-201 cells 
along with CaV2.2-bbs, β1b and either α2δ-1, α2(3C)δ-1 or empty vector. TASK-3 
is a constitutively active K+ channel and hyperpolarised the plasma membrane 
when expressed in tsA-201 cells to about -70mV (Kadurin et al, 2016). After 48 h 
expression I again used α-BTX AF488 live-labelling and post-fixation 
immunocytochemistry to identify membrane-inserted and total CaV2.2 in these 
cells which was assessed using confocal microscopy and image analysis (Fig 
3.8D). I found that CaV2.2-bbs plasma membrane expression is increased by 164% 
when coexpressed with WT α2δ-1 and 150% when expressed with α2(3C)δ-1 
relative to no α2δ (Fig 3.8E). Total CaV2.2 was also increased when expressed with 
α2δ-1 (31%) or α2(3C)δ-1 (30%) relative to no α2δ (Fig 3.8F). These data are in line 
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with previous observations in both N2a and non-hyperpolarised tsA-201 cell lines, 
it therefore seems highly unlikely that membrane polarity is a key determinant of 
α2δ-1-mediated CaV trafficking and membrane expression.  
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Fig 3.8. Legend continued on page 94.  
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3.5 Summary 
The aim of this study was to establish the functional consequences of proteolytic 
processing of α2δ on the subcellular localisation of α2δ and the α1 subunit CaV2.2 
in non-neuronal cell lines. This study complemented parallel work carried out in 
primary neuronal cultures to help develop a more complete understanding of the 
role of proteolytic α2δ processing (Kadurin et al., 2016). To achieve this, I first 
characterised the cell-surface and intracellular expression of three α2δ cleavage 
mutants: α2(V6)δ-1-HA, α2(Th)δ-1-HA and α2(3C)δ-1-HA in which the endogenous 
“LEAVEME” cleavage site between α2 and δ was substituted for a non-cleavable 
sequence. Western blot analysis has shown that each of these α2δ cleavage 
mutants express as a single unprocessed band. However, cleavage of α2(Th)δ-3 
and α2(3C)δ-1 can be induced by coexpression of Thrombin or 3C protease 
Figure 3.8 Cell-surface and total expression of CaV2.2-bbs coexpressed 
with β1b and either WT, (3C) or no α2δ-1 in tsA-201s under basal and 
hyperpolarised conditions 
(A) Confocal images of cell-surface CaV2.2-bbs expression with β1b, and: 
empty vector (left), WT α2δ-1-HA (middle) or α2(3C)δ-1-HA (right) in tsA-201 
cells. Top row: cell-surface CaV2.2-bbs (grey-scale); bottom row: total CaV2.2 
(red). Scale bar 10 µm. (B) Normalised mean cell-surface CaV2.2-bbs 
expression (bar chart) in tsA-201 cells with β1b empty vector (black bar, n = 
128), WT α2δ-1 (red bar, n = 120) or α2(3C)δ-1 (blue bar, n = 121). (C) 
Normalised mean total CaV2.2-bbs expression in tsA-201 cells with β1b empty 
vector (black bar), WT α2δ-1 (red bar) or α2(3C)δ-1 (blue bar). (D) Example 
confocal images of cell-surface CaV2.2-bbs expression with β1b, TASK3, and 
empty vector (left), WT α2δ-1-HA (middle) or α2(3C)δ-1-HA (right) in tsA-201 
cells. Top row: CaV2.2-bbs cell-surface staining (grey-scale); bottom row: total 
CaV2.2 (red). Scale bar 5µm (E) Normalised mean cell-surface CaV2.2-bbs 
expression (bar chart) in tsA-201 cells co-expressing TASK3, with empty 
vector (black bar, n = 70), WT α2δ-1 (red bar, n = 73) or α2(3C)δ-1 (blue bar, 
n = 81). (F) Normalised mean total CaV2.2-bbs expression (bar chart) in tsA-
201 cells with β1b empty vector (black, striped bar), WT α2δ-1 (red, striped 
bar) or α2(3C)δ-1 (blue, striped bar).  Data are plotted ± SEM values. Statistical 
significance was determined using one-way ANOVA and Bonferroni post-hoc 
test ***p<0.001, *p<0.05. 
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respectively (Kadurin et al., 2016). I used confocal microscopy to compare the level 
of cell-surface and intracellular α2(V6)δ-1-HA, α2(Th)δ-1-HA and α2(3C)δ-1-HA 
relative to WT α2δ-1-HA expressed in N2a cell lines; each α2δ-1 variant was 
expressed in the presence or absence of CaV2.2 and β1b subunits (Fig 3.2-3.4). I 
found that cell-surface expression relative to WT α2δ-1 is reduced for α2(V6)δ-1 
(62%), α2(Th)δ-1 (33%) and α2(3C)δ-1 (24%) in the absence of additional subunits 
(Fig 3.2B, 3.3B, 3.4B). Coexpression of CaV2.2 and β1b produced a proportional 
reduction in cell-surface signal intensity for both WT and uncleaved α2δ-1 mutants 
typically between 70-90% relative to their signal when expressed independently of 
CaV2.2 (Fig 3.2B, 3.3B, 3.4B). Previous studies have shown the loss of α2δ-HA 
signal with CaV2.2 coexpression to be a consequence of HA epitope occlusion 
resulting from interactions between the α2 domain of α2δ-1 and CaV2.2 (Cassidy et 
al., 2014), my results suggest that such an interaction is conserved in the 
uncleaved α2δ mutants.  
Notably, α2(V6)δ-1 showed a 65% higher intracellular signal intensity than WT 
when expressed without CaV subunits (Fig 3.2C) which, when coupled with 
diminished cell-surface expression, could indicate intracellular α2(V6)δ-1 
aggregation, possibly as a consequence of the large hydrophobic valine sequence 
present. No such effect was observed for α2 (Th)δ-1 or α2(3C)δ-1, with the former 
displaying no difference in intracellular signal from WT (Fig 3.3B) and the latter 
showing a 40% reduction in relative intracellular signal (Fig 3.4B). The effect of 
induced proteolysis on α2δ localisation was assessed by expressing α2(3C)δ-3-HA 
in N2a cells with and without 3C-protease coexpression (Fig 3.5A). However, I 
found no change in either cell-surface or intracellular α2(3C)δ-3 expression when 
coexpressed with 3C-protease (Fig 3.5B, C). Next, I compared the cell-surface and 
total expression of exofacially bbs-tagged CaV2.2 when coexpressed with β1b and 
either WT or (3C) α2δ-1 in N2a cells (Fig 3.6A). WT α2δ-1 increased cell-surface 
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CaV2.2-bbs expression by 136%, while α2(3C)δ-1 coexpression resulted in a 124% 
increase in cell-surface CaV2.2-bbs relative to no α2δ (Fig 3.6B). Total CaV2.2 
levels, measured by expression of the intracellular II-III loop epitope, was 
increased by with both WT α2δ-1 (70%) and α2(3C)δ-1 (47%) (Fig 3.6C) relative to 
no α2δ. In addition, I found no difference in total or cell-surface CaV2.2-bbs when 
expressed with α2(3C)δ-1 and either 3C-protease or empty vector (Fig 3.6E, F). I 
then used the same approach to compare the effect of WT α2δ-3 or α2(3C)δ-3 on 
CaV2.2-bbs (Fig 3.8A). I find that WT α2δ-3 produced a relatively small but 
consistent 31% increase in cell-surface CaV2.2-bbs, while α2 (3C)δ-3 showed only 
a 9% increase that was not statistically different from no α2δ (Fig 3.7B). An increase 
in CaV2.2 II-III loop expression was observed with coexpression of either WT α2δ-
3 (47% increase) or α2(3C)δ-3 (31% increase) (Fig 3.7C). As with α2(3C)δ-1, I saw 
no change in either cell-surface or intracellular CaV2.2-bbs when expressed with 
α2(3C)δ-3 and either 3C-protease or empty vector (Fig 3.7E, F). I next examined 
the effect of α2(3C)δ-1 on CaV2.2-bbs trafficking in tsA-201 to establish whether 
my results in undifferentiated N2a cells were consistent in another non-neuronal 
cell line. Using the same approach as previously described (section 3.2.1), I 
compared cell-surface and total CaV2.2-bbs expression in tsA-201 cells when 
coexpressed with β1b and either WT α2δ-1, α2 (3C)δ-1 or no α2δ (Fig 3.8A). Under 
these conditions, I found that α2(3C)δ-1 enhanced cell-surface CaV2.2-bbs by 
(60%) with WT α2δ-1 producing a (140%) increase relative to no α2δ (Fig 3.8B). 
Total CaV2.2 was increased by both WT and (3C) α2δ-1 by ~30% (Fig 3.8C). tsA-
201 cells have a membrane potential of between -10mV and -30mV while 
hippocampal neurons are typically around -70mV; I tested whether the difference 
in membrane potential could explain discrepancies observed in the trafficking of 
unprocessed α2δ and CaV2.2 between neurons and non-neuronal cell lines 
(Kadurin et al., 2016). To do this, I expressed the constitutively active K+ channel 
TASK3 in tsA-201 cells to hyperpolarise the plasma membrane together with 
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CaV2.2-bbs, β1b and either WT α2δ-1, α2(3C)δ-1 or no α2δ and measured cell-
surface and total CaV2.2 as described previously (section 3.5). Under 
hyperpolarised conditions, I found that both WT and (3C) α2δ-1 produced a ~2.5-
fold increase in cell-surface CaV2.2 and a 30% increase in total CaV2.2 level 
relative to no α2δ (Fig 3.8D, E). I found no difference in the effect of α2δ-1 WT or 
α2(3C)δ-1 on CaV2.2 under hyperpolarised conditions, suggesting that membrane 
polarity is not a determinant of α2δ-mediated CaV2.2 trafficking. 
 
3.6 Discussion 
Proteolytic cleavage between the α2 and δ moieties of α2δ is reported for all known 
subtypes (Annette C. Dolphin, 2012). This form of post-translational processing is 
well established for each α2δ subtype. However, the functional significance of 
proteolytic processing has been difficult to determine, in part due to a failure to 
identify the relevant protease(s) responsible, as well as the subcellular location of 
proteolysis. Previous studies have shown that α2δ-1 in brain and muscle tissue is 
almost entirely in its processed form (Jay et al., 1991; Patel et al., 2003), this is 
also true of cerebellar α2δ-2 (Davies et al., 2006). Incomplete α2δ proteolysis is 
found in heterologous expression systems, although this is primarily for 
intracellular α2δ with very little pro-α2δ at the plasma membrane (Davies et al., 
2010; Kadurin et al., 2012). Native pro-α2δ has also been reported at the cell bodies 
of DRG neurons although these populations are fully processed at the axons 
(Bauer et al., 2009); of particular note is that this axonal α2δ is fully processed in 
intracellular vesicles suggesting that proteolytic processing occurs during or prior 
to trafficking from the cell soma. However, cleavage of the α2(Th)δ-3 mutant can 
be induced by application of external Thrombin with a commensurate increase in 
CaV2 currents demonstrating restoration of function (Kadurin et al., 2016).   
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Mutations to positions around the cleavage site of α2δ-1 were previously shown to 
reduce but not abolish CaV current enhancement (Andrade et al., 2007) suggesting 
a role for α2δ-1 processing therein. It has since been conclusively established that 
α2δ processing is required for CaV2.2 current enhancement from studies using non-
cleavable α2δ mutants (Kadurin et al., 2016). Experiments in heterologous systems 
have variously shown that α2δs increase maximal CaV conductance by 3-10 fold 
(Cantí et al., 2005; Hendrich et al., 2008). This does not appear to be result of 
changes to single channel properties with only a minimal change reported in CaV 
open probability and no change in single channel conductance (Wakamori et al., 
1999). A hyperpolarising shift in voltage-dependent activation of CaV1.2 by α2δ-1 
is reported, this would increase the probability of channel activation in neurons, 
although this shift is far smaller in CaV2.2 and is unlikely to account for the observed 
α2δ-mediated current enhancement (Savalli et al., 2016; Cantí et al., 2005; Kadurin 
et al., 2012). The minimal effect of α2δ on CaV single-channel properties, could lead 
one to conclude that α2δ-mediated current enhancement is a product of increased 
plasma membrane CaV expression, documented in previous reports (Cassidy et 
al., 2014) as well as the present study (Fig 3.4). However, recent studies with non-
cleavable α2δ mutants reveal that they do not amplify CaV currents in cell lines 
(Kadurin et al., 2016) which, coupled to fact that they still amplify CaV surface 
expression (at least for α2δ-1), demonstrates a partitioning of α2δ function between 
enhancement of CaV trafficking and enhancement of CaV currents. To further 
complicate matters, uncleaved α2(3C)δ is unable to facilitate trafficking of CaV2.2 
from the cell body to neuronal processes when expressed in primary neuronal 
cultures, however this can be rescued by induced cleavage with 3C-protease 
(Kadurin et al., 2016). This strongly suggests that additional features - present in 
neurons but absent in non-neuronal cell lines – provide a layer of regulation to the 
CaV trafficking which prevents or severely limits exit of the immature complex from 
the cell body. Surprisingly, CaV2.2 expressed with α2(3C)δ-1 and α2(3C)δ-3 was 
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not found to accumulate in neuronal cell bodies, despite inhibited trafficking to the 
neurites (Kadurin et al., 2016); this could indicate that immature CaV/α2δ 
complexes are routinely degraded in neurons. Interestingly, α2(3C)δ-1 and 
α2(3C)δ-3 were able themselves to traffic to hippocampal neurites when expressed 
independently of additional CaV subunits (Kadurin et al., 2016) which may suggest 
that the conformation of α2(3C)δ in complex with CaV2.2 precludes an interaction(s) 
with relevant trafficking proteins.  
It is tempting to consider that α2δ offers a degree of temporal regulation to CaV 
activity as a means of controlling Ca2+ flux. Ca2+ acts as a second messenger in a 
multitude of cellular processes such as activating transcription factors and Ca2+ 
dependent kinases. The potency of Ca2+ as a second messenger requires that 
intracellular Ca2+ be tightly controlled, with basal cytosolic free Ca2+ generally in 
the nM range in most cells. Higher intracellular Ca2+ concentrations are found in 
the mitochondria and ER which act as Ca2+ buffers in conjunction with a 
preponderance of Ca2+-binding proteins (Solovyova & Verkhratsky, 2002). The ER 
is a principal Ca2+ store, with luminal free [Ca2+] typically between 500µM – 1mM 
under basal conditions (Solovyova & Verkhratsky, 2002). The ER membrane 
potential is mainly determined by a large K+-selective conductance mediated by 
Trimeric Intracellular Cation (TRIC) channels (Garcia & Miller, 1984; Yazawa et al., 
2007). As such, the ER membrane potential is shunted towards the Nernst 
potential of K+ (0mV) since cytosolic and ER luminal [K+] are similar (Somlyo et al., 
1981). As the ER membrane potential is close to 0mV, one might expect nascent 
CaV channels in the ER to be in an open or inactivated conformation which, due to 
the sizeable [Ca2+] gradient between ER and cytosol, should precipitate depletion 
of ER Ca2+ through these open channels, something that has not been reported. 
An interesting possibility, is that pro-α2δ serves to inhibit immature CaV channels 
during these early stages of synthesis with subsequent α2δ processing occurring 
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only once the CaV complex has exited the ER. Consistent with this notion, 
unprocessed α2(3C)δ-1 enhances cell-surface CaV2.2 in heterologous systems 
(Fig 3.6B) but does not enhance CaV2.2 currents over those without α2δ (Kadurin 
et al., 2016). This would strongly suggest that the additional plasma membrane 
CaV population is inactive and indicate an inhibitory role for unprocessed α2δ. 
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Chapter 4. Mutations to Ca2+ binding glutamate 
residues in CaV2.2 pore disrupt channel trafficking  
4.1 Introduction 
Voltage-gated calcium channels are highly Ca2+ selective, allowing exclusive Ca2+ 
permeation despite far higher extracellular concentrations of monovalent cations, 
particularly Na+, under physiological conditions. The high fidelity of VGCC 
permeation is largely determined by a conserved glutamate residue in the pore-
forming loop between S5 and S6 in each domain of CaVα1 (illustrated below, 
Fig.4.1). Seminal work on the L-type channel (α1C), in which these glutamates 
were systematically substituted, revealed that these residues form a high affinity 
Ca2+ binding site and substitution of all four glutamates to glutamine or alanine was 
sufficient to abolish Ca2+ or Cd2+ block of monovalent cation currents (Yang et al., 
1993; Ellinor et al., 1995). More recently, a study using the bacterial voltage-gated 
Na+ channel, (NaVAb) has developed our understanding of the CaV selectivity filter 
(Tang et al., 2014). NaVAb is a homotetrameric channel closely related to 
vertebrate CaVs and possessing similar structural features. The NaVAb selectivity 
filter is comprised of four identical pore motifs “175TLESWSM181” and substitution 
of the underlined residues to aspartate is sufficient to impart Ca2+ selectivity on the 
mutant channel, termed CaVAb (Tang et al., 2014); notably, E177 is positionally 
equivalent to the glutamate residues of mammalian CaV selectivity filters. While 
NaVAb carries an outward Na+ current and is Ca2+-impermeant, CaVAb allows a 
voltage-dependent inward Ca2+ current (Tang et al., 2014). Crystallographic and 
physiological analysis of CaVAb revealed the presence of three sequential Ca2+ 
binding sites, site 1, 2 and 3 from an extracellular to intracellular view.  Site 1 and 
2 coordinate high affinity Ca2+ binding, site 1 is thought to confer Ca2+ selectivity 
while site 2 – the highest Ca2+ binding affinity site – appears to be required for 
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divalent cation block. Site 3 is found to have a lower Ca2+ affinity consistent with a 
role facilitating Ca2+ exit from the selectivity filter into the central cavity (Tang et al., 
2014). The four conserved glutamate residues in the CaV selectivity filter are 
predicted to coordinate site 2 through their side chain carbonyl groups (Tang et al., 
2014; Wu et al., 2016). In the model proposed by Tang et al (2014), the proximity 
of each Ca2+ binding site to one another precludes concurrent Ca2+ occupation of 
all three sites. Instead, only sites 1 and 3 or site 2 may be Ca2+-bound, prompting 
a sequential movement of Ca2+ through the selectivity filter as extracellular Ca2+ 
approaches site 1 (Tang et al., 2014).  
Pore mutants of CaV channels have been used in a number of studies to elucidate 
the effect of non-conducting CaVs on pre and postsynaptic function and have been 
suggested to function as dominant negative mutants (Cao et al., 2004; Cao & 
Tsien., 2010; Krey et al., 2013). However, there has been relatively little direct 
investigation into whether these pore mutants are normally expressed and 
trafficked either in cell lines or a neuronal context. Initial studies of pore mutant L-
types noted the presence of a large outward current in cells expressing these 
constructs, taking this as evidence that the channels are well expressed at the 
plasma membrane (Yang et al., 1993; Ellinor et al., 1995). In addition, some studies 
have used intracellularly-tagged CaV pore mutants in fluorescence imaging 
experiments, defining them as membrane-inserted based on overlapping signal 
peaks with known plasma membrane markers (Cao et al., 2004). This method can 
give false positives as proteins may be in membranes very close to the plasma 
membrane without being inserted, particularly in an overexpression system. In the 
past, our group has argued that labelling of the exofacial surface of CaVs is required 
to reliably quantitate cell surface CaV expression, at least with regards to imaging 
experiments (Cassidy et al., 2014). The ability to distinguish between cell surface 
and intracellular populations is of particular importance when interpreting data from 
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ostensibly non-conducting channels, as diminished currents could be attributed to 
reduced channel conductance, reduced cell surface expression, or a combination 
of these factors.  A previous study by Cao et al (2004) explored the idea that cell-
surface expression of CaV channels at the presynaptic membrane is limited to a 
finite number of channel-preferring slots (Cao et al., 2004). The study found that 
expression of pore-mutated CaV2.1 reduced EPSC generation in primary 
hippocampal neurons, attributing this to competition between non-conducting 
CaV2.1 mutants and endogenous WT CaV2.1 for available presynaptic slots (Cao 
et al., 2004); Cell surface expression of pore-mutated CaV2.1 was assessed by 
measuring the overlap of fluorescence intensity between N-terminally GFP-tagged 
CaV2.1 constructs with the membrane-targeted Lyn tyrosine kinase, concluding 
that cell-surface expression of pore-mutants was not significantly different from WT 
(Cao et al., 2004). As mentioned earlier, this method of assessing cell-surface 
channel expression can be susceptible to inaccuracy as it does not distinguish 
between plasma-membrane inserted channels and intracellular channels in close 
proximity to the plasma membrane. This can be especially problematic when using 
overexpression systems due to the elevated intracellular expression of the given 
protein.  
The Dolphin lab developed a number of exofacially-tagged CaV2.2 and CaV2.1 pore 
mutants, wherein the conserved P-loop glutamate residues were substituted for 
lysine or alanine. The CaV2 pore mutants were developed in order to directly 
address whether such mutants retain the trafficking and localisation characteristics 
of their WT counterparts. The aim of the present study was to identify whether the 
conserved P-loop glutamate residues of CaV2.2 were determinants of trafficking 
and cell surface expression in neurons and non-neuronal cell lines. 
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4.2. Mutation of domain IV P-loop glutamate to lysine ablates 
cell-surface expression of CaV2.2 
In this study, I used an immunocytochemical approach to compare the cell-surface 
expression of an exofacially-HA tagged CaV2.2 pore mutant to WT channels in N2A 
cells (Fig 4.2). N2a cells were transiently transfected with either WT or EIVK CaV2.2 
along with auxiliary α2δ-1 and β1b subunits 48 hours prior to fixation. Fixed cells 
were then probed for cell-surface HA-tag expression under non-permeabilised 
conditions to identify the population of plasma membrane-inserted channels, 
followed by permeabilisation and immunostaining for the intracellular II-III loop 
epitope of CaV2.2; II-III loop staining was used to quantify total CaV2.2 expression 
in cells. Visualisation of the II-III loop suggested that both WT and EIVK CaV2.2 
were well expressed in N2A cells (Fig 4.2A). However, detection of the exofacial 
HA-tag on the cell surface was severely diminished for EIVK relative to WT 
channels (Fig 4.2.A). 
Cell-surface and total CaV2.2 expression was quantified using the ImageJ freehand 
tool (as described, Methods 2.4.4) to manually draw and measure fluorescence 
Figure 4.1 Diagram of CaV2.2-HA in complex with β.  
The position of the exofacial HA tag in Domain II is shown in purple. 
Conserved P-loop glutamate residues of each domain are 
indicated by green arrows. 
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along the perimeter and total area (excluding the nucleus) of cells positive for II-III 
loop expression. Mean cell surface EIVK CaV2.2 expression was reduced by 88% 
relative to WT CaV2.2 (Fig 4.2.B). In contrast, II-III loop staining was more than 2-
fold higher for EIVK relative to the control (Fig 4.2.C) strongly suggesting that 
reduced EIVK membrane expression did not occur through an inability of the pore 
mutant to express in this cell line. From these data it would be difficult to attribute 
reduced whole-cell currents through CaV2.2 EIVK to an inability of the channel to 
permit current rather than a reduction in plasma-membrane expression. Previous 
studies have interpreted P-loop mutant CaV channels as being well expressed at 
the plasma membrane, even suggesting a dominant negative effect due to 
competing with WT channels for position in the presynaptic membrane (Cao et al., 
2004), if other pore-mutants have similarly impaired membrane expression such 
results may require reinterpretation.   
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Figure 4.2 Expression of WT and EIVK pore mutant CaV2.2-HA in N2a cells. 
(A) Confocal images of wild-type (left) and EIVK (right) CaV2.2-HA expressed in N2a 
cells. Cell surface expression using HA Ab in non-permeabilised cells (top row) total 
expression with II-III loop Ab in permeabilised cells (bottom row) (scale bar = 5μm). 
(B) Normalised mean cell-surface CaV2.2 expression of WT CaV2.2-HA with β1b/α2δ-
1 (black; n = 66 cells), CaV2.2-HA EIVK with β1b/α2δ-1 (red; n = 70 cells) (C) 
Normalised mean total expression of CaV2.2 for conditions in panel B. Data were 
collected from 2 separate transfections. Data analysis was blinded. Data are plotted 
± SEM values. Statistical significance was determined using Student’s unpaired t test 
(***p<0.001).  
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4.3. E to A P-loop CaV2.2 mutants show reduced plasma 
membrane expression but retain dependence on α2δ and β 
subunits for cell-surface expression. 
The limited membrane expression of CaV2.2 EIVK (Fig 4.2B) suggests that a 
relatively small mutation in the pore-forming region of the channel can be sufficient 
to disrupt normal trafficking and/or folding. However, the severity of this effect 
makes it difficult to determine whether EIVK retains normal Ca2+ permeation. 
Previous mutational studies of the CaV P-loop glutamates have suggested an 
unequal contribution of these residues to the permeation pathway despite their 
seemingly equivalent positions (Tang et al, 2014). In our lab, a range of CaV2.2 
pore mutants were generated featuring E to A substitutions to different domains. 
Whole-cell current recordings of these mutants revealed that inward Ba2+ currents 
are abolished by simultaneous mutation of all four P-loop glutamates to alanine, 
with partial inward current observed in single and double domain mutants.  
In this study, I assessed the membrane insertion of two exofacially HA-tagged P-
loop CaV2.2 mutants: Domain I E to A (EIA) which has reduced inward current and 
Domain I, II, III, IV E-A (EI,II,III,IVA) which has no inward current. The aim was to 
establish whether these partial or non-conducting CaV2.2 mutants retained normal 
trafficking functionality and to further examine whether they retained β and α2δ 
dependence for expression and localisation as seen for WT CaV2.2. 
I first expressed HA-tagged WT, EIA or EI,II,III,IIIA CaV2.2 with β1b in N2A cells in the 
presence or absence of α2δ-1 and immunostained them under non-permeabilised 
conditions for exofacial HA expression (Fig 4.3A). Following this, cells were 
permeabilised and probed for II-III loop expression as a transfection marker and to 
identify the border of cells with little or no cell-surface staining. When coexpressed 
with α2δ-1, cell surface EIA and EI,II,III,IIIIA was reduced by 54% and 68% 
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respectively relative to WT (Fig 4.3B) although membrane expression was clearly 
visible for both mutants unlike earlier findings for EIVK CaV2.2 (Fig 4.2B). In the 
absence of α2δ, membrane-inserted CaV2.2 was similarly reduced in all conditions 
(Fig 4.3B) suggesting that both EIA and EI,II,III,IIIIA CaV2.2 retain an interaction with 
α2δ-1 which enhances their cell surface expression consistent with previous 
reports for WT CaV2.2 (Cassidy et al, 2014). 
Using the same approach, I then compared cell surface expression of WT, EIA or 
EI,II,III,IIIIA CaV2.2 expressed with α2δ-1 in the presence or absence of β1b (Fig 
4.3C). Once again, cell surface expression of both pore mutants was reduced 
relative to WT when expressed with α2δ-1 and β1b: EIA (51%) and EI,II,III,IIIIA (39%) 
(Fig 4.3D). I found that cell surface CaV2.2 expression without β1b is reduced 
across all conditions; however, WT CaV2.2 appears to be more strongly affected 
than either pore mutant, in particular EI,II,III,IIIIA: WT (80% reduction), EIA (75% 
reduction) and EI,II,III,IIIIA (57% reduction)  (Fig 4.3D).  
These data strongly suggest that E-A mutations to P-loop glutamates in CaV2.2 
disrupt membrane insertion but do not abolish it. There is little difference in cell 
surface expression between partially conducting EIA and non-conducting EI,II,III,IIIIA 
across the conditions tested (Fig 4.3B, Fig 4.3D). As such, it is unlikely that 
diminished cell surface expression is solely a function of lost channel permeation. 
It is interesting to note that EI,II,III,IIIIA appeared to be less susceptible to the loss of 
β1b than WT which could indicate that mutations to the P-loop binding pockets 
affect the interaction of the α1 subunit and β.  
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Figure 4.3 Cell-surface expression of WT, EIA and EI,II,III,IIIIA CaV2.2-HA in 
N2a cells in the presence or absence of α2δ and β subunits. 
(A) Confocal images of WT CaV2.2-HA (left), CaV2.2-HA EIA (middle) and 
CaV2.2-HA EI,II,III,IVA (right) in N2a cells when coexpressed with β1b and α2δ-1 
(top row) or in the absence of α2δ-1 (bottom row) (scale bar = 5µm). (B) 
Normalised mean cell-surface expression (bar chart) of WT CaV2.2-HA with 
β1b (blue open; n = 150 cells), WT CaV2.2-HA with β1b/α2δ-1 (blue solid; n = 
126 cells) , CaV2.2-HA EIA with β1b (red open; n = 69 cells), CaV2.2-HA EIA 
with β1b/α2δ-1 (red solid; n = 86 cells), CaV2.2-HA EI,II,III,IVA with β1b (green 
open; n = 134 cells), CaV2.2-HA EI,II,III,IVA with β1b/α2δ-1 (green solid; n = 130 
cells) in N2a cells. (C) Confocal images of WT CaV2.2-HA (left), CaV2.2-HA EIA 
(middle) and CaV2.2-HA EI,II,III,IVA (right) in N2a cells when coexpressed with 
α2δ-1 and β1b (top row) or in the absence of β1b (bottom row) (scale bar = 
5µm). (D) Normalised mean cell-surface expression (Bar chart) WT CaV2.2-HA 
with α2δ-1 (blue open; n = 116 cells), WT CaV2.2-HA with β1b/α2δ-1 (blue solid; 
n = 95 cells) , CaV2.2-HA EIA with α2δ-1 (red open; n = 96 cells), CaV2.2-HA 
EIA with β1b/α2δ-1 (red solid; n = 97 cells), CaV2.2-HA EI,II,III,IVA with α2δ-1 
(green open; n = 81 cells), CaV2.2-HA EI,II,III,IVA with β1b/α2δ-1 (green solid; n = 
86 cells) in N2a cells. Data were collected across 3 separate transfections. Data 
analysis was blinded. Data are plotted ± SEM values. Statistical significance 
was determined using one-way ANOVA and Bonferroni post hoc tests 
(***p<0.001). 
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4.4. In the absence of β coexpression, cell-surface and 
intracellular CaV2.2 EI,II,III,IIIIA is higher than WT CaV2.2 in N2a 
cells.  
The interaction between CaVβ and the AID sequence of the CaVα1b I-II loop 
facilitates correct folding of the α1 subunit and masks a site targeting α1 for 
proteasomal degradation (Waithe et al., 2011). In the absence of β1b, cell surface 
expression of EI,II,III,IIIIA CaV2.2 was reduced by a lower proportion than observed 
for WT (Fig 4.3D) raising the possibility that these P-loop CaV2.2 mutants are less 
β-dependent than WT CaV2.2. To further investigate this possibility, I expressed 
HA-tagged WT or EI,II,III,IIIIA CaV2.2 in N2a cells with α2δ-1 in the presence or 
absence of β1b, then used a double HA-immunostaining protocol (as described in 
methods 2.4.1) to identify distinct cell surface and intracellular CaV2.2 populations 
(Fig 4.4A). Many of the experiments in this study used an in-house anti-II-III loop 
antibody to quantify total CaV2.2 expression. However, during this time a lack of 
available, functional II-III loop antibody necessitated an alternative method to 
quantify intracellular CaV2.2. The approach used was to label cell-surface CaV2.2-
HA from non-permeabilised N2a cells using an anti-HA rat antibody, followed by 
anti-rat biotin in order to mask cell-surface HA epitopes. Following this, N2a cells 
were permeabilised and probed for intracellular HA expression. Consistent with 
earlier observations, cell surface EI,II,III,IIIIA is 50% lower than WT when expressed 
with β1b and, once again, the reduction in cell surface expression in the absence 
of β1b is more drastic for the WT (96.7%) than EI,II,III,IIIIA (75.5%) (Fig 4.4B). When 
expressed with β1b, there is little difference in relative intracellular expression of 
WT and EI,II,III,IIIIA (112% of WT) CaV2.2 (Fig 4.4C). However in the absence of β1b, 
I observe a statistically significant 38.6% decrease in intracellular expression of 
WT CaV2.2 and a more modest 20.4% decrease for EI,II,III,IIIIA (Fig 4.4C). Together 
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these data suggest that both cell surface and intracellular expression of EI,II,III,IIIIA 
are higher than WT CaV2.2 in the absence of β1b and support the notion that 
EI,II,III,IIIIA is less β-dependent than WT.  
The conserved P-loop glutamate residues of CaV channels are strongly suggested 
to form a high affinity Ca2+ binding site that facilitates the highly selective entry of 
Ca2+ into the central vestibule (Tang et al, 2014). An interesting but unexplored 
possibility is that binding of Ca2+ to these sites is also important for the interaction 
of α1 and auxiliary β subunits during early stages of channel maturation. It is 
possible that the loss of Ca2+ binding within the selectivity filter disrupts α1-β 
binding. Alternatively, the β-AID interaction could promote Ca2+ binding in the 
channel pore, with the coordinated Ca2+ ion facilitating further structural maturation. 
In either instance, one would expect normal folding and trafficking of the mutant 
channels to be disrupted, consistent with the observations in this study. 
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Figure 4.4 Cell-surface and intracellular expression of WT and EI,II,III,IIIIA 
CaV2.2 in the presence or absence of β1b. 
(A) Confocal images of cell-surface CaV2.2 (top panel) and intracellular CaV2.2 
(bottom panel) in N2a cells expressing: WT CaV2.2 with α2δ-1 or CaV2.2-HA 
EI,II,III,IVA with α2δ-1 in the presence or absence of β1b (scale bar = 5 µm) (B) 
Normalised mean cell-surface expression (bar chart) of CaV2.2-HA with β1b (blue 
open; n = 116 cells) , CaV2.2-HA with β1b/α2δ-1 (blue solid; n = 95 cells) , CaV2.2-
HA EIA with β1b (red open; n = 96 cells), CaV2.2-HA EIA with β1b/α2δ-1 (red solid; 
n = 97 cells), CaV2.2-HA EI,II,III,IVA with β1b (green open; n = 81 cells), CaV2.2-HA 
EI,II,III,IVA with β1b/α2δ-1 (green solid; n =  86 cells) in N2a cells. (C) Normalised 
mean intracellular CaV2.2-HA expression for conditions in panel G. Data were 
collected across 3 separate transfections. Data analysis was blinded. Data are 
plotted ± SEM values. Statistical significance was determined using one-way 
ANOVA and Bonferroni post hoc tests (*p<0.05, ***p<0.001).  
114 
 
4.5 E-A CaV2.2 pore mutants have reduced neurite 
expression in primary hippocampal cultures but retain α2δ 
dependence 
In hippocampal neurons, trafficking of CaV2.2 to the neurites and plasma 
membrane insertion therein is largely dependent on proteolytically processed α2δ; 
however, processed α2δ is not required for plasma membrane CaV2.2 expression 
in non-neuronal cell lines such as tsA-201 cells and undifferentiated N2a cells 
(Cassidy et al., 2014; Kadurin et al., 2016). When expressed in tsA-201 cells, non-
cleaved α2δ-1 was shown to increase cell-surface CaV2.2 expression but was 
unable to enhance whole-cell CaV currents (Kadurin et al., 2016). These 
observations led to the idea of a neuron-specific mechanism that prevents 
immature CaV2.2 complexes from trafficking to the neurites (Kadurin et al., 2016). 
In this study, I sought to determine whether non-functional or partially-functional 
CaV2.2 mutants expressed in hippocampal neurons are able to efficiently traffic to 
the neurites when compared to WT CaV2.2. To do this, I expressed WT CaV2.2-
HA, CaV2.2-HA EIA or CaV2.2-HA EI,II,III,IIIIA in primary rat hippocampal neurons with 
β1b, free mCherry as a transfection marker, and either α2δ-1 or empty vector. After 
7 d expression, neurons were fixed and immunostained for cell-surface HA under 
non-permeabilised conditions and imaged using confocal microscopy (Fig 4.4.1A). 
I then compared the level of plasma membrane-inserted CaV2.2-HA between these 
conditions in hippocampal neurites at least 100µm from the cell soma (Fig 4.4.1.B). 
When expressed with β1b and α2δ-1, I find that cell-surface neurite CaV2.2-HA is 
reduced by 55% and 76% for CaV2.2-HA EIA and CaV2.2-HA EI,II,III,IIIIA respectively, 
relative to WT CaV2.2-HA (Fig 4.4.1B). When α2δ-1 is absent, relative cell-surface 
expression is reduced by 67% for WT CaV2.2-HA, 61% for CaV2.2-HA EIA and 59% 
for CaV2.2-HA EI,II,III,IIIIA (Fig 4.4.1B). These data suggest that CaV2.2-HA EIA and 
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CaV2.2-HA EI,II,III,IIIIA have a reduced ability to express at the neurite cell surface, 
however they appear to retain a similar dependence on α2δ to that shown by WT 
CaV2.2, as there was a proportional loss of cell-surface expression for each CaV2.2 
variant in the absence of α2δ (Fig 4.4.1B). These data do not quantify total CaV2.2-
HA expression within the neurites, so it is unclear whether CaV2.2-HA EIA and 
CaV2.2-HA EI,II,III,IIIIA have impaired trafficking to the neurites themselves or 
whether they reach the neurites but are unable to insert into the plasma membrane 
as efficiently as WT CaV2.2. 
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Figure 4.4.1 Plasma membrane-inserted CaV2.2 is reduced at 
hippocampal neurites for E-A CaV2.2 pore mutants. 
(A) Confocal Images of WT CaV2.2-HA (left), CaV2.2-HA EIA (middle) or 
CaV2.2-HA EI,II,III,IVA (right) expressed in non-permeabilised hippocampal 
neurons when coexpressed with β1b in the absence of α2δ-1 (top panel) or 
with α2δ-1 coexpression (bottom panel) (scale bar = 20µm). (B) Normalised 
mean cell-surface HA expression (bar chart) for HA in neuronal processes of 
non-permeabilised hippocampal neurons transfected with: WT CaV2.2-
HA/β1b (blue open; n = 33 cells), CaV2.2-HA/β1b/α2δ-1 (blue solid; n = 41 
cells), CaV2.2-HA EIA/β1b (red open; n = 20 cells), CaV2.2-HA EIA/β1b/α2δ-1 
(red solid; n = 21 cells) or CaV2.2-HA EI,II,III,IVA/β1b (green open; n = 36 cells 
processes), CaV2.2-HA EI,II,III,IVA/β1b/α2δ-1 (green solid; n = 26 cells). Data 
were collected across 3 separate transfections. Data analysis was blinded. 
Data are plotted ± SEM values. Statistical significance was determined using 
one-way ANOVA and Bonferroni post hoc tests (***p<0.001).  
 
A 
B 
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4.5.1 Total expression of E-A CaV2.2 pore mutants at hippocampal 
neurites is reduced relative to WT CaV2.2. 
CaV2.2-HA EIA and CaV2.2-HA EI,II,III,IIIIA were shown to have diminished cell-
surface expression in hippocampal neurites, relative to WT CaV2.2 (Fig 4.4.1B). 
Reduced neurite cell-surface expression of these P-loop CaV2.2 mutants could 
reflect a defect in trafficking to the neurites as well as – or instead of – an inability 
to insert into the plasma membrane of the neurites. To test this, I expressed WT 
CaV2.2, CaV2.2-HA EIA or CaV2.2-HA EI,II,III,IIIIA in primary rat hippocampal neurons 
with β1b and α2δ-1 and free mCherry as a transfection marker. After 7 d 
expression, neurons were fixed, permeabilised and probed for total HA in neurites 
beginning 100µm from the soma (Fig 4.4.2A). I found that total CaV2.2-HA 
expression is reduced by 52% for CaV2.2-HA EIA and 51% for CaV2.2-HA EI,II,III,IIIIA 
relative to WT CaV2.2 (Fig 4.4.2B). The reduction of total neurite expression of 
CaV2.2 EIA and EI,II,III,IVA could suggest that these mutants are poorly trafficked to 
the neurites relative to WT CaV2.2. It is possible that reduced cell-surface CaV2.2-
HA EIA and CaV2.2-HA EI,II,III,IIIIA at hippocampal neurites is primarily a 
consequence of defective trafficking from the neuronal soma, rather than an 
inability of the mutant channels to localise to the neurite plasma membrane. 
While CaV2.2-HA EIA and CaV2.2-HA EI,II,III,IIIIA have reduced neurite expression 
relative to WT CaV2.2, the difference is similar to my earlier observations for 
plasma membrane expression of CaV2.2-HA EIA and CaV2.2-HA EI,II,III,IIIIA in 
undifferentiated N2a cells (Fig 4.3B). It therefore seems unlikely that reduced 
neurite expression of CaV2.2-HA EIA and CaV2.2-HA EI,II,III,IIIIA is a consequence of 
a neuron-specific regulatory mechanism.  
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Figure 4.4.2. Total expression of E-A CaV2.2 pore mutants is 
reduced at hippocampal neurites relative to WT CaV2.2 
(A) Confocal images of WT CaV2.2-HA (left), CaV2.2-HA EIA (middle) or 
CaV2.2-HA EI,II,III,IVA (right) in permeabilised rat hippocampal neurons 
coexpressed with β1b and α2δ-1 (scale bar = 20µm). (B) Normalised 
mean total expression (bar chart) for WT CaV2.2-HA (blue, n = 97 cells), 
CaV2.2-HA EIA (red, n = 71 cells) or CaV2.2-HA EI,II,III,IVA (green, n = 55 
cells processes) in permeabilised hippocampal processes coexpressed 
with β1b and α2δ-1. Data were collected across 3 separate transfections. 
Data analysis was blinded. Data are plotted ± SEM values. Statistical 
significance was determined using one-way ANOVA and Bonferroni post 
hoc tests (***p<0.001; ns: p>0.05). 
EIA 
B 
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4.6 Summary  
In this study I sought to establish whether trafficking and plasma membrane 
expression of CaV2.2 is influenced by mutations to conserved P-loop glutamate 
residues which coordinate a Ca2+-binding site thought to be responsible for the 
high Ca2+ fidelity of permeation of these channels (Tang et al., 2014). To achieve 
this I compared the cell-surface and total expression of exofacially HA tagged WT, 
EIVK, EIA and EI,II,III,IIIIA CaV2.2 in undifferentiated N2a cells. Thereafter I compared 
the neurite expression of WT, EIA and EI,II,III,IIIIA CaV2.2 to determine whether my 
observations in cell lines were conserved in neurons. I find that EIVK CaV2.2 has 
extremely limited plasma membrane expression in N2a cells despite showing 
extremely high total expression relative to WT CaV2.2 (Fig.4.2). Following this, I 
compared cell-surface expression of WT, EIA and EI,II,III,IIIIA CaV2.2 in N2a cells 
when expressed in the presence or absence of α2δ and β subunits. I found that 
CaV2.2 EIVA (which has partial inward current) and CaV2.2 EI,II,III,IIIIA (no inward 
current) have reduced cell-surface expression relative to WT by 49% and 61% 
respectively when expressed with α2δ-1 and β1b (Fig 4.3B). In the absence of α2δ-
1, cell-surface expression of WT, EIA and EI,II,III,IIIIA CaV2.2 is similarly reduced (Fig 
4.3B). In the absence of β1b, I observe a reduction in cell-surface expression of 
80% for WT, 75% for EIA and 57% for EI,II,III,IIIIA CaV2.2 (Fig 4.3D). Further 
investigation showed that intracellular expression of WT CaV2.2 is reduced by 38% 
in the absence of β whereas intracellular EI,II,III,IIIIA CaV2.2 expression had a smaller 
20% reduction under these conditions (Fig 4.4B) which could suggest that EI,II,III,IIIIA 
CaV2.2 expression is less dependent on β than WT channels. I next compared WT, 
EIA and EI,II,III,IIIIA CaV2.2 expression at the neurites of primary hippocampal 
neurons and found that both cell-surface and total neurite expression was reduced 
for EIA and EI,II,III,IIIIA CaV2.2 relative to WT (Fig 4.4.1, Fig 4.4.2). Cell-surface 
neurite expression was lower for both EIA (55% reduction) and EI,II,III,IIIIA CaV2.2 
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(76% reduction) relative to WT CaV2.2 (Fig 4.4.1B) when expressed with β1b and 
α2δ-1. Cell-surface expression was proportionally reduced for WT, EIA and 
EI,II,III,IIIIA CaV2.2 in the absence of α2δ-1 (Fig 4.4.1B). When comparing total neurite 
expression, I found that EIA and EI,II,III,IIIIA CaV2.2 are 52% and 51% lower than WT 
respectively (Fig 4.4.2B) suggesting that these mutants have impaired trafficking 
to the neurites resulting in a commensurate loss of cell-surface neurite expression. 
 
4.7 Discussion  
All members of the CaV channel family permit highly selective Ca2+ current due to 
the presence of a conserved glutamate residue in the pore-forming loop of each 
domain. These conserved glutamates have been shown to form the second of 
three consecutive Ca2+ binding site responsible for the high Ca2+ fidelity of these 
channels. A number of early studies introduced mutations to these P-loop residues 
for the purpose of investigating permeation mechanisms in these channels (Yang 
et al., 1993; Sather et al., 1994) , while later physiological experiments have used 
P-loop CaV mutants as non-conducting channels, with some suggesting that they 
function as dominant negatives, under the belief that they are well expressed at 
the plasma membrane due to the presence of a large outward current (Cao et al., 
2004). In this study, the P-loop CaV2.2 mutants EIA and EI,II,III,IIIIA were shown to 
have diminished neurite expression relative to WT CaV2.2 (Fig 4.4.2B), as such 
the findings of a number of previous studies involving P-loop mutants may require 
reinterpretation. In particular, the slots hypothesis proposed by Cao et al (2004) 
suggests that plasma membrane insertion of CaV channels at presynaptic terminal 
active zones is restricted by a finite number of available slots for these channels to 
occupy (Cao et al., 2004). Among the pieces of evidence given for this hypothesis, 
was the finding that expression of the non-functional CaV2.1(E4A) mutant – 
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featuring E-A substitutions of all 4 conserved P-loop glutamates – reduced synaptic 
transmission, which was interpreted as a consequence of competition with WT 
CaV2.1 for presynaptic slots (Cao et al., 2004). CaV2.1 (E4A) was characterised as 
having normal cell surface expression in HEK293 cells, although this assessment 
relied on fluorescence overlap between a known plasma membrane marker and 
intracellularly GFP-tagged CaV2.1(E4A) (Cao et al., 2004) which does not 
definitively identify CaV2.1(E4A) as plasma membrane-inserted.     
Previous work by Kadurin et al (2016), suggested the presence of an intracellular 
trafficking checkpoint in neurons that prevents immature or incorrectly folded 
CaV2.2 channels from reaching the cell surface. This hypothesis was based on the 
observation that CaV2.2 channels are unable to traffic to the cell surface in 
hippocampal neurons when in the absence of α2δ or when expressed with non-
proteolytically processed α2δ (Kadurin et al., 2016). Unprocessed α2δ does not 
permit voltage-dependent activation of CaV2 channels leading to the hypothesis 
that α2δ might act as a sensor for channel functionality as part of this trafficking 
checkpoint (Kadurin et al., 2016). The long term aim of the present study, was to 
determine whether non-conducting CaV2.2 pore mutants are able to express and 
traffic efficiently to the cell surface in neurons, or whether mutations to these 
residues – which disrupt Ca2+binding in the pore – preclude trafficking due to the 
presence of a neuronal checkpoint mechanism. However, when examining the 
expression and trafficking of a number of P-loop CaV2.2 mutants in non-neuronal 
cell lines, I found that these channels already have severely diminished cell-
surface expression, despite coexpression with α2δ and β subunits. One 
interpretation for this result is that either binding of Ca2+ in the pore, or Ca2+ 
conduction through the pore, is necessary for normal channel trafficking. Previous 
studies have shown that Ca2+ remains bound to the pore of CaV1 channels even at 
µM Ca2+ levels (Yang et al., 1993). An interesting possibility is that Ca2+ binding to 
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the pore is involved in optimising the structure of the channel for trafficking 
potentially through interactions with auxiliary subunits. One way this might occur 
would be by allowing the β subunit to promote α-helix formation in the I-II linker 
which is required for correct folding and trafficking of the channel (Findeisen & 
Minor, 2009). Consistent with this idea, I found that cell-surface CaV2.2 EI,II,III,IIIIA 
expressed in N2a cells is higher than WT CaV2.2 when expressed in the absence 
of the β subunit, while the reverse is true with β coexpression (Fig 4.4B,C). This 
could suggests that β is less effective at promoting CaV2.2 EI,II,III,IIIIA trafficking than 
WT CaV2.2, potentially indicating an impaired interaction between these subunits 
or an impaired effect of β on the mutant channels. It seems unlikely that CaV2.2 
pore mutants have an altered interaction with α2δ subunits as I observe a 
proportional decrease in plasma membrane expression for both WT and E-A pore 
mutants when expressed in the absence of α2δ in N2a cells (Fig 4.3B) and 
hippocampal neurons (Fig 4.4.1B). These data also strongly suggest that neither 
Ca2+ binding to the pore or Ca2+ conductance through the pore are criteria of the 
neuron-specific intracellular trafficking checkpoint proposed by Kadurin et al 
(2016).   
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Chapter 5 Trafficking of α2δ and CaV2.2 
5.1. Introduction 
α2δs have long been known to enhance whole-cell currents through CaV channels 
(Gurnett et al., 1996; Felix et al., 1997; Wakamori et al., 1999). However, there is 
limited evidence that α2δs influence the single-channel properties of CaVs. As such 
α2δ-enhanced CaV currents have often been attributed to increased channel 
trafficking and plasma membrane-insertion (Wakamori et al., 1999; Davies et al., 
2006; Hendrich et al., 2008; Cassidy et al., 2014). The recent development of 
functional exofacially-tagged CaV2 constructs has allowed us to define populations 
of plasma membrane-inserted CaV2 channels. This was previously used to 
demonstrate that α2δ-1 does indeed increase cell-surface CaV2.2 expression 
(Cassidy et al., 2014). However, more recent studies on the proteolytic processing 
of α2δ found that unprocessed α2δ-1 is unable to enhance macroscopic CaV 
currents despite increasing cell-surface CaV2.2 in cell lines (Kadurin et al., 2016). 
This provides convincing evidence that α2δ-mediated increases in CaV2.2 currents 
can only partially relate to changes in cell-surface CaV2.2 expression. Presently it 
is unclear if α2δs differ significantly in their ability to enhance CaV currents and it 
remains to be seen if α2δ subtypes have uniform trafficking mechanisms 
particularly with regard to their effect on CaV localisation. 
In a previous study by Tran Van Minh & Dolphin (2010), it was found that cell-
surface α2δ-2, heterologously expressed in tsA-201 cells, was increased through 
recycling from Rab11a-dependent endosomes back to the plasma membrane. 
Rab11a belongs to the 66 strong Rab family of small GTPases which regulate a 
multitude of intracellular trafficking pathways, facilitating membrane targeting, 
cargo sorting and vesicle fusion events through recruitment of effectors and direct 
interactions with cargo proteins (see Li & Marlin, 2015 review for details). Inhibition 
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of Rab11a-dependent recycling can be achieved through expression of the 
dominant negative mutant Rab11aS25N, which is locked in an inactive GDP-bound 
conformation. Cell-surface expression of α2δ-2 is reduced in the presence of 
Rab11aS25N with subsequent application of Gabapentin providing no further 
decrease (Tran-Van-Minh & Dolphin, 2010). These data provide a mechanistic 
explanation of Gabapentin action whereby α2δ-2 bound to Gabapentin is prevented 
from recycling to the plasma membrane via Rab11-positive endosomes, resulting 
in a loss of cell-surface expression. Mutational studies have suggested that 
Gabapentin binds to an RRR motif in the α2 domain present only in α2δ-1 and α2δ-
2. Gabapentin is thought to displace an endogenous α2δ ligand, potentially 
inducing a conformational change that prevents trafficking through the Rab11a-
recycling pathway. While the putative endogenous ligand has yet to be identified, 
the amino acids leucine and isoleucine have been found to bind α2δ, albeit with a 
lower affinity than Gabapentin (Brown et al., 1998). Leucine and isoleucine are 
present at micromolar concentrations in human cerebrospinal fluid making them 
interesting candidates as endogenous small molecule modulators of α2δ (Perry et 
al., 1975). It is interesting to consider the possibility that α2δ subtypes might be 
differentially regulated through small molecule binding. Modulation of α2δ by small 
molecules might allow for subcellular partitioning among α2δ subtypes. Indeed, 
divergence in α2δ localisation would presumably influence the trafficking and 
localisation of associated CaV channels.         
The initial aim of this chapter was to determine whether enhancement of plasma 
membrane CaV2.2 expression – a feature of α2δ-1 function – is conserved among 
other α2δ subtypes. Thereafter, I sought to elucidate the mechanisms through 
which α2δs increase cell-surface CaV2.2, and to understand how this process 
influences the localisation and function of CaV2.2 in cell lines and hippocampal 
neurons. To achieve this, I used immunocytochemical, live-labelling and 
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electrophysiological approaches to compare the effect of different α2δ subtypes on 
the trafficking and function of exofacially-tagged CaV2.2. I find that α2δs have a 
differential effect on CaV2.2 trafficking, with α2δ-1 and α2δ-2 increasing the net 
forward trafficking of CaV2.2; by contrast α2δ-3 was not found to influence CaV2.2 
forward trafficking, over the period examined. Further examination suggests 
enhanced forward trafficking is a rab11a-dependent effect and that α2δ-1 and α2δ-
2 participate in rab11a-positive recycling, whereas α2δ-3 does not. A number of 
studies have linked both Rab11a and α2δ-1 to neurite outgrowth and growth cone 
development (Eroglu et al., 2009; van Bergeijk et al., 2015; Nguyen et al., 2016). 
As I have demonstrated distinct trafficking pathways for α2δ-1 and α2δ-3, it is 
tempting to consider that α2δs have subtype specific functions related to their 
distinct subcellular localisation. 
 
5.2. α2δ subunits differentially affect CaV2.2 expression 
In undifferentiated N2a cells, overexpression of α2δ-1 was reported to increase 
cell-surface CaV2.2 by approximately 2-fold (Cassidy et al., 2014). Here I compare 
steady-state plasma membrane and total CaV2.2-bbs expression in N2a cells when 
coexpressed with auxiliary β1b and either α2δ-1, α2δ-2 or α2δ-3 compared to a 
control lacking α2δ (Fig 5.1A-C). I find that all three α2δ subtypes produce an 
increase in total and plasma membrane CaV2.2 expression when compared to 
control conditions. α2δ-1 coexpression was shown to produce a 140% increase in 
relative plasma membrane CaV2.2 (Fig 5.1D) consistent with previous reports 
(Cassidy et al., 2014; Kadurin et al., 2016). However, α2δ-2 and α2δ-3 expression 
produced notably smaller increases to plasma membrane CaV2.2 of 42% and 31% 
respectively (Fig 5.1E, F).  
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Expression of the intracellular II-III loop epitope of CaV2.2 was used as a measure 
of total CaV2.2. I observe an increase in II-III loop expression in the presence of 
α2δ-1 (74%), α2δ-2 (23%) and α2δ-3 (47%) relative to conditions lacking α2δ (Fig 
5.1D-F). α2δ-2 appears to produce the smallest increase in II-III loop expression 
among the subtypes tested. Interestingly, α2δ-3 expression correlated with a 
greater increase in total CaV2.2 than with α2δ-2 (47% and 23% respectively) but a 
smaller increase in cell-surface CaV2.2 expression (31% and 42% respectively) 
(Fig 5.1E, F). Increased presynaptic CaV2.1 expression has previously been 
reported with α2δ-1 (Hoppa et al., 2012) consistent with my observations for CaV2.2 
in N2a cells. My data suggest that α2δ-1 and α2δ-2 produce a greater increase in 
cell-surface CaV2.2 than total CaV2.2. This may indicate that these α2δ subtypes 
actively promote CaV2.2 trafficking to, or stability at, the plasma membrane. It is 
possible that increases to cell-surface CaV2.2 are secondary to an increase in total 
CaV2.2 when α2δ is expressed. However, in this scenario one might expect a 
commensurate increase in cell-surface and total CaV2.2 expression with α2δ, which 
is not observed in the presence of α2δ-3.  
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Figure 5.1 Steady-state expression of CaV2.2-bbs/β1b with α2δ-1, -2 or -3 in 
N2a cells. 
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5.3. α2δ-1 and α2δ-2 enhance net forward CaV2.2 trafficking  
The above study provided evidence that steady-state plasma membrane CaV2.2 
expression is enhanced by α2δ-1 and α2δ-3, albeit to differing degrees (Fig.5.1). I 
considered two possible explanations for α2δs-enhanced cell-surface CaV2.2: (1) 
α2δs increase forward trafficking of CaV2.2 to the cell surface (2) α2δs reduce the 
rate of CaV2.2 endocytosis from the cell surface. Previously, Cassidy et al (2014) 
compared rates of CaV2.2 endocytosis when expressed in N2a cells in the 
presence or absence of α2δ-1. This study reported that, while α2δ-1 enhanced 
plasma membrane CaV2.2 expression, the rate of CaV2.2 endocytosis was not 
altered by expression of α2δ-1 (Cassidy et al., 2014). In the present study, I used 
an α-BTX live-labelling approach to compare the rates of net forward CaV2.2 
trafficking in N2a cells expressing CaV2.2-bbs and β1b with either: α2δ-1, α2δ-2, 
α2δ-3 or empty vector pcDNA3 (control) (Fig 5.2A). When compared to control 
Figure 5.1. Steady-state expression of CaV2.2-bbs/β1b with α2δ-1, α2δ-2 or 
α2δ-3 in N2a cells. 
(A) Confocal images of N2a cells expressing CaV2.2-bbs with β1b and either no 
α2δ (left column) or α2δ-1 (right column). Top row, BTX-488 live-labelling. Bottom 
row, permeabilised II-III loop immunostaining. Scale bar = 5µm. (B) Confocal 
images of N2a cells expressing CaV2.2-bbs with β1b and either: no α2δ (left 
column) or α2δ-2 (right column). Top row, BTX-488 live-labelling. Bottom row, 
permeabilised II-III loop immunostaining. Scale bar = 5µm. (C) Confocal images 
of N2a cells expressing CaV2.2-bbs with β1b and either: no α2δ (left column) or 
α2δ-3 (right column). Top row, BTX-488 live-labelling. Bottom row, permeabilised 
II-III loop immunostaining. Scale bar = 5µm. (D) Normalised mean cell-surface 
(left) or total (right) CaV2.2-bbs (bar chart) with β1b and either: no α2δ (black, n = 
191) or α2δ-1 (red, n = 205). (E) Normalised mean cell-surface (left) or total (right) 
CaV2.2-bbs (bar chart) with β1b and no α2δ (black, n = 99) or α2δ-2 (blue, n = 
88). (F) Normalised mean cell-surface (left) or total (right) CaV2.2-bbs (bar chart) 
with β1b and no α2δ (black, n = 188) or α2δ-3 (green, n = 188). Mean fluorescence 
intensities were normalised to CaV2.2-bbs/β1b condition for each experiment 
then pooled from 3 separate transfections. Data analysis was blinded. Data are 
plotted ± SEM values. Statistical significance was determined using Student’s 
unpaired t test, **P <0.01, ***P <0.001. 
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conditions, I find that coexpression of α2δ-1 and α2δ-2 produced significantly higher 
cell surface CaV2.2 at each time point tested (Fig 5. 2B). Cell-surface CaV2.2 levels 
between control and α2δ-3 conditions did not differ significantly up to the 45 min 
time point, becoming statistically significant at 60 min; this increase of 23% at 60 
min is consistent with earlier steady-state observations (Fig 5.2B). Estimates for 
initial rates of net forward CaV2.2 trafficking were made using the slope value of a 
straight line between the first two time points (0-15 minutes) for each condition. I 
found no significant difference in initial CaV2.2 trafficking rates between control and 
α2δ-3 conditions, 0.029 and 0.034 a.u. min respectively (Fig 5.2D). However, I 
report a significant increase in initial rate of CaV2.2 traffic with α2δ-1 coexpression, 
0.079 a.u.min (Fig 5.2E) suggesting that α2δ-1 actively accelerates this process. 
Together these data support a role for α2δ-1 and α2δ-2 in enhancing plasma 
membrane-insertion of CaV2.2 by increasing the rate of forward trafficking. α2δ-3 
had no clear effect on the initial forward CaV2.2 trafficking rate despite a slight 
increase in maximal cell surface CaV2.2 (23%) relative to control at 60 mins (Fig 
5.2B) consistent with my observations of steady-state CaV2.2 expression. It should 
be noted that this assay only estimates “net” forward movement and I cannot 
discount changes in rate of endocytosis that may be present, this will be addressed 
in future work. However, current literature has found no direct effect of α2δ-1 on 
CaV2.2 endocytosis (Cassidy et al., 2014; Dahimene et al., 2018) 
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Figure 5.2. Net forward trafficking of CaV2.2-bbs expressed with β1b and 
either either α2δ-1, α2δ-2, α2δ-3 or empty vector PCDNA3 
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5.4. α2δ-3 expression and localisation is unaffected by 
Rab11a-recyling 
Trafficking through Rab11a-positive recycling endosomes enhances α2δ-2 
membrane expression with Gabapentinoids shown to interrupt α2δ-2 recycling 
through this pathway (Tran-Van-Minh & Dolphin, 2010). The α2 domain of α2δ-1 
and α2δ-2 possess a triple RRR motif – identified through alanine scanning 
mutagenesis - required for GBP binding and lacking in α2δ-3 and α2δ-4 (Wang et 
al., 1999). This study considered the possibility that α2δ-1 and α2δ-2 enhance cell-
surface CaV2.2 expression by facilitating the recycling of CaV2.2 through Rab11a-
Figure 5.2. Net forward trafficking of CaV2.2-bbs expressed with 
β1b and either α2δ-1, α2δ-2, α2δ-3 or empty vector PCDNA3 
(A) Example images from forward trafficking assay for CaV2.2-bbs 
expressed in N2a cells with β1b and α2δ-1. Cells were live-labelled with 
α-BTX-AF488 for 0, 15, 30, 45 and 60 minutes. Scale bar = 5μm. (B) 
Normalised mean cell-surface CaV2.2-bbs fluorescence over time in 
N2a cells expressing CaV2.2-bbs and β1b with either α2δ-1, α2δ-2, α2δ-
3, or PCDNA3. Cells were live-labelled with α-BTX-AF488 for 0, 15, 30, 
45 and 60 minutes at 37ºC following pre-incubation with unlabelled α-
BTX at 17ºC for 30 minutes.  An average of 30-60 cells were analysed 
per time point, for each condition in an individual experiment. The data 
were collected as paired experiments between CaV2.2/β1b + PCDNA3 
(control) and CaV2.2/β1b + α2δ. 3 transfections were carried out per 
CaV2.2/β1b + α2δ condition, with a total of 9 for CaV2.2/β1b + PCDNA3. 
Individual experiments were normalised to mean 60 min fluorescence 
of the paired CaV2.2/β1b + PCDNA3 condition, before being pooled 
together. Data were plotted using Graphpad 5 software and fitted with 
a one-phase exponential association equation shown on graph. (C) 
Statistical comparison of mean fluorescence values again control 
condition at each time point was determined using one-way ANOVA and 
Bonferroni post-hoc tests. (D, E) Initial rate of net forward CaV2.2-bbs 
trafficking. The gradient of straight line between 0-15 min was obtained 
as an average for each individual experiment and summarised (in a.u. 
min). Panel D compares CaV2.2/β1b + PCDNA3 (black, n=3) and 
CaV2.2/β1b + α2δ-1 (red, n=3). Panel E compares CaV2.2/β1b + 
PCDNA3 (black, n=3) and CaV2.2/β1b + α2δ-3 (green, n=3). **P<0.01 
(Student’s unpaired t-test). Data are plotted ± SEM values. 
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positive endosomes. Further to this, I speculated that α2δ-3 traffics independently 
of the Rab11a-positive recycling endosomes and consequently is unable to 
enhance CaV2.2 forward trafficking through this pathway. To test my hypothesis, I 
used the dominant negative Rab11aS25N mutant in which a key serine to 
asparagine substitution locks Rab11a in an inactive GDP-bound state. Previously, 
Rab11aS25N has been confirmed to inhibit α2δ-2 forward trafficking, and a similar 
result is expected for α2δ-1 (Tran-Van-Minh & Dolphin, 2012). Here I use 
immunocytochemistry to compare cell-surface and intracellular expression of HA-
tagged α2δ-1 and α2δ-3 in N2a cells when paired with Rab11aS25N (Fig 5.3A). 
Cell-surface α2δ-3 immunostaining is typically weaker than α2δ-1, so antigen 
retrieval was applied to all samples prior to immunostaining in order to maximise 
available HA signal. I find a reduction in relative cell-surface and intracellular α2δ-
1-HA staining of 47% and 26% respectively, when expressed with Rab11aS25N 
(Fig 5.3B, C). α2δ-3 showed no significant difference in either cell surface or 
intracellular expression whether expressed with Rab11aS25N or empty vector (Fig 
5.3B, C). These data provide evidence that α2δ-1 - like α2δ-2 - is regulated by 
Rab11a-dependent recycling and suggest that α2δ-3 does not traffic through this 
endosomal pathway.  
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Figure 5.3. Steady-state cell-surface expression of HA-tagged α2δ-1 
and α2δ-3 in the presence or absence of Rab11aS25N. 
(A) Confocal images of cell-surface (bottom row) and intracellular (top row) 
HA staining in N2a cells expressing α2δ-1-HA (left) or α2δ-3-HA (right) in the 
presence or absence of Rab11aS25N. Scale bar = 5μm. (B) Normalised 
mean cell-surface α2δ expression: α2δ-1 control (red), α2δ-1 + Rab11aS25N 
(red, striped), α2δ-3 control (green), α2δ-3 + Rab11aS25N (green, striped). 
(C) Normalised mean total α2δ expression: α2δ-1 control (red), α2δ-1 + 
Rab11aS25N (red, striped), α2δ-3 control (green), α2δ-3 + Rab11aS25N 
(green, striped). Mean fluorescence intensities were normalised to α2δ 
control conditions for each experiment and then pooled from 3 separate 
transfections. Each cell was measured for cell surface and total HA 
expression: α2δ-1 control (n = 159), α2δ-1 + Rab11aS25N (n = 161), α2δ-3 
control (n = 134), α2δ-3 + Rab11aS25N (n = 135). Data analysis was blinded. 
Data are plotted ± SEM values. Statistical significance was determined using 
Student’s unpaired t test, *P <0.05, ***P <0.001. 
 A 
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5.5. Cell-surface CaV2.2 expression is reduced by 
Rab11aS25N when α2δ-1 or α2δ-2 are present. 
Rab11a-recycling enhances the plasma membrane expression of both α2δ-1 and 
α2δ-2. Inhibition of α2δ-2 recycling through Rab11a-positive endosomes has been 
shown to reduce whole-cell CaV2.2 currents (Tran-Van-Minh & Dolphin, 2010). 
However, a direct effect on plasma membrane insertion of associated CaV 
channels has yet to be demonstrated. Here I compare the plasma membrane 
expression of exofacially-tagged CaV2.2-bbs with β1b in N2a cells when 
coexpressed with α2δ-1, α2δ-3 or no α2δ (empty vector PCDNA3) in the presence 
or absence of Rab11aS25N (Fig 5.4A). bbs-tagged CaV2.2 was used to maintain 
consistency with my previous experiments. Consistent with my earlier reports, I 
find that plasma membrane–inserted CaV2.2 increased by 92% and 38% when 
coexpressed with α2δ-1 and α2δ-3 respectively (Fig 5.4B). However, I find that 
Rab11aS25N coexpression reduced the plasma membrane expression of CaV2.2 
by 53% when α2δ-1 was present but had no effect with α2δ-3 or no α2δ (Fig 5.4B). 
Following this, I compared the effect of Rab11aS25N on plasma membrane 
CaV2.2-bbs in the presence or absence of α2δ-2 (Fig 5.4C). As with α2δ-1, cell-
surface α2δ-2 expression is reduced by Rab11aS25N (Tran-Van-Minh & Dolphin, 
2010). As such, Rab11aS25N was expected reduce cell-surface CaV2.2-bbs levels 
when coexpressed with α2δ-2. I find that cell-surface CaV2.2 expressed with α2δ-2 
and β1b is reduced by 35% in the presence of Rab11aS25N (Fig 5.4D). I find no 
change in cell-surface CaV2.2 when Rab11aS25N was expressed with α2δ-3 or 
with no α2δ (Fig 5.4B). Interestingly, α2δ-3 coexpression produced a 38% increase 
in CaV2.2 expression independent of Rab11aS25N coexpression. Together, these 
data suggest that α2δ-1 and α2δ-2 enhance cell-surface CaV2.2 expression through 
Rab11a-dependent recycling which CaV2.2 is unable to access independently. α2δ-
3 appears to traffic independently of Rab11a, and inhibition of Rab11-recycling 
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does not affect cell-surface expression of α2δ-3 or coexpressed CaV2.2. Despite 
this, the α2δ-3-mediated increase in cell-surface CaV2.2 is present, regardless of 
Rab11a-recycling, suggesting that α2δ-3 promotes cell-surface CaV2.2 through a 
manner distinct from α2δ-1 and α2δ-2. 
 
 
Figure 5.4. Steady-state cell-surface CaV2.2 is reduced by Rab11aS25N only 
when expressed with α2δ-1 α2δ-2. 
D C 
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5.6. Rab11aS25N reduces neurite CaV2.2 expression in 
primary hippocampal cultures when coexpressed with α2δ-
1 
Previously, I have demonstrated that CaV2.2 can be well expressed and inserted 
into the plasma membrane of non-neuronal cells in the absence of α2δ (Cassidy et 
al., 2014; Kadurin et al., 2016). However, in primary hippocampal neurons α2δ 
expression - and proteolytic processing of α2δ - was found to be essential for 
efficient expression and localisation of CaV2.2 to the neurites (Kadurin et al., 2016). 
Here, I examine whether CaV2.2 expression is influenced by Rab11a at both 
hippocampal neurites and soma in an α2δ-dependent manner. To do this, I 
expressed and immunostained GFP-CaV2.2-HA in primary rat hippocampal 
neurons with β1b, free mCherry and either: empty vector (PCAGGS), α2δ-1 or α2δ-
3. Each condition was paired with an empty vector (control) or Rab11aS25N (Fig 
5.5A). For these experiments, I use an exofacially HA-tagged and N-terminally 
GFP-tagged CaV2.2 construct allowing me to quantify cell-surface and total CaV2.2 
expression in non-permeabilised neurons. In accordance with previous reports, 
Figure 5.4. Steady-state cell-surface CaV2.2 is reduced by Rab11aS25N 
only when expressed with α2δ-1 and α2δ-2. 
(A) Confocal images of cell-surface CaV2.2-bbs expressed in N2a cells with β1b 
and either: α2δ-1, α2δ-3 or no α2δ (empty vector) in the presence or absence of 
Rab11aS25N. Scale bar = 5μm. (B) Normalised mean cell-surface CaV2.2-bbs 
with β1b expressed in N2a cells with: no α2δ  (black, n = 142), no α2δ + 
Rab11aS25N (grey, n = 145), α2δ-1 (red, n = 148), α2δ-1 + Rab11aS25N (pink, n 
= 140), α2δ-3 (dark green, n = 132), α2δ-3 + Rab11aS25N (light green, n = 144). 
Statistical significance was determined using one-way ANOVA and bonferroni 
post hoc tests, ns>0.05, ***P <0.001. (C) Confocal images of cell-surface CaV2.2-
bbs/β1b expressed in N2a cells with α2δ-2 in the presence or absence of 
Rab11aS25N. Scale bar = 5µm. (D) Normalised mean cell-surface CaV2.2-bbs 
expressed in N2a with β1b and either: α2δ-2 + empty vector (black, n = 97), α2δ-
2 + Rab11aS25N (purple, striped, n = 114). Data are collected from 3 separate 
transfections. Data analysis was blinded. Data are plotted ± SEM values. 
Student’s unpaired t test, ***P <0.001. 
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neurite and soma expression of CaV2.2 was extremely low in the absence of α2δ.  
I report a 233% increase in neurite CaV2.2-HA expression with α2δ-1 and 177% 
with α2δ-3 relative to empty vector controls (Fig 5.5B). Neurite GFP expression was 
also elevated with both α2δ-1 and α2δ-3 coexpression by ~122% in each case (Fig 
5.5C). Consistent with my findings in N2a cells, neurite CaV2.2-HA was reduced 
by coexpression of Rab11aS25N only when expressed with α2δ-1 and not α2δ-3. I 
observed a 44% reduction in neurite CaV2.2-HA signal when expressed with α2δ-
1 + Rab11aS25N relative to the + α2δ-1 control (Fig 5.5B). However, I saw no 
change in neurite GFP expression between conditions expressing α2δ-1 with either 
Rab11aS25N or empty vector (Fig 5.5C). This result suggests that Rab11aS25N 
reduces plasma membrane-inserted CaV2.2 at the neuronal processes when 
expressed with α2δ-1, rather than by depleting the CaV2.2 population. I report no 
change in neurite HA or GFP signal intensity between conditions expressing 
Rab11aS25N or empty vector when CaV2.2 is paired with α2δ-3 or no α2δ in 
agreement with my observations in N2a cells (Fig 5.5B, C). I next examined cell-
surface GFP-CaV2.2-HA expression at the neuronal cell body of these primary 
hippocampal neurons (Fig 5.5D). Contrary to my findings at the hippocampal 
neurites, I found no difference in plasma membrane CaV2.2 expression between 
conditions with or without Rab11aS25N regardless of whether α2δ was 
coexpressed (Fig 5.5E). This could indicate that the role of Rab11a-recycling is 
absent or limited at the cell soma relative to the neurites. Although the possibility 
should be considered that CaV2.2 overexpression at the soma might obscure small 
changes in channel trafficking therein. Interestingly, I find that plasma membrane 
CaV2.2 at the soma was 66% higher with α2δ-3 than α2δ-1 (Fig. 5.5E), contrasting 
with my observations in both hippocampal neurites and in cell lines. A simple 
explanation for this discrepancy would be that α2δ-3 is less efficient at promoting 
the trafficking of CaV2.2 to the neurites, resulting in a bottleneck effect at the soma. 
However, it is possible that α2δ-3 preferentially targets CaV2.2 to the soma, 
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reflecting different roles between α2δs in subcellular CaV localisation. Together my 
data suggest that Rab11a-recyling enhances neurite CaV2.2 expression in an α2δ-
dependent manner and suggest that Rab11a-recycling is less influential – if at all 
– at the neuronal cell body. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.5 Rab11aS25N reduces plasma membrane-inserted CaV2.2 at 
hippocampal neurite when expressed with α2δ-1 but not α2δ-3 
 
A 
B C 
GFP-CaV2.2-HA/β1b/mCherry 
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Figure 5.5. Rab11aS25N reduces plasma membrane-inserted CaV2.2 at 
hippocampal neurite when expressed with α2δ-1 but not α2δ-3     
(A) Confocal images of rat hippo pyramidal neurons expressing GFP-CaV2.2-
HA/β1b/mCherry with: empty vector, empty vector + Rab11aS25N, α2δ-1, α2δ-
1 + Rab11aS25N, α2δ-3 or α2δ-3 + Rab11a(S25N). Scale bar = 20 μm. (B) 
Normalised mean cell-surface GFP-CaV2.2-HA in the processes of pyramidal 
rat neurons expressed with β1b/mCherry and either: empty vector (black, n = 
30 cells), Rab11aS25N (black, striped, n = 19 cells), α2δ-1 (red, n = 51 cells), 
α2δ-1 + Rab11aS25N (red, striped, n = 42 cells), α2δ-3 (blue, n = 46 cells) or 
α2δ-3 + Rab11aS25N (blue, striped, n = 40 cells). (C) Normalised mean total 
GFP-CaV2.2-HA in the processes of pyramidal rat neurons expressed with 
β1b/mCherry and either: empty vector (black), Rab11aS25N (black, striped), 
α2δ-1 (red), α2δ-1 + Rab11aS25N (red, striped), α2δ-3 (blue) or α2δ-3 + 
Rab11aS25N (blue, striped). Total of 3 transfections. (D) Confocal images of 
pyramidal rat neurons expressing GFP-CaV2.2-HA/β1b/mCherry at the cell 
soma with: empty vector, empty vector, α2δ-1 or α2δ-3 or α2δ-3. Scale bar = 
10 µm (E) Normalised mean cell-surface GFP-CaV2.2-HA expressed at the 
soma of pyramidal rat neurons with β1b/mCherry and either: empty vector 
(black, n = 30), Rab11aS25N (black, striped, n = 20), α2δ-1 (red, n = 35), α2δ-
1 + Rab11aS25N (red, striped, n = 33), α2δ-3 (blue, n = 44) or α2δ-3 + 
Rab11aS25N (blue, striped n = 31). Data analysis was blinded. Data are 
plotted ± SEM values. Statistical significance was determined using one-way 
ANOVA and Bonferroni post hoc tests, ns>0.05, ***P <0.001. 
 
D E 
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5.7 Rab11aS25N reduces whole-cell CaV2.2 currents when 
coexpressed with Rab11a-sensitive α2δ-1 
Previously, we have demonstrated that α2δs have distinct roles in CaV trafficking 
regulation and enhancement of whole-cell currents (Kadurin et al., 2016). While 
there is variance in the literature, studies using heterologous expression systems 
such as xenopus oocytes and HEK293 cells, have reported increases in CaV 
currents by as much as 9-fold (Gao et al., 2000). Despite a sizeable increase in 
CaV2.2 currents (approximately 5-fold), only a 2-fold increase plasma membrane 
CaV2.2 with α2δ-1 was reported using tsA201 cells (Cassidy et al., 2014). This 
apparent discrepancy may reflect the limited availability of sites at the plasma 
membrane whereby nascent CaV2.2 may be localised to the cell surface but be 
inactive; if so, reductions in CaV2.2 membrane expression by Rab11aS25N may 
not correlate to significant changes in whole-cell CaV2.2 currents. Here, I 
investigate whether the reduction in cell-surface CaV2.2 expression by 
Rab11aS25N correlates to a change in whole-cell CaV currents and whether any 
change I observe is α2δ-dependent. I used voltage-clamp recording to measure 
whole-cell Ba2+ currents in tsA201 cells expressing CaV2.2/β1b/α2δ-1 with either 
Rab11aS25N or empty vector (Fig 5.6A). I find that mean Ba2+ current density 
(pA/pF) is reduced by 58% when α2δ-1 and Rab11aS25N are coexpressed 
compared to α2δ-1 expressed alone (Fig 5.6A, B). Mean maximum conductance 
(Gmax) values were 1.4±0.2 pS/pF and 0.7±0.1 pS/pF for α2δ-1 control and α2δ-1 + 
Rab11aS25N conditions respectively (Fig 5.6C). I saw no significant changes to 
steady-state inactivation or V50 act between α2δ-1 control and α2δ-1 + Rab11aS25N 
conditions (Fig 5.6D, E) agreeing with a conclusion that current density changes 
occurred as a result of reduced membrane CaV2.2 expression rather than changes 
to biophysical properties. This data does not discount the possibility of changes to 
the single channel conductance of CaV2,2, although Rab11a has not been reported 
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to influence single channel conductance properties and there is limited evidence 
to suggest that α2δs strongly influence these properties either. 
 
 
Figure 5.6 Rab11aS25N reduces whole-cell CaV2.2 currents when expressed 
with α2δ-1 
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5.8 Rab11aS25N has no effect on α2δ-3-mediated CaV2.2 
current enhancement 
Having established that Rab11aS25N reduces both α2δ-1 cell-surface expression 
and α2δ-1-mediated CaV2.2 current enhancement it was necessary to confirm 
whether a similar reduction occurred in α2δ-3-mediated current enhancement. In 
agreement with my immunocytochemistry data, I found no difference in mean 
current density (Fig 5.7A. B), Gmax (Fig 5.7C), V50 act of CaV2.2 (Fig 5.7D) or steady-
state inactivation (Fig 5.7E) when Rab11aS25N was coexpressed with either α2δ-
3 + Rab11aS25N or α2δ-3 alone. This result is consistent with my earlier 
observations that cell-surface expression of CaV2.2 is unaffected by Rab11a-
recycling when expressed with α2δ-3 or in the absence of α2δ.  
 
 
 
 
Figure 5.6. Rab11aS25N reduces whole-cell CaV2.2 currents when 
expressed with α2δ-1 
(A) Example whole-cell current traces of CaV2.2 with: β1b/α2δ-1 (black) and 
β1b/α2δ-1 + Rab11aS25N (red). (B) Mean IV plots for CaV2.2 with: β1b/α2δ-1 
(black squares, n = 15) and β1b/α2δ-1 + Rab11aS25N (red circles, n = 14) 
fitted by a modified Boltzmann function (see methods). (C) Mean Gmax values 
obtained by fitting each individual trace in panel B to a modified Boltzmann 
function CaV2.2/β1b/α2δ-1 (black) 1.389 ± 0.1979 nS/pF, CaV2.2/β1b/α2δ-1 + 
Rab11aS25N (red) 0.7085 ± 0.1352 nS/pF. (D) Mean steady-state inactivation 
for CaV2.2 with: β1b/α2δ-1 (black squares; n = 7), β1b/α2δ-1 + Rab11aS25N 
(red circles; n = 7). (E) Mean V50, inact obtained by fitting each individual trace 
in panel D to Boltzmann function, CaV2.2/β1b/α2δ-1 (black) -71.81 ± 3.577 mV 
and CaV2.2/β1b/α2δ-1 + Rab11aS25N (red) -73.78 ± 3.943 mV. Data are 
plotted ± SEM values. Student’s unpaired t-test ns>0.05, **p<0.01.  
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Figure 5.7 Rab11aS25N has no effect on whole-cell α2δ-3-mediated 
CaV2.2 current enhancement 
(A) Example whole-cell current traces of CaV2.2 with: β1b/α2δ-3 (black) and 
β1b/α2δ-3 + Rab11aS25N (green). (B) Mean IV plots for CaV2.2 with: 
β1b/α2δ-3 (black squares; n = 15) and β1b/α2δ-3 + Rab11aS25N (red 
circles; n = 14 fitted by a modified Boltzmann function (see methods). (C) 
Mean Gmax values obtained by fitting each individual trace in panel B to a 
modified Boltzmann function, CaV2.2/β1b/α2δ-3 (black) 2.424 ± 0.484 nS/pF, 
CaV2.2/β1b/α2δ-3 + Rab11aS25N (green) 2.111 ± 0.318 nS/pF. (D) Mean 
steady-state inactivation for CaV2.2 with: β1b/α2δ-1 (black squares; n = 7), 
CaV2.2/β1b/α2δ-1 + Rab11aS25N (red circles; n = 7). (E) Mean V50, inact 
obtained by fitting each individual trace in panel D to Boltzmann 
function CaV2.2/β1b/α2δ-1 (black) -71.48 ± 2.52 mV and CaV2.2/β1b/α2δ-1 + 
Rab11aS25N (green) -69.32 ± 3.38 mV. Data are plotted ± SEM values. 
Student’s unpaired t-test, ns >0.05. 
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5.9 Rab11aS25N reduces net forward trafficking of α2δ-1  
Here, I use a forward trafficking assay to compare net forward trafficking rates of 
α2δ-1-bbs in the presence or absence of Rab11aS25N (Fig 5.8A). I find that net-
forward trafficking of α2δ-1-bbs is reduced by coexpression of Rab11aS25N with a 
41% reduction in cell-surface α2δ-1-bbs with Rab11aS25N after 30 minutes (Fig 
5.8B), consistent with my measurements cell-surface α2δ-1-HA + Rab11aS25N 
under steady-state conditions. I then compared net forward trafficking rates for 
CaV2.2-bbs/β1b when expressed with: empty vector, empty vector + Rab11aS25N, 
α2δ-1 + empty vector or α2δ-1 + Rab11aS25N (Fig 5.8C). I find that coexpression 
of α2δ-1 enhances net-forward trafficking of CaV2.2 and that the presence of 
Rab11aS25N is sufficient to abolish this increase (Fig 5.8 D). In addition, I saw no 
difference in net forward CaV2.2 trafficking rates between conditions lacking α2δ-1 
and α2δ-1 + Rab11aS25N (Fig 5.8D). These data support the conclusion that α2δ-
1 membrane expression is enhanced by forward-trafficking from Rab11a-positive 
recycling endosomes, and that CaV2.2 can traffic through this pathway only when 
coexpressed with Rab11a-sensitive α2δs. 
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Figure 5.8 Rab11aS25N reduces net forward trafficking of α2δ-1 and 
CaV2.2/α2δ-1 
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5.10. Summary  
In this study I have shown that α2δs differentially enhance plasma membrane 
expression of exofacially-tagged CaV2.2 in both cell lines and primary neuronal 
cultures (Fig.5.2, Fig.5.5). When expressed in N2a cells, I find that α2δ-1, α2δ-2 
and α2δ-3 enhance cell-surface and total CaV2.2 levels, albeit to varying degrees 
(Fig 5.1). Upon further investigation, I find that α2δ-1 and α2δ-2 actively promote 
net forward CaV2.2 traffic through Rab11a-dependent recycling endosomes (Fig 
5.2). However, α2δ-3 does not appear to participate in Rab11a-dependent 
Figure 5.8 Rab11aS25N reduces net forward trafficking of α2δ-1 and 
CaV2.2/α2δ-1 
(A) Confocal images of α2δ-1-bbs expressed in tsA-201 cells with either 
empty vector PCDNA3 (top row) or Rab11aS25N (bottom row) at each time 
point of net forward trafficking assay. Nuclei staining with DAPI. Scale bar = 
5μm. (B) Net forward α2δ-1-bbs trafficking. Normalised mean cell-surface 
α2δ-1-bbs expressed with either Rab11aS25N or empty vector. Cells were 
live-labelled with α-BTX-AF488 for 0, 10, 20, and 30 minutes at 37ºC following 
pre-incubation with unlabelled α-BTX at 17ºC for 30 minutes. Data were 
collected across 3 transfections with approximately 30 to 50 cells analysed 
per time point in each experiment. Individual experiments were normalised to 
mean 30 min fluorescence of α2δ-1-bbs condition, before being pooled 
together. Data were plotted using Graphpad 5 software and curve fitted using 
a one-phase exponential association equation (shown on graph). Statistical 
significance was determined using Student’s t test to compare mean 
fluorescence values between conditions at each time point, **P<0.01, 
***P<0.001. (C) Confocal images of cell-surface CaV2.2-bbs expressed in 
N2a cells with β1b and either PCDNA3 or α2δ-1 in the presence or absence 
of Rab11aS25N after 30 min of net forward trafficking assay. Scale bar = 
5μm. (D) Net forward CaV2.2-bbs trafficking assay. Normalised mean cell-
surface CaV2.2-bbs expressed in N2a cells with β1b and: PCDNA3 (black), 
PCDNA3 + Rab11aS25N (red), α2δ-1 + PCDNA3 (blue) and α2δ-1 + 
Rab11aS25N (green). Cells were live-labelled with α-BTX-AF488 for 0, 10, 
20 and 30 minutes at 37ºC following pre-incubation with unlabelled α-BTX at 
17ºC for 30 minutes.  An average of 30-50 cells were analysed per time point, 
for each condition. Data represents all cells from 3 transfections. (E, F, G) 
mean fluorescence values at 10, 20, and 30 min time points from panel B. 
Data analysis was blinded. Data are plotted ± SEM values. Statistical 
significance was determined using one-way ANOVA and Bonferroni post hoc 
tests (*P<0.05, ***P<0.001)  
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recycling (Fig. 5.3) and did not increase net forward CaV2.2 trafficking (Fig.5.2). 
Despite this, I do report a consistent increase in both total (47%) and plasma 
membrane-inserted (30%) CaV2.2 with α2δ-3 under steady-state conditions 
(Fig.5.1). Further investigation using the dominant negative Rab11aS25N mutant, 
showed that Rab11a-depedent recycling enhances cell-surface CaV2.2 expression 
only in the presence of Rab11a-sensitive α2δ-1 or α2δ-2 (Fig 5.4). Inhibition of 
Rab11a-recycling had no effect on CaV2.2 localisation when expressed with α2δ-3 
or no α2δ; these results were consistent in both N2a cell lines and at primary 
hippocampal neurites, although I saw no effect at hippocampal cell bodies 
(Fig.5.5). Inhibition of Rab11a-dependent recycling reduced whole-cell CaV2.2 
currents in tsA201 cells when expressed with α2δ-1 (Fig 5.6) but had no effect with 
α2δ-3 (Fig.5.7). Using our forward trafficking assay, I demonstrated that net forward 
α2δ-1-bbs trafficking is reduced by Rab11aS25N consistent with reports by Tran-
Van-Minh & Dolphin (2010) for α2δ-2-bbs trafficking. Furthermore, Rab11aS25N 
reduced CaV2.2 forward traffic when α2δ-1 was coexpressed (Fig.5.8). I find no 
difference in net CaV2.2 trafficking rates between conditions expressing “α2δ-1 + 
Rab11aS25N” and “no α2δ” suggesting that – in non-neuronal cell lines - α2δ-1-
enhanced CaV2.2 plasma membrane-insertion is principally driven by Rab11a-
depdendent recycling. In primary hippocampal neurons, I find that CaV2.2 
membrane expression is largely dependent on α2δ, both at the cell soma and 
neuronal processes (Fig.5.5). Under basal conditions, cell-surface CaV2.2 was 
most abundant at the hippocampal processes when paired with α2δ-1, and cell 
soma when paired with α2δ-3. Inhibition of Rab11a-recycling did diminish cell 
surface CaV2.2 at the neurites in the presence of α2δ-1. However, CaV2.2 
expression with α2δ-1 + Rab11aS25N was still significantly higher than in the 
absence of α2δ entirely. As I do not see an effect of Rab11a-inhibition on CaV2.2 
at neuronal cell bodies, it would suggest that CaV2.2 traffic from the soma to 
processes, requires α2δ but through a Rab11a-independent pathway.  
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5.11 Discussion 
Earlier work has shown that α2δ-2 participates in recycling through Rab11a-
positive recycling endosomes and that this pathway appears to be interrupted by 
Gabapentin ( Tran-Van-Minh & Dolphin, 2010). Gabapentinoid drugs - which bind 
to both α2δ-1 and α2δ-2 - inhibit recycling of α2δ-2 through Rab11a-positive 
endosomes thereby reducing forward trafficking and cell-surface expression of 
α2δ-2. α2δ-3 and α2δ-4 do not bind gabapentin and lack an RRR motif - the putative 
GBP binding site - present in the α2 domain of α2δ-1 and α2δ-2. The RRR motif is 
positioned just upstream of the VWA domain in α2. It has been hypothesised that 
gabapentinoids displace an endogenous ligand for the RRR site necessary for 
proper function in α2δ-1 and α2δ-2 (Davies et al., 2006; Hendrich et al., 2008). 
Previous mutational studies using the α2δ-1(R217A) or α2δ-2(R282A) mutants - 
which do not bind Gabapentin – found them to have reduced currents through CaVs 
compared to WT counterparts, as well as reduced endosomal recycling (Davies et 
al., 2006; Field et al., 2006; Hendrich et al., 2008; Tran-Van-Minh & Dolphin, 2010). 
These findings are consistent with the notion that binding of an endogenous ligand 
induces conformational changes to these α2δ – possibly at the VWA domain – 
important for association of α2δ-1 and α2δ-2 with endosomal sorting partners. As 
α2δ-3 lacks a Gabapentin binding site and does not strongly influence CaV2.2 
trafficking in cell lines, I speculated that it does not participate in Rab11a-
dependent recycling and is thereby unable to promote forward trafficking of CaV2.2 
through this pathway. In agreement with this, I find Rab11a-recyling did not 
influence α2δ-3 trafficking and effects on CaV2.2 net forward trafficking was 
observed only in the presence of α2δ-1 or α2δ-2. Presently it is unclear why α2δ-3 
does not participate in Rab11a-dependent recycling. α2δ-3 shares only 25.7% 
sequence homology with α2δ-1 (ClustalO) which may result in conformational 
differences that preclude an interaction with Rab11a or a Rab11a effector. This 
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result could hint at diverging roles among α2δ subtypes in both subcellular CaV 
localisation as well as CaV-independent activity. A number of previous studies have 
provided evidence for α2δ functions independent of direct action of CaVs. An 
example of CaV-independent α2δ function was previously described in Drosophila 
reporting that the α2δ-3 homologue, Straightjacket, promotes the generation of 
synaptic boutons at motor neuron terminals however, depletion of α1 subunits did 
not influence synaptic bouton generation (Kurshan et al., 2009). More recently, it 
was reported that UNC-36, a homologue of α2δ in C. elegans, binds to a synaptic 
adhesion molecule, Neurexin-1, decreasing UNC-36 availability at synaptic 
elements and resulting in a decrease in acetylcholine release at neuromuscular 
junctions (Tong et al., 2017). As part of this study, heterologously expressed 
mammalian Neurexin-1α was shown to selectively bind α2δ-3 and reduce CaV2.2 
currents while having no effect with α2δ-1 or α2δ-2 coexpression. α2δ-1 and α2δ-2 
showed no affinity for Neurexin-1α, presumably due to conformational differences 
with α2δ-3. It is tempting to consider that the VWA domain of α2δ-1/2, augmented 
by the binding of an endogenous ligand at the RRR motif, precludes an interaction 
with Neurexin-1α, although this is yet to be investigated. Surprisingly, a 2018 study 
by Brockhaus et al (2018) found that Neurexin-1α enhanced CaV2.1 currents in 
heterologous systems when expressed with α2δ-1 but had no effect in the presence 
of α2δ-3 (Brockhaus et al., 2018). Tong et al (2017) and Brockhaus et al (2018) 
reach opposing conclusions regarding the subtype specificity of interactions 
between α2δ and Neurexin-1α. However, both studies suggest subtype-dependent 
interplay between α2δ and Neurexin-1α, indicative of distinct functional roles 
among α2δ subtypes.   
Interestingly α2δ-1 has also been reported to enhance synaptogenesis, 
independently of CaV channels, through extracellular interactions between the 
VWA domain of α2δ-1 and Thrombospondins (TSPs). TSPs are multi-domain 
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extracellular matrix proteins typically secreted by astrocytes that perform a range 
of functions including synaptogenesis, in particular promoting the formation of 
silent synapses (Christopherson et al., 2005). In vitro application of Gabapentin 
has been found to reduce TSP-mediated synaptogenesis in cultured retinal 
ganglion neurons while having no effect on established synapses (Eroglu et al., 
2009). The authors propose that Gabapentin allosterically inhibits the interaction 
between neuron-expressed α2δ-1’s VWA domain and Epidermal growth factor 
(EGF)-like repeats of TSPs in co-cultured astrocytes and were able to inhibit TSP-
induced synapse formation through application of antibodies directed against the 
VWA domain of α2δ-1. More recently, a study by Lana et al. (2016) further 
investigated the relationship between α2δs and TSP4, finding an inverse 
correlation between the binding of α2δ-1 to Gabapentin or to TSP4 (Lana et al., 
2016). However, Lana et al (2016) were unable to demonstrate any interaction 
between cell-surface expressed α2δ-1 and TSP4 nor were they able to 
demonstrate the importance of the EGF-like domains of TSP4 in this interaction, 
as has been previously reported, concluding that α2δ-1 and TSP4 may only interact 
intracellularly at high concentrations; It should also be noted that this study was 
carried out using heterologous expression in tsA-201 cells which may lack as-yet-
unknown mediators of the TSP4-α2δ-1 interaction.    
α2δs have been shown to promote exocytosis from presynaptic terminals through 
two distinct mechanisms: enhancing presynaptic CaV expression and increasing 
vesicle release probability (Hoppa et al., 2012). Increases or decreases to α2δ-1 
expression were shown to enhance or reduce presynaptic CaV2.1 respectively in 
primary hippocampal neurons, a result confirmed for α2δ-2 and α2δ-3 (Hoppa et 
al., 2012). The same study found that overexpression of eGFP-tagged CaV2.1 
alone did not increase presynaptic CaV2.1 despite significant increases in somatic 
CaV expression. My data largely agree with Hoppa et al (2012), finding a significant 
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reduction in both total and plasma membrane-inserted CaV2.2 at hippocampal 
neurites in the absence of α2δ coexpression (Fig. 5.6). While I am able to visualise 
neurite CaV2.2 expression without overexpressing α2δ present I must consider that 
my data does not specifically assess presynaptic CaV expression or discount a 
compensatory role for endogenously expressed α2δ. In future work, presynaptic 
markers such as vesicular glutamate transporter (vGlut), could be used to identify 
and quantify presynaptic CaV2.2 expression, while endogenous α2δ could 
potentially be knocked down using shRNAs or CRISPR approaches. 
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Chapter 6 
General discussion and future perspectives 
6.1 Proteolytic α2δ processing 
Proteolytic processing is a well-established post-translational modification present 
in all α2δ subtypes (Dolphin, 2013).  A previous study by Andrade et al (2007) 
alluded to the functional importance of α2δ processing for CaV current 
enhancement. This study mapped the α2δ-1 cleavage site to a hexapeptide 
sequence from R941 and V946 (Andrade et al., 2007). Point mutations at the 
cleavage site of α2δ-1 were sufficient to reduce, but not abolish whole-cell CaV2.2 
current enhancement (Andrade et al., 2007). In addition, mutation of the entire 
hexapeptide sequence was required to abolish cleavage entirely (Andrade et al., 
2007). Subsequent studies by the Dolphin lab have partially agreed with Andrade 
et al (2007) requiring a 6-peptide mutation to entirely abolish cleavage of α2δ-1 
(Ferron et al., 2018; Kadurin et al., 2016). Interestingly, the cleavage-insensitive 
α2δ mutants generated by the Dolphin lab exhibit a complete loss of CaV current-
enhancement not previously reported (Kadurin et al., 2016). The discrepancy 
between older and more recent studies on α2δ processing may reflect subtle 
differences in the exact position of the hexapeptide mutation: K943 to M948 in 
Kadurin et al., R941 to V946 in Andrade et al (2007) but may also relate to the 
coexpression of auxiliary β1b in contemporary studies rather than β3 previously. 
The requirement of a 6-residue mutation to completely abolish α2δ-1 cleavage 
suggests the cleavage site is rather robust, possibly due to redundancy among the 
protease(s) responsible. Furthermore, the difficultly of inhibiting α2δ cleavage 
presents a challenge for any future attempts to design small molecule modulators 
of this process either as a potential therapy or molecular tool. 
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In chapter 3, the behaviour of proteolytically-insensitive α2δ was examined in 
heterologous expression systems complementing parallel work in primary neuronal 
cultures (Kadurin et al., 2016). Comparing α2δ behaviour in neuronal or non-
neuronal cells reveals a context-dependent effect of α2δ proteolysis. When 
expressed in non-neuronal cell lines, unprocessed α2(3C)δ mutants display no 
defects in their ability to enhance cell-surface CaV2.2 expression, however, they 
are unable to enhance whole-cell CaV conductance despite increasing the total 
number of plasma membrane-inserted CaV channels (Kadurin et al., 2016). On this 
evidence, one might conclude that “pro-α2δ” acts as an inhibitor of CaV 
conductance while retaining its role as a facilitator of CaV transport. However, 
examining the function of pro-α2δ mutants in primary hippocampal neurons reveals 
a clear proteolysis-dependent effect on CaV trafficking to the neurites (Kadurin et 
al., 2016). CaV2.2 appears to be largely unable to exit the neuronal soma in the 
absence of proteolytically processed α2δ and coexpression of α2(3C)δ mutants 
does not significantly increase CaV2.2 neurite expression (Kadurin et al., 2016). 
However, coexpression of 3C-protease with α2(3C)δ is sufficient to rescue neurite 
CaV2.2 expression (Kadurin et al., 2016). Interestingly, uncleaved α2(3C)δ itself 
does not exhibit defects in neuronal trafficking when expressed alone, suggesting 
that the conformation of the immature α2δ-CaV2.2 complex precludes efficient 
trafficking to the neurites (Kadurin et al., 2016). Importantly, in both neuronal and 
non-neuronal cells, induced cleavage of α2(3C)δ constructs with 3C-protease 
rescues normal α2δ function. This is shown by enhanced whole-cell CaV2.2 
currents (tsA-201 cells) and increased neurite CaV2.2 expression (primary 
hippocampal neurons) (Kadurin et al., 2016). 
As discussed earlier, α2(3C)δ retains the ability to promote cell-surface CaV2.2 
expression in cell lines despite being unable to enhance whole-cell CaV2.2 
currents. This may indicate that unprocessed α2δ suppresses channel activation. 
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Recently, Savalli et al (2016) utilised voltage-clamp fluorometry to track the 
activation of the four voltage-sensor domains of CaV1.2 expressed with β3 in the 
presence or absence of α2δ-1. This study found that the voltage-dependence of 
the channel had a rightward shift in the absence of α2δ-1 such that currents would 
generally develop at non-physiological membrane potentials (Savalli et al., 2016). 
The authors attribute the positive shift in voltage-dependence to weak VSD-pore 
interactions in the absence of α2δ. In the presence of α2δ-1, the voltage-sensitivity 
of VSDI-III was increased thereby facilitating channel activation (Savalli et al., 
2016). As unprocessed α2(3C)δ does not enhance channel activation, it is possible 
that pro-α2δ might stabilise the down-state of the VSDs, thereby reducing the 
voltage-sensitivity of the channel. In principle, this could be investigated using the 
techniques employed by Savalli et al (2016) on CaV channels coexpressed with 
the uncleaved α2(3C)δ mutants developed by the Dolphin lab.   
The importance of Ca2+ as a modulator of numerous physiological functions 
necessitates extremely tight regulation of intracellular [Ca2+]. As such, it is tempting 
to consider that proteolytic maturation of α2δ subunits offers temporal VGCC 
regulation whereby “pro-α2δ” inhibits channel activity prior to appropriate 
subcellular localisation.  As discussed in Chapter 3, the ER is a principal Ca2+ store 
with a basal membrane potential close to 0 mV (Solovyova & Verkhratsky, 2002). 
At 0 mV, one might expect nascent VGCCs to adopt an open conformation, 
potentially facilitating the flow of Ca2+ from ER to cytosol. It is possible that pro-α2δ 
prevents this outcome by inhibiting the channel prior to exit from the ER.  
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6.2 Ca2+-binding sites in the VGCC selectivity filter 
The selectivity filter of VGCCs is thought to be comprised of three sequential Ca2+ 
binding sites (Tang et al., 2014; Wu et al., 2016). The second Ca2+ binding site 
(site 2) is formed by four P-loop glutamate residues, with each domain repeat 
contributing one glutamate residue (see Chapter 4, Fig 4.1). Previous studies have 
introduced point mutations to the P-loop CaV glutamates, with concurrent mutation 
of all four residues apparently sufficient to abolish Ca2+ permeability (Ellinor et al., 
1995; Yang et al., 1993). Indeed, Cao et al (2004, 2010) utilised CaV2.1 and CaV2.2 
mutants featuring four P-loop E to A substitutions as a dominant negative channel 
(Cao et al., 2004; Cao & Tsien, 2010). Previously, P-loop CaV mutants were 
believed to be well expressed at the plasma membrane owing to the presence of 
a large outward current (Cao et al., 2004). However, direct quantification of plasma 
membrane CaV populations has been lacking due to the difficulty of exofacially 
tagging these channels without disrupting channel function. In chapter 4, I present 
data quantifying the plasma membrane expression of exofacially HA-tagged 
CaV2.2 P-loop glutamate mutants in both neuronal and non-neuronal cell types. 
Relative to WT CaV2.2, plasma membrane expression was diminished for all P-
loop mutants tested. Of particular note, the introduction of a single E to K 
substitution in the IV repeat domain of CaV2.2 produced an 88% reduction in cell-
surface expression relative to WT, while total CaV2.2 expression (measured by II-
III loop staining) was found to be 2-fold higher than WT. This result could suggest 
that EIVK CaV2.2 is unable to efficiently exit either the ER or Golgi network to reach 
the plasma membrane. Intracellular retention of CaV2.2 could be indicative of 
significant protein misfolding, however, in such an event, one might expect the 
construct to be targeted for ubiquitination and subsequent degradation. Given that 
DIV E-K CaV2.2 exhibited far higher total expression that WT, it seems unlikely to 
be subject to extensive proteolytic degradation. It is clear however, that mutation 
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of a single P-loop glutamate residue can be sufficient to substantially alter the 
trafficking behaviour of the channel, something not considered in previous studies. 
I next compared the plasma membrane expression of two additional P-loop CaV2.2 
mutants featuring E to A substitutions; DI E-A and DI,II,III,IV E-A CaV2.2 which 
exhibited partial or complete loss of inward current respectively (data unpublished). 
Importantly, these constructs do exhibit a large outward current, consistent with 
previous studies (Cao and Tsien, 2010). When compared to WT CaV2.2, cell-
surface expression was reduced for both E to A mutants (EIA 49%, EI,II,III,IVA 61%) 
in N2a cells when expressed with auxiliary α2δ-1 and β1b subunits. Cell-surface 
expression of either E to A CaV2.2 pore mutants did not appear to be diminished 
to the extent seen for EIVK CaV2.2. In addition, the difference in cell-surface 
expression between EIA and EI,II,III,IVA CaV2.2 was subtle, despite EI,II,III,IVA CaV2.2 
possessing more mutations. With these data in mind, it seems unlikely that the 
reduced plasma membrane expression of P-loop CaV2.2 mutants is solely due to 
a loss of channel permeation. Previous reports, supported in the present study, 
suggest that α2δ-1 coexpression with CaV2.2 increases plasma membrane CaV2.2 
by approximately 2-fold (Cassidy et al., 2014). I considered the possibility that E to 
A P-loop CaV2.2 mutants might be unable to interact normally with α2δ-1, reducing 
the α2δ-1-mediated increase cell-surface CaV2.2 expression. However, I find that 
both WT and E to A P-loop CaV2.2 mutants display comparable reductions in cell-
surface expression in the absence of α2δ-1. These data would seem to indicate 
that the relationship between CaV2.2 and α2δ-1 is unaffected by mutations to P-
loop glutamates insofar as this relates to channel trafficking. I next considered that 
P-loop CaV2.2 mutants may in fact be deficient in their interaction with auxiliary β 
subunits. I compared the cell-surface expression of WT, EIA and EI,II,III,IIIIA CaV2.2 
in the presence or absence of β1b. I find that cell-surface expression of WT, EIA 
and EI,II,III,IIIIA CaV2.2 is reduced in the absence of β1b, however the relative 
decrease in cell-surface expression was greater for WT CaV2.2 than either P-loop 
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mutant. β subunits have a well-defined role in promoting correct folding of CaV2.2 
as well preventing polyubiquitination and proteasomal degradation of CaV2.2 
allowing exit from the ER (Waithe et al., 2011).  I examined whether intracellular 
CaV2.2 expression of WT and EI,II,III,IIIIA CaV2.2 was comparable in the absence of 
β1b by immunostaining the extracellular HA-tag present on my CaV2.2 constructs, 
prior to permeabilisation and immunostaining for intracellular HA-tag expression. 
This method allowed me to distinguish and quantify cell-surface and intracellular 
CaV2.2-HA populations. In the absence of β1b, I find relative cell-surface and 
intracellular expression of EI,II,III,IVA CaV2.2 to be higher relative than WT CaV2.2.  It 
is not immediately apparent why mutations to P-loop glutamates would influence 
the relationship between CaV2.2 and β1b. A possible consideration is that Ca2+ 
binding to sites within the selectivity filter is important in facilitating structural 
rearrangements in the channel, potentially affecting the interaction with β1b. If so, 
one might expect reduced cell-surface expression of P-loop glutamate mutants and 
higher levels of intracellular retention, something observed for both EI,II,III,IVA and 
previously with EIK CaV2.2. 
Structural rearrangements of α1 upon β subunit binding are thought to extend from 
I-II linker to S6 of domain I (IS6). 22 residues bridge the gap between the C-
terminal cytoplasmic end of IS6 and the N-terminal end of the AID α-helix, referred 
to at the AID-IS6 linker (Opatowsky et al., 2004; Van Petegem et al., 2004). 
Findeisen & Minor (2009) have argued that the CaVβ and IS6-AID linker strongly 
influence CDI, VDI and CDF properties of the α1 subunit. The residues of IS6-AID 
linker denote a high α-helix propensity; α-helix formation of the AID sequence 
(upon β binding) is likely to induce helix formation in the IS6-AID linker. Mutational 
studies of the IS6-AID linker, featuring a mid-sequence GGG insertion to prevent 
putative helix formation, suggest that α-helix rearrangement is required for IS6-AID 
linker-mediated effects on VDI (Findeisen & Minor, 2009). Given the proximity of 
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IS6 to the pore, and its involvement in VDI, it is possible that structural changes to 
the IS6-AID linker upon β subunit binding are involved in correct folding of the 
channel pore. 
It has been demonstrated that trafficking regulation of CaV2.2 can vary 
considerably when expressed in a neuronal or non-neuronal context (Kadurin et 
al., 2016). It was necessary to determine whether P-loop CaV2.2 mutants have 
reduced cell-surface expression in primary neurons, consistent with my 
observations in N2a cells (Fig 4.2B, Chapter 4). In non-permeabilised hippocampal 
neurons EIA and EI,II,III,IVA CaV2.2 exhibit reduced cell-surface neurite expression 
relative to WT CaV2.2, when expressed with α2δ-1 and β1b subunits (Fig 4.3.1B). 
In the absence of α2δ, cell-surface neurite CaV2.2 expression was reduced by 
~60% for WT and P-loop E-A CaV2.2 mutants (Fig 4.3.1B, Chapter 4). I then 
repeated this assay under permeabilised conditions to compare total neurite 
expression of WT, EIA and EI,II,III,IVA CaV2.2. I find that total neurite expression of 
EIA and EI,II,III,IVA CaV2.2 is ~50% lower than WT CaV2.2 (Fig 4.3.2, Chapter 4). 
These data suggest that both E-A CaV2.2 P-loop mutants have reduced trafficking 
to the neurites with a commensurate reduction in neurite cell-surface expression.   
As mentioned earlier, the four P-loop glutamates are conserved in all members of 
the VGCC family, which along with other residues in the P1 and P2 helices, form 
three Ca2+ binding sites. Structure function studies by Tang et al (2014) using the 
mutant channel CaVAb suggest that the middle site has the highest Ca2+ affinity 
and provides the molecular basis for divalent cation block (Tang et al., 2014). Site 
2 is likely to be constitutively bound to Ca2+ and this may contribute to the stability 
of structural features within the channel that influence its interactions with other 
binding partners. However, as there is no current structural information for VGCCs 
lacking these high affinity Ca2+ binding sites, it is difficult to speculate further on 
this point. The present findings do suggest that extreme care should be taken when 
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using P-loop CaV mutants as a model for non-conducting or even dominant 
negative channels. In particular, previous interpretations of P-loop mutants as 
lacking Ca2+ conductance may be difficult to interpret due to the likelihood of 
diminished cell-surface expression (Cao et al., 2004).  
 
6.3 Distinct trafficking mechanisms among α2δ subtypes    
All α2δ subtypes have been shown to enhance whole-cell CaV currents in a number 
of heterologous expression systems (Gurnett et al., 1997; Liu et al., 1996; 
Wakamori et al., 1999). The ability of α2δs to enhance whole-cell CaV currents has 
often been attributed to an α2δ-mediated increase in cell-surface CaV expression 
of the α1 subunit. In chapter 5, I examined whether cell-surface CaV2.2 was similarly 
enhanced when expressed with different α2δ subtypes. I found that α2δ-1 
coexpression produced a 2-fold increase in cell-surface CaV2.2 consistent with 
previous reports, as well as a ~50% increase in total CaV2.2 expression (Cassidy 
et al., 2014). Somewhat surprisingly, coexpression of α2δ-3 produced only a ~30% 
increase in cell-surface CaV2.2 expression despite a ~50% increase in total CaV2.2 
expression comparable to the effect of α2δ-1. These data indicate that α2δs are 
unequal in their ability to enhance cell-surface CaV2.2 expression, but also 
suggests that increases in cell-surface CaV2.2 expression are not solely due to an 
increase in total CaV2.2 per cell, as this would have likely produced similar results 
for both α2δ-1 and α2δ-3, something I did not observe. Previously, α2δ-1 has been 
reported to increase stability of the ternary CaV1.2/β3 complex, demonstrated by a 
reduced rate of degradation upon arrest of protein synthesis (Bourdin et al., 2015). 
This increased stability of the CaV complex may be a general feature of integrating 
α2δ subunits into the channel complex, independent of an additional role for α2δ in 
channel trafficking. 
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The development of exofacially-tagged CaV2.2 by Cassidy et al (2014) allowed for 
the first direct insight into how α2δ-1 influences the trafficking of CaV2.2. Cassidy 
et al (2014) found that α2δ-1 increased cell-surface CaV2.2 expression but found 
no difference in the rate of CaV2.2 endocytosis between conditions expressing or 
lacking α2δ (Cassidy et al., 2014). With these data in mind, I used an α-BTX live-
labelling assay to compare the net forward trafficking of CaV2.2 when expressed in 
N2a cells with β1b and either α2δ-1, α2δ-2, α2δ-3 or no α2δ. I found that 
coexpression of α2δ-1 or α2δ-2 considerably increased net forward CaV2.2 
trafficking. However, the rate of CaV2.2 trafficking was not significantly different 
when expressed with either α2δ-3 or without α2δ.   
Previously, Tran Van Minh & Dolphin (2010) provided compelling evidence that 
α2δ-2 cell-surface expression is enhanced through recycling from Rab11a-positive 
recycling endosomes (Tran-Van-Minh & Dolphin, 2010). Indeed, the antiepileptic 
drug Gabapentin was shown to reduce cell-surface α2δ-2 expression by inhibiting 
Rab11a-dependent recycling (Tran-Van-Minh & Dolphin, 2010). α2δ-1 and α2δ-2 
possess a Gabapentin binding site in the α2 domain, absent in α2δ-3 and α2δ-4. I 
considered the possibility that α2δ-1 and α2δ-2 facilitate Rab11a-dependent 
recycling of CaV2.2 whereas α2δ-3 – and possibly α2δ-4 – cannot. To confirm 
whether Rab11a-recycling is conserved among α2δ subtypes, I compared steady-
state cell-surface expression of α2δ-1 and α2δ-3 in the presence or absence of 
Rab11aS25N, a dominant negative mutant. I found that α2δ-1 cell-surface 
expression is reduced when expressed with Rab11aS25N, while α2δ-3 appears to 
be unaffected. Following this I compared cell-surface CaV2.2 expression when 
paired with either α2δ-1, α2δ-2, α2δ-3 or no α2δ in the presence or absence of 
Rab11aS25N. Consistent with my hypothesis, Rab11aS25N reduced cell-surface 
CaV2.2 expression only when paired with α2δ-1 or α2δ-2. Rab11aS25N had no 
effect on CaV2.2 levels in the absence of α2δ or with α2δ-3 coexpression. These 
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data were consistent in undifferentiated N2a cells as well as at the processes of 
primary hippocampal neurons. Interestingly, I found no effect of Rab11aS25N at 
the hippocampal soma which could suggest a small or absent role for Rab11a-
dependent recycling at the neuronal cell body. As proof of principle, I compared 
whole-cell Ba2+ currents in tsA-201 cells expressing CaV2.2, β1b and either α2δ-1 
or α2δ-3 in the presence or absence of Rab11aS25N. Whole-cell currents were 
reduced by Rab11aS25N coexpression only when paired with α2δ-1 suggesting a 
loss of functional cell-surface CaV2.2. To confirm that Rab11aS25N was inhibiting 
the recycling of α2δ-1/CaV2.2, I used α-BTX live-labelling to compare the net 
forward trafficking of bbs-tagged α2δ-1 with or without Rab11aS25N. I also 
compared net forward trafficking of bbs-tagged CaV2.2 when expressed with α2δ-
1 or no α2δ in the presence or absence of Rab11aS25N. I found that net forward 
trafficking of α2δ-1-bbs is reduced by Rab11aS25N, while net forward CaV2.2 
trafficking is reduced by Rab11aS25N only when α2δ-1 is present. Together, these 
data suggest that α2δ-1 and α2δ-2 enhance forward trafficking of CaV2.2 by 
allowing the channel to participate in Rab11a-dependent recycling. 
α2δ-3 was not found to enhance net forward trafficking of CaV2.2, although it did 
produce a consistent increase in steady state cell-surface CaV2.2 (20-30%) and 
total CaV2.2 expression (~50%) when compared to “no α2δ” in cell lines. It is 
possible that α2δ-3 reduces the rate of CaV2.2 internalisation, which would increase 
the plasma membrane CaV2.2 population. However, the live-labelling assay used 
in this study assesses “net” forward traffic and should account for significant 
changes in rate of endocytosis.  
In Chapter 5, I have provided evidence that α2δ subtypes have a differential 
influence on the trafficking of CaV2.2 resulting in α2δ-subtype specific changes to 
plasma membrane CaV2.2 expression. Rab11a-dependent recycling of CaV2.2 
appears to be dependent on coexpression of the appropriate α2δ subtype. 
162 
 
However, it is unclear what the major distinguishing biophysical characteristics 
between α2δ subtypes are. As mentioned previously, α2δ-1 and α2δ-2 possess a 
Gabapentin-binding site (RRR motif) in the α2 domain, absent in α2δ-3 and α2δ-4. 
Occupation of the RRR motif by Gabapentin was shown to be sufficient to abolish 
Rab11a-dependent recycling of α2δ-2 (Tran-Van-Minh & Dolphin, 2010). The RRR 
motif of α2δ-1 and α2δ-2 is positioned just upstream of the VWA domain and 
Gabapentin has been proposed to displace the binding of an endogenous ligand, 
leading to conformational changes in the α2δ structure (Brown et al.,1998; Gee et 
al., 1996), possibly in the VWA domain, that impede protein-protein interactions 
involved in intracellular trafficking. It would be interesting to examine whether the 
introduction of a complete RRR motif equivalently positioned in α2δ-3 would impart 
Rab11a-dependent recycling on both itself and coexpressed CaV2.2. If so, one 
could reasonably expect Gabapentin to obstruct α2δ-3 recycling. The size and 
extensive glycosylation of α2δ proteins is poorly suited to structural studies utilising 
crystallographic or NMR-based methods, however structural comparisons 
between WT and RRR mutated α2δ-1 variants, using cryoEM might shed some 
light on the features involved with participation in Rab11a-dependent recycling in 
the future. 
The Low-density Lipoprotein Receptor-related Protein 1 (LRP1) is a large 
multifunctional endocytic receptor belonging to the LRP receptor family. In vitro 
experiments in tsA-201 cells have shown that LRP1 binds to α2δ-1 and, when 
coexpressed with the ER chaperone Receptor-Associated Protein (RAP), 
increases the cell-surface expression of α2δ-1 (Kadurin et al., 2017). In addition, 
LRP1/RAP increases cell-surface expression of CaV2.2 in an α2δ-1-dependent 
manner. Recently, LRP1 was identified as a direct binding partner of β1-integrin, 
promoting endocytosis but also directing the complex toward Rab11-positive 
recycling endosomes (Theret et al., 2017). It is possible that conformational 
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differences between α2δ-1 and α2δ-3 allow for the selective binding and direction 
of α2δ-1 by LRP1 towards the Rab11-dependent recycling pathway. 
Comparing cell-surface and total levels of CaV2.2 expressed in cell lines with or 
without α2δ, I found that total CaV2.2 – measured through II-III loop epitope 
expression - was 40-50% lower in the absence of α2δ. Both α2δ-1 and α2δ-3 
produce a similar increase in total CaV2.2 expression, despite significant 
differences observed at the cell surface. It is possible that the discrepancy in cell 
surface CaV2.2 expression reflects distinct endosomal sorting pathways between 
these conditions. Upon endocytosis of plasma membrane proteins to the early 
endosome, cargo is initially segregated between entry to the lysosomal pathway 
for degradation, recycling pathways or retrograde transport to the trans-Golgi 
network (TGN). Sorting Nexins (SNXs), which are typically localised to the early 
endosome are heavily involved in cargo sorting, with SNX17 and SNX27 reportedly 
involved in retrieving cargo destined for lysosomal degradation (Steinberg et al., 
2012).  It may be that CaV channels are normally targeted for lysosomal 
degradation upon arrival at the early endosome with α2δ subunits interacting 
directly or indirectly with SNX proteins to direct CaVs away from the lysosomal 
pathway. If so, one would expect expression levels of CaV2.2 in the absence of α2δ 
subunits to be reduced, which was observed in the present study. 
Net forward CaV2.2 trafficking rates were not significantly different in the presence 
or absence of α2δ-3. This would seem to suggest that α2δ-3 does not alter forward 
trafficking pathways to which CaV2.2 is targeted. The CaV2.2/α2δ-3 complex does 
not appear to be targeted for Rab11-dependent recycling and total CaV2.2 
expression was found to be similarly elevated by coexpression of either α2δ-1 or 
α2δ-3. This suggests that internalised α2δ-3 or the α2δ-3/CaV2.2 complex is not 
expressly targeted for either lysosomal degradation or towards rab11a-dependent 
recycling pathways. An interesting possibility is that internalised α2δ-3 or α2δ-3/CaV 
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complexes undergo retrograde transport to the TGN from which they might re-enter 
the secretory pathway. Sorting from the early endosome to the TGN is heavily 
mediated by the multi-protein Retromer complex (Seaman, 2012). Retromer itself 
is recruited to early endosomes by Rab7 and it would be interesting to see whether 
mutations to Rab7, such as the dominant negative T22N mutant would differentially 
affect α2δ trafficking (Wandinger-Ness & Zerial, 2014). 
It has previously been shown that both α2δs expressed in cell lines and native α2δs, 
concentrate in cholesterol rich plasma membrane regions (DRMs/lipid rafts) 
(Kadurin et al., 2012). It is possible that α2δs might increase the capacity of the 
plasma membrane for CaV channels by increasing the number of membrane 
regions to which CaVs can localise. This could explain how α2δ-3 increases 
plasma-membrane CaV2.2 expression without influencing net-forward trafficking. 
This concept could potentially be investigated using cholesterol-depleting agents 
such as β-cyclodextrin on cell lines expressing exofacially-tagged CaV2.2 with and 
without α2δ-3 (Mahammad & Parmryd, 2015). An alternative explanation for the 
elevation of total CaV2.2 with α2δ coexpression, is that inclusion of α2δ to the CaV 
complex increases stability of the structure making it less prone to misfolding and 
proteolytic degradation. It may be possible to investigate this by comparing the 
degree of colocalisation between CaV channels and lysosomal or proteasomal 
markers in the presence or absence of α2δ subunits.  
 
6.4 Considerations and critique of experimental approach 
6.4.1 Overexpression systems 
The work presented here uses several overexpression systems to study the 
behaviour of CaV2.2 and the associated subunits. Overexpression is often 
necessary for fluorescence imaging due to the high expression requirement for 
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data acquisition. However, a number of caveats must be considered when 
interpreting data that relies on this approach. Principally, excessive protein 
expression in a given cell often results in aberrant protein localisation, likely due to 
overloading of endogenous trafficking mechanisms. Further to this, the trafficking 
of endogenous proteins might be hindered by competing overexpressed proteins. 
In addition, it may be difficult to interpret the secondary effects that a given 
overexpressed protein will exert on other cellular pathways, particularly when 
localised to unintended subcellular regions. A final consideration, particularly for 
fluorescence imaging, is signal saturation as a result of excessive protein 
expression. Measurements obtained from a saturated fluorescence signal will 
invariably underestimate the total fluorescence output. In turn, estimates of relative 
expression between proteins of interest will be skewed, with fluorescence from 
saturating proteins being underrepresented relative to non-saturating counterparts. 
To reduce the effect of signal saturation on confocal imaging experiments, laser 
power, pixel dwell times and gain settings were optimised to reduce saturation 
while maintaining an adequate signal-to-noise ratio during data acquisition. 
Thereafter individual cells that express saturating fluorescence signal, either at the 
cell surface or intracellularly, were excluded from analysis. While specific confocal 
settings may vary between experimental repeats, they are consistent for conditions 
in a single experiment and must be normalised to appropriate internal controls 
before data are pooled from experimental repeats. 
 
6.4.2 Experimental diversity 
In the present study, protein expression and localisation were principally 
determined using immunocytochemistry and confocal microscopy. While this 
method offers a significant body of information regarding these processes, this 
study acknowledges that additional methods of validation would improve 
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confidence in the data shown. In particular, western blotting and cell-surface 
biotinylation assays provide comparable insights into cell surface and intracellular 
protein expression using biochemical tools. These assays were used to 
independently validate the confocal data presented in Chapters 2 and 3 (Kadurin 
et al 2016; Meyer et al 2018 (submitted)). However, they have yet to be employed 
for the data presented in Chapter 5 and this will need to be addressed in future 
work.  
 
6.4.3 Single section confocal imaging vs Z-stacks 
 A significant proportion of data presented in the present study uses an 
immunocytochemical approach to label cell surface and intracellular proteins of 
interest, subsequently quantified using confocal microscopy and image analysis. 
Confocal images contain y, x and z planes allowing for three-dimensional image 
construction by amalgamating sequential optical sections along the z axis, known 
as a z-stack. In principle, a z-stack will provide a more complete picture of 
fluorescence distribution across a cell than could be expected from a single optical 
section through a cell. However, to be effective z-stacks must be constituted from 
a large number of narrow optical sections, which is generally inappropriate for 
small and flat cell types such as N2a and tsA-201 cell lines used throughout this 
study. In addition, generating z-stacks, while useful for single cell analysis, is not 
practical when obtaining images from an extremely large cell population, as is the 
case when imaging from cell lines. Doing so would necessitate more specific cell 
selection during imaging acquisition which in turn introduces bias to the data 
acquisition process. The present study attempted to address the concerns of single 
optical section image acquisition by capturing tile scans rather than single field-of-
view images. Through this method, it was possible to make high-throughput 
fluorescence measurements of a large number of cells, thus removing bias in cell 
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selection and reducing the influence of cell-to-cell variance in physical size and 
protein expression. In addition, optical section thickness was adjusted depending 
on the cell type being imaged.  For cell line data acquisition, a 1 µm optical section 
was used with the focal plane of each tile being adjusted to bring the nuclear region 
of cells into focus, in order to improve consistency between imaged cells. With this 
section thickness, a small deviation in the z-plane would result in a significant loss 
of focus and fluorescence signal, suggesting that a large proportion of a cell’s depth 
was acquired. Subsequent analysis excluded all out-of-focus cells acquired in each 
tile scan. Unlike the cell lines used in this study, primary neuronal cultures are 
relatively large with developed neuronal processes often occupying a sizeable 
three-dimensional space. In addition, the number of successfully transfected 
neurons per culture is far lower than can be achieved with cell line expression 
systems. As such, use of z-stacks is more appropriate to this system, and could 
have been employed when acquiring neuronal cell body images which were 
captured at a 63x magnification with 1 µm optical section. For acquisition of 
neuronal processes, the specifications used were a lower 20x magnification and 
4.5 µm optical section. These settings reasonably accommodate the irregular 
structure of neurites. However, higher resolution image reconstitution could have 
been achieved through the use of narrow optical section z-stacks, if seeking more 
detailed intracellular data. 
 
6.4.4 Stages of neuronal development 
Neurons are polarised cells, with distinct somatodendritic and axonal components. 
Maintenance of neuronal polarity is largely dependent on the formation of the 
axonal initial segment (AIS). The AIS is a 10-60 µm region proximal to the axon 
and distal to the axonal hillock, which plays an important role in both action 
potential generation and maintenance of neuronal polarity (Jones and Svitkina, 
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2016; Nelson and Jenkins, 2017). Observations of hippocampal neurons in vitro 
suggest that AIS formation begins with the clustering of AnkyrinG (AnkG) following 
axon specification after 1.5 days in vitro (DIV) (Jones and Svitkina, 2016). After 7 
DIV axons and dendrites progressively mature to form synapses although 
complete maturation of these processes and optimisation of the AIS may continue 
up to 21 DIV (Jones and Svitkina, 2016).  In the present study, primary 
hippocampal neurons were cultured in vitro for 7 days prior to transfection and a 
further 7 days in culture thereafter, before fixation and immunostaining. At the point 
of transfection (DIV 7) the AIS is presumed to be established. As such, axonal 
accumulation of transfected CaV2.2 complexes should be beholden to sorting 
processes at the AIS.  
Prior to AIS formation, it would be surprising if trafficking specificity differed 
significantly among the constructs used, due to the non-distinct nature of neurites 
prior to specification. However, all neuronal experiments were carried out in 
established in vitro cultures, in which cell polarity is achieved. It is difficult to 
speculate as to the specificity of trafficking among constructs used in this study. 
However, CaV2.2/α2δ-3 coexpression did produce greater plasma membrane 
expression at the neuronal soma than CaV2.2/α2δ-1 with an inverse observation at 
the neuronal processes. This may reflect differential cargo sorting at the AIS, 
however further investigation in developing neurons prior to AIS formation would 
be required to determine this.  
 
6.5 Future perspectives  
The present study has highlighted the complexity of the interplay between CaV2.2 
and α2δ subunits. There is now considerable evidence that α2δ subunits generally 
play a key role in facilitating neuronal CaV transport.  However, the nature of the 
CaV- α2δ relationship appears to be heavily dependent on both the subtype pairing 
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and cell type in which they are expressed. In neurons, α2δ subunits appear to be 
necessary for CaV cell-surface expression and trafficking to neurites. However, in 
non-neuronal cell lines, considerable levels of cell-surface CaV expression can be 
achieved in the absence of α2δ. Comparative studies of α2δ behaviour between 
neuronal and non-neuronal expression systems suggest that α2δs have distinct 
mechanisms for regulating CaV trafficking and current enhancement (Kadurin et 
al., 2016). Proteolytic processing of α2δs has been identified as a crucial regulator 
of CaV activity, appearing to influence current enhancement in non-neuronal cell 
lines and channel trafficking in neurons. α2δ-1 upregulation is closely associated 
with onset of neuropathic pain, presumably due to increased presynaptic CaV 
activity, or tighter coupling of Ca2+ entry- to neurotransmitter release. Recent 
studies strongly suggest that unprocessed α2δ is unable to facilitate transport of 
CaV2.2 from soma to neurite (Ferron et al., 2018; Kadurin et al., 2016). 
Identification of the protease(s) involved in α2δ processing could offer a novel 
target(s) for reducing the onset of neuropathic pain following nerve injury. 
However, it is currently unclear whether a single protease carries out this function, 
and whether inhibitors can be developed to target specific α2δ subtypes, to reduce 
the likelihood of off-target effects.  
Investigation into the mechanism of Gabapentin action suggests that Rab11a-
dependent recycling of α2δ-1 and α2δ-2 is interrupted, reducing forward trafficking 
of these α2δs with a commensurate decrease in CaV activity and trafficking. α2δ-3 
appears to traffic independently of Rab11a-recycling although an alternative 
endosomal pathway is yet to be determined. Rab7b has been identified as a 
mediator of endosome-to-TGN trafficking and this pathway can be disrupted by 
expression of the dominant-negative Rab7b T22N (Vonderheit & Helenius, 2005). 
In future studies, a potential role for retrograde trafficking in α2δ-3 behaviour could 
be investigated using α-BTX live-labelling to track the endosomal movement of 
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bbs-tagged α2δs coexpressed with Rab7b T22N or the activating mutant Q67L 
(Bucci et al., 2000). While α2δ-3 is not a target for any current therapies, the 
CACNA2D3 gene has been implicated as a tumour-suppressor in several cancers 
(Wong et al., 2013; Jin et al., 2017). In particular, α2δ-3 appears to be 
downregulated in unfavourable-prognosis neuroblastomas as well as some gastric 
carcinomas (Thorell et al., 2009). Improving our understanding of α2δ-3 behaviour 
may enable the design of specific α2δ-3 modulators either in a therapeutic capacity 
or as molecular tools.    
Current data regarding tissue or cell type specific expression of α2δ remains 
incomplete, largely due to the unavailability of reliable specific antibodies for 
specific subtypes. A notable exception is the extremely restricted expression of 
α2δ-4, present mainly in the retina and endocrine tissues but largely absent in the 
brain  (Wycisk et al., 2006). α2δ-1 appears to be the predominant subtype of the 
peripheral nervous system, with notably high expression in small nociceptive 
DRGs (Newton et al., 2001). Available information from online expression 
databases, such as the human protein atlas, suggest that central protein 
expression of α2δ-1 is highest in neuronal cells of the hippocampus, whereas α2δ-
2 is most prominent in the purkinje cells of the cerebellum as well as the caudate 
nucleus (Human Protein Atlas). α2δ-1 and α2δ-2 are reported to have lower 
expression in the cerebral cortex, with RNA expression of α2δ-3 being notably high 
there.  
Perhaps some insight can be gleaned from the therapeutic potential and side 
effects of gabapentin. While both α2δ-1 and α2δ-2 are binding targets of 
gabapentin, studies in α2δ-2 -/- KO mice as well as the ducky mouse model suggest 
the therapeutic potential of gabapentin – at least in regards to neuropathic pain – 
are mediated by α2δ-1, likely reflecting the dominance of α2δ-1 at peripheral nerve 
terminals (Brodbeck et al., 2002; Donato et al., 2006). Anti-epileptic and anxiolytic 
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properties are also attributed to gabapentin, however the specific targets that 
facilitate these effects are difficult to determine. Indeed, there are recent reports 
that gabapentin directly activates KCNQ3 and KCNQ5 channels, as well as 
reducing currents through HCN4 channels(Tae et al., 2017; Manville and Abbott, 
2018). KCNQ channel activators such as retigabine are effective therapeutics in a 
number of epilepsy models, and it is possible that gabapentin acts similarly in this 
regard (Tatulian et al., 2001). HCN4 channels, while predominantly expressed in 
pace maker regions of the heart, are also present at low levels in several 
hippocampal regions (Tae et al., 2017). HCN4 knockdown in the dorsal 
hippocampus was recently reported to produce anxiety-like behaviour in mice 
further complicating attempts to identify the key facilitators of gabapentin activity 
(Günther et al., 2019). 
 
An aspect of α2δ behaviour that has been gaining attention, is the interplay 
between α2δ subtypes and interacting partners distinct from CaVs, such as α-
neurexins. The importance of these interactions is suggested by the distinct activity 
of α2δs between native tissue and heterologous expression systems. Modulation 
of α2δ activity through additional binding partners offers another layer to the 
regulation of Ca2+ entry and vesicle release at presynaptic terminals. A recent 
study examining the role of α-neurexins in primary hippocampal neurons, 
concluded that α-neurexins influence presynaptic Ca2+ entry through specific 
modulation of α2δ-1 (Brockhaus et al., 2018). Neurexins are large extracellular 
proteins, with 3 distinct genes (NRX1-3) each encoding a longer α form and shorter 
β form. Triple knockout (TKO) of α-Neurexin was found to reduce presynaptic Ca2+ 
entry and evoked-vesicle release in primary hippocampal cultures, which was 
partially rescued by overexpression of NRX1α (Brockhaus et al., 2018). 
Coexpression of NRX1α and α2δ-1 produced even greater Ca2+ entry/vesicle 
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release in TKO models as well as CaV2.1 current-enhancement in heterologous 
expression systems. Interestingly, coexpression of NRX1α with α2δ-3 did not affect 
presynaptic Ca2+ entry or CaV currents in cell lines, indicative of distinct roles 
among α2δ subtypes. Quantum dot imaging of single α2δ proteins in both WT and 
α-Neurexin TKO hippocampal neurons, found that α2δ-1 had increased plasma 
membrane motility in the absence of α-Neurexin while α2δ-3 showed reduced 
motility under the same conditions. That α-Neurexins can exert seemingly opposed 
influence on different α2δ subtypes emphasises the complexity of α2δ-regulation. 
Greater understanding of the interplay between CaVs, auxiliary subunits and the 
increasing number of known regulators will be crucial to understanding normal and 
pathological neuronal function. 
 
6.6 Conclusion 
This study provides evidence that endosomal CaV2.2 trafficking is heavily 
influenced by the specific pairings with α2δ subtypes. Additionally, I find that post-
translational proteolysis of α2δs is an essential regulatory step for normal CaV2.2 
function affecting channel trafficking in neurons and current-enhancement in 
heterologous systems. Further determinants of CaV trafficking remain poorly 
understood, demonstrated by the surprising finding that point mutations to P-loop 
glutamate residues in CaV2.2 produce significant trafficking defects. My findings in 
this study highlight the importance of α2δ subtype distribution in understanding CaV 
behaviour in different cell-types.  
Thank you for reading. 
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